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CHAPTER 
1 
General review 
1.1 Myotonie dystrophy: The clinical 
picture 
Myotonic dystrophy (DM) or Curschmann 
Steinert disease (extensively reviewed by 
Harper 1989) is the most common of adult 
muscular dystrophies, with an incidence of 1 
in 8000. The disorder is slowly progressive 
and autosomal dominant and has a complex 
clinical picture, in which not only voluntary 
muscle, but also other tissues and organs may 
be affected. Based on age at onset and pheno-
typical appearance, DM patients can be clas-
sified into three groups. The first group of 
patients, carriers with late onset myotonic 
dystrophy, have very mild symptoms. Cata-
ract is commonly the only feature. The sec-
ond group comprises patients with adult onset 
or classical DM. Sometimes, this category is 
subdivided in early and late onset forms. 
Apart from the characteristic myotonia and 
muscle weakness and wasting, several ad-
ditional features (that may occur in any com-
bination) can be found in this group, inclu-
ding cardiac conduction defects, mitral valve 
prolapse, atrial fibrillation, or sudden cardiac 
death, smooth muscle impairment in the 
gastrointestinal tract, mental changes, hyper-
somnia, cataract, testicular atrophy and en-
docrine disfunction. The congenital and early 
onset cases of DM constitute the third group 
and show severe hypotonia and facial diple-
gia. Jaw weakness, respiratory and feeding 
difficulties are also seen, and mental retar-
dation becomes evident in most patients that 
survive the neonatal period. 
Frequently, patients with disease severity 
varying from mild to congenital are found 
within one family, with increasing severity 
and earlier age at onset in subsequent genera-
tions (anticipation; Höweler et al. 1989). 
Together with the overrepresentation of non-
manifesting males in the last generation be-
fore expression of the DM phenotype (Brun-
ner et al. 1993a), and the fact that the oc-
currence of congenital DM is (with a few 
exceptions) restricted to maternal transmis-
sion, this renders DM a most peculiar and 
complex genetic disease. These particular 
aspects of DM were not understood prior to 
the identification of the underlying mutation. 
1.2 Cloning of the DM locus 
Early biochemical studies revealed distinct 
changes in membrane systems, when mem-
branes of controls and DM-patients were 
compared (reviewed by Harper 1989). How-
ever, most of these data were inconclusive 
and did not elucidate the primary defect 
underlying DM. Major advances were only 
made when genetic approaches were used to 
identify the gene and gene products involved 
in DM. At the time when the studies for this 
thesis begun, the DM mutation was physically 
and genetically mapped to chromosome seg-
ment 19ql3.3 (Schonk 1991; Smeets 1991). 
Part of this region, flanked by the proximal 
ERCC1-VSSM marker (Smeets et al. 1991) 
and the distal X75b-VSSM marker (Jansen et 
al. 1992a), was cloned in a 700 kbp contig 
formed by overlapping cosmids and yeast 
artificial chromosomes (YACs) (Aslanidis et 
al. 1992; Jansen et al. 1992a; Shutler et al. 
1992). The subsequent search for the gene 
and mutation involved in DM was greatly 
facilitated by the identification of an unstable 
genomic fragment located within the candi-
date region (Aslanidis et al. 1992; Buxton et 
al. 1992; Harley et al. 1992). This fragment 
showed increasing expansion in DM-carriers 
in subsequent generations, but no instability 
in normal individuals. Upon further charac-
terization, the expansion in DM carriers was 
traced back to a (CTG)n trinucleotide repeat 
located in the 3' untranslated region (UTR) of 
a gene expressed predominantly in muscle 
(Brook et al. 1992; Fu et al. 1992; Mahade-
van et al. 1992), which was predicted to 
encode a serine-threonine specific protein 
kinase (Brook et al. 1992; Fu et al. 1992; 
Jansen et al. 1992b). This protein is now 
commonly referred to as DM-protein kinase 
(DM-PK; Jansen et al. 1993; Mahadevan et 
al. 1993; Shaw et al. 1993b) or myotonin 
protein kinase (Fu et al. 1992). 
The DM-PK gene has been cloned for 
both man and mouse and was found to be 
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Figure 1. Genomic organization of the DM locus in mouse and man. The fifteen DM-PK exons are 
depicted as black boxes, the five DMR-N9 exons as open boxes. For the sake of simplicity the genomic 
organization of the human DMR-N9 or 59 gene is depicted as in the mouse. Putative DM-PK transcrip­
tion start sites and poly-adenylation sites [poly(A)] are indicated. The region of human chromosome 19 
containing the last DMR-N9 exon [open box up to the genomic poly(A) stretch], the intergenic region 
and the first DM-PK exon [striated box as described by Mahadevan et al. (1993); black box Shaw et al. 
(1993)] is drawn as a continuum, but may be not much different from the situation in the mouse. 
Putative translation start sites are marked with a directional arrow. Translation stops are indicated (*), as 
well as the location of the (CTG),, repeat in the human DM-PK gene. The mouse DM-PK gene does not 
contain a perfect CTG-repeat, but has a stable - CTGCTGCAGCAGCTG - sequence instead. The 
chromosomal orientations of the human and mouse (putative) clusters are indicated. EMBL accession 
numbers for the mouse DMR-N9 and DM-PK genes: Z38011, Z38012, Z38013 and Z38015. 
highly homologous in these species (86% 
identical ала 90% similar on amino acid 
level). The genomic structure of the DM 
locus in mouse and man is shown in Figure 
1. The gene comprises 15 exons (Fu et al. 
1993; Mahadevan et al. 1993; Shaw et al. 
1993b) and includes several regions which are 
alternatively spliced. The last exon in the 
human gene specifies the 3' UTR and brack­
ets the polymorphic or unstable (CTG)
n
 re­
peat. We can conclude that this sequence 
came up rather recently in evolution as the 3' 
UTR in the mouse gene contains a predeces­
sor sequence - CTGCTGCAGCAGCTG -
which is centred in a stretch of nucleotides 
with rather weak homology to the human 3' 
UTR. In contrast, the actual 3' end and the 
position of the polyadenylation signal is simi­
lar in both genes. 
The situation with respect to the gene's 5' 
end, specifically the location of the first two 
exons of the DM-PK gene remains more 
controversial. The first exon as proposed by 
Fu et al. (1993) in the human gene overlaps 
the first intron and second exon as defined by 
others for both the human and mouse genes 
(Mahadevan et al. 1993; Shaw et al. 1993b). 
The determination of the complete mouse 
DM-PK gene sequence revealed no homology 
between human and mouse sequences in the 
first intron. In addition our group found no 
signs of transcriptional activity in this region 
in the mouse (Jansen et al. unpublished). 
Therefore, we consider the gene structure and 
organization as established by Mahadevan et 
al. (1993), and later confirmed by Shaw et al. 
(1993b), to be the most likely. 
Thus far, the exact location of the trans­
criptional initiation site has not been estab­
lished. Mahadevan et al. (1993) described two 
putative start sites of transcription in the 
human gene, at positions -776 and -756 with 
respect to the putative translation initiation 
codon. If confirmed this would indicate that 
the human DM-PK gene encodes mRNAs 
with an extraordinarily long 5' UTR, that 
includes an unusual poly-adenine stretch 
located approximately 650 bp upstream to the 
AUG start codon. However, these findings 
should be interpreted with caution, as Shaw 
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and coworkers (1993b) described a human 
cDNA that extended up to position -127 as 
their longest clone. An additional argument 
for the 5' UTR to be of "normal size for 
mRNAs" comes from the fact that in the 
segment of 780 bp upstream of the AUG in 
the human mRNA, only the last 280 bp are 
significantly homologous to the mouse se-
quence. Also, in this region there is a bipha-
sic distribution of C/G content (55% C/G in 
the first 500 bp as opposed to 71% in the last 
280 bp) which may be of functional signifi-
cance. Furthermore, our preliminary data in 
mouse apparently position transcriptional 
initiation sites at -143, -134, -124 and -118 
bp (Jansen et al. unpublished). Finally, the 
predicted size of mRNAs with the shorter 5' 
UTRs correlates better with the length ob-
served by Northern blot analysis (3 - 3.3 kb; 
Brook et al. 1992; Jansen et al. 1992b). 
Nevertheless, this evidence is circumstantial 
and we cannot as yet exclude the possibility 
that the DM-PK gene uses alternative promo-
ters. Species differences in the use of trans-
criptional initiation sites may also exist. 
The cloning of the DM locus resulted also 
in the identification of the DMR-N9 or 59 
gene (Jansen et al. 1992b & paragraph 2.5; 
Mahadevan et al. 1993; Shaw et al. 1993b), 
immediately upstream from the DM-PK gene 
(Fig. 1). In the mouse the DM-PK and DMR-
N9 genes are separated by an intergenic 
region with a maximum length of 1077 bp, 
depending on the actual site of transcriptional 
initiation of the DM-PK gene, and the use of 
two polyadenylation signals located 40 bp 
apart in the last exon of the DMR-N9 gene. If 
the initiation of transcription of the DM-PK 
gene occurs at positions -776/-756 (Mahade-
van et al. 1993) this would reduce the inter-
genic region to approximately 600 bp, which 
is unusually short. Moreover, DMR-N9 trans-
cripts were found that span this entire area 
and terminate at the poly-A tract within the 
putative 5' UTR of the DM-PK gene. Most 
likely, these cDNAs represent readthrough 
mRNAs, as the polyadenylation signals of the 
DMR-N9 gene are quite unusual and may be 
inefficient. Therefore, we should for the time 
being consider the DM-PK and DMR-N9 
genes to be two independent transcription 
units, each with their own characteristic 
features. The DMR-N9 gene comprises five 
exons, encoding a 650 amino acid protein 
with a predicted molecular weight of 68,660 
Da. Data base searches identified two partial 
WD-repeat motifs in the protein (Neer et al. 
1994; van der Voorn and Ploegh 1992). 
These highly conserved repeats are found in 
many different proteins that regulate cellular 
functions. Further clues to the function of the 
gene came from its tissue-specific expression 
pattern. High expression was already found 
ubiquitously in 9.5 days old mouse embryos. 
Later in development, expression remained 
high in the central nervous system. In adult 
mice, highest expression of DMR-N9 was 
detected at distinct locations in the brain and 
at certain stages of spermatocyte maturation 
in the testis, and to a lesser extent in other 
tissues (Jansen et al. 1992b & paragraph 2.5). 
The location of the DMR-N9 gene, very close 
to the expanding CTG repeat, and its ubi-
quitous expression in tissues involved in DM 
raise the distinct possibility that it may be 
involved in the development of mental and 
testicular symptoms of DM in the classical 
and early onset forms of disease. 
1.3 The DM mutation 
With the identification of the unstable 
CTG repeat and its intergenerational expan-
sion in DM families, the controversial phe-
nomenon of anticipation has been explained 
(Harper et al. 1992). Several groups found a 
clear, although not absolute, correlation be-
tween expansion size, severity and age at 
onset of the disease (reviewed by Wieringa 
1994). In the normal population the (CTG)D 
repeat is polymorphic and varies in length 
between 3 (H.J.M. Smeets et al. unpublished) 
or 5 CTGs and 37 repeat units (Brunner et al. 
1992b). Beyond 35 to 40 CTGs the repeat 
becomes prone to instability. The two smal-
lest repeats reported on DM chromosomes are 
35 (Redman et al. 1993) and 41 CTGs (Brun-
ner et al. 1993a), but carriers may have 
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alleles with repeat lengths of up to ISO CTGs 
and remain minimally affected or non-mani­
festing. Classical DM patients carry larger 
repeats, between 150 and 1000 CTGs. The 
largest expansions can be found in congenital 
cases with 500 to over 2000 CTGs, with the 
majority in the 4.5-6 kbp range (1500-2000 
CTGs). There is, however, significant over­
lap between the repeats of these patient 
groups and frequently the DM phenotype fails 
to correlate with CTG expansion as deter­
mined from blood DNA. Therefore, the CTG 
repeat length cannot be used as a reliable 
prognostic criterium for the clinical status of 
patients (Brunner 1993; Harley et al. 1993; 
Novelli et al. 1993a; Thibault et al. 1993; 
Wieringa 1994). 
Thus far, expanding trinucleotide repeats 
have been found to be causally involved in 
eight human genetic disorders: Spinal and 
bulbar muscular atrophy or Kennedy disease 
(SBMA; La Spada et al. 1991), fragile Χ 
syndrome (FRAXA; Fu et al. 1991; Oberlé et 
al. 1991; Verkerk et al. 1991), myotonic 
dystrophy (Brook et al. 1992; Fu et al. 1992; 
Mahadevan et al. 1992), Huntington disease 
(HD; The Huntington's Disease Collaborative 
Research Group 1993), spinocerebellar ataxia 
type 1 (SCA1; Orr et al. 1993), FRAXE 
mental retardation (Knight et al. 1993), den-
tatorubral and pallidoluysian atrophy 
(DRPLA; Koide et al. 1994; Nagafuchi et al. 
1994) and Makado-Joseph disease (MJD; 
Kawaguchi et al. 1994). Furthermore, two 
fragile sites, not associated with a disease 
phenotype, were found to be caused by the 
amplification of trinucleotide repeats, 
FRA16A (Nancarrow et al. 1994) and 
FRAXF (Parrish et al. 1994). Among these 
mutations there are conspicuous differences, 
including the involvement of distinct triplets 
(CTG/CAG in DM, SBMA, SCA1, HD, 
DRPLA and MJD and GCC/CGG in 
FRAXE, FRAXF, FRAXA and FRA16A) 
and the location of repeats in translated 
(SBMA, SCA1, HD, DRPLA, MJD), 5', or 
3' untranslated regions (respectively FRAXA 
and DM). In the case of FRAXE, FRA16A 
and FRAXF thusfar no genes have been iden-
tified that contain the repeat. Also, the extent 
of repeat expansion which is correlated to the 
repeat location, is strikingly different between 
the disorders: Doubling or tripling of the 
repeat in HD, SCA1, SBMA, DRPLA and 
MJD, but huge expansions in DM, FRAXA 
and FRAXE mental retardation, FRA16A and 
FRAXF. Based on the differences between 
the distinct repeats, these diseases may all 
have a different molecular etiology. However, 
as all the repeats show the same threshold 
length of 105-120 bp for a stretch of 35^40 
uninterrupted trinucleotides above which 
extreme instability occurs, the expansion may 
be caused by a common dynamic mutational 
mechanism (Richards and Sutherland 1992). 
1.4 CTG-repeat expansion timing 
An important aspect of the mutational 
mechanism is the timing of the intergenera-
tional repeat expansion. At first, instability 
was thought to occur only, or predominantly, 
during meiosis. However, heterogeneity of 
the repeat length was observed during the 
first detailed genetic analyses of the expan-
ding genomic fragment (Aslanidis et al. 1992; 
Buxton et al. 1992; Harley et al. 1992). This 
phenomenon can be seen not only in blood 
DNA, but also in DNA from several other 
tissues examined from congenital and adult 
DM patients (Jansen et al. 1994; Lavedan et 
al. 1993; Shelboume et al. 1992; Wieringa et 
al. 1992), and must result from mitotic repeat 
instability. In addition, three other groups 
detected repeat length heterogeneity in 23 
patients, with consistently larger repeats in 
skeletal muscle than in peripheral blood (An-
vret et al. 1993; Ashizawa et al. 1993b; 
Thornton et al. 1994). A similar phenomenon 
was described for the HD repeat where the 
largest CAG lengths were found in the af-
fected regions of the brain (Telenius et al. 
1994). These findings suggest that repeat 
instability may be dependent on tissue type or 
gene expression and correlated to the disease 
pathology, but further study is necessary. The 
only firm conclusion that can be drawn is that 
somatic repeat heterogeneity contributes 
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significantly to the variable phenotypic ex-
pression of DM and is a complicating factor 
when determining disease prognosis based 
solely on the repeat length in lymphocytes. 
Mitotic instability of the FRAXA trinu-
cleotide repeat (Devys et al. 1992; Kruyer et 
al. 1994; Nelson and Warren 1993; Wöhrle et 
al. 1992 & 1993) and minisatellite loci in the 
mouse (Gibbs et al. 1991 & 1993; Kelly et al. 
1989) has been proposed to occur predomi-
nantly early in embryogenesis. The finding of 
comparable repeat lengths in different sam-
ples from muscle (Thornton et al. 1994) or 
brain (Jansen et al. 1994), but clearly diver-
gent from the repeat length in the other tis-
sues tested, suggests that in DM such devel-
opmental mechanisms also exist. This asser-
tion was supported by comparisons between 
CTG-repeats in sperm (and blood) of male 
DM patients with mild symptoms and their 
offspring (Jansen et al. 1994). Most remarka-
bly, in several father child pairs no overlap 
could be seen between the repeat length in the 
child and that in the father's sperm (or 
blood). Also in a mutation reversal case the 
child's allele could not be demonstrated in the 
father's sperm (Brunner et al. 1993b). Al-
though in some cases the child's allele can be 
found in the father's sperm (Giordano et al. 
1994; Jansen et al. 1994), these findings 
indeed support the early embryonal expansion 
model mentioned above. Whether or not a 
further contribution to the enhanced instability 
during male gametogenesis (Jansen et al. 
1994; MacDonald et al. 1993) could come 
from meiotic events remains the subject of 
further study. 
1.5 Intergenerational (CTG)„ trans-
mission 
Another feature that might help to eluci-
date the dynamic mutational mechanism, is 
the atypical segregation pattern. All the trinu-
cleotide repeats that have been implicated in 
human genetic diseases show a propensity to 
expand. In DM the chance that the repeat 
(>40 CTGs) will show intergenerational 
enlargement has been estimated to be 93-
94%. The remaining 6-7% show no measura-
ble change in size or a length decrease (re-
viewed in Ashizawa et al. 1993a), including 
the few full mutation reversions that have 
been reported until now (Brunner et al. 
1993b; O'Hoy et al. 1993; Shelboume et al. 
1992). 
Apart from the predominant expansion 
upon intergenerational transmission of the 
repeat, the sex of the transmitting parent is 
important in almost all these disorders. In 
DM, where these effects are particular evi-
dent, it has been shown that the methylation 
status of normal and DM chromosomes is not 
significantly different (Shaw et al. 1993a) and 
that imprinting is not involved in the expres-
sion of the DM-PK mRNA in both mouse and 
man (Jansen et al. 1993). Population genetic 
studies have shown that the sex bias in DM 
transmission is due to differential CTG repeat 
stability upon paternal and maternal transmis-
sion (reviewed by Wieringa 1994). Contrac-
tion of the repeat has been shown to occur 
predominantly upon paternal transmission 
(three to one probability) by Ashizawa et al. 
(1993a). Maternal transmission seems to be 
involved in the formation of very large CTG 
expansions, which explains the restriction of 
congenital DM to maternal transmission 
(Harley et al. 1993; Lavedan et al. 1993; 
Mulley et al. 1993). However, intergenera-
tional expansion of alleles shorter than 100 
CTGs is more marked upon paternal trans-
mission. This observation would explain the 
overrepresentation of nonmanifesting males in 
the generation before phenotypic expression 
becomes evident (Brunner et al. 1993a). 
Enhanced instability of repeats upon male 
transmission has also been reported for anon-
ymous minisatellite elements in mice and man 
(Gibbs et al. 1991; Jeffreys et al. 1987 & 
1988; Vergnaud et al. 1991; Weber and 
Wong 1993) and for the trinucleotide repeats 
in SBMA, HD, SCA1 and DRPLA (Biancala 
et al. 1992; Chung et al. 1993; Koide et al. 
1994; La Spada et al. 1991; Nagafuchi et al. 
1994; Telenius et al. 1994; The Huntington's 
Disease Collaborative Research Group 1993). 
We have hypothesized (Jansen et al. 1994) 
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that this may reflect the fact that a larger 
number of cell divisions are involved in male 
gametogenesis than in oogenesis. In females 
the ovum to ovum sequence involves 30 cell 
divisions, whereas spermatogenesis takes 
between 50 and several hundred divisions 
during the effective fertile life span (Edwards 
1989). 
The most simple model to explain the 
absence of extreme repeat expansion during 
paternal transmission is that selection against 
very long repeats occurs during spermatogen-
esis. This results in the absence of large 
alleles in paternal gametes, as has recently 
been shown in DM and FRAXA patients. In 
nine severely affected DM males with >. 700 
CTGs in blood, similar or smaller repeats 
were found in sperm, but larger signals were 
completely absent (Jansen et al. 1994). Re-
peats longer than approximately one thousand 
CTGs could not be detected in these sperm 
samples. In FRAXA only small repeats were 
found in sperm of patients with large repeat 
expansions in blood. This was interpreted as 
evidence for a selective dormancy of premu-
tated alleles in germ cells (Reyniers et al. 
1993). However, transmission of long repeats 
may be blocked at some point in spermato-
genesis (or embryonic divisions in germ line 
cells before spermatogenesis) with a more 
stringent barrier for larger alleles in FRAXA 
than in DM. This selection process could 
involve delayed replication of expanded re-
peats (Hansen et al. 1993). The testicular 
pathology seen in both diseases (macroor-
chidism of FRAXA males and testicular 
atrophy in adult-onset DM males) and altered 
expression in testis of the gene(s) involved, 
FMR1 in FRAXA (Bächner et al. 1993) and 
DMR-N9 in DM (Jansen et al. paragraph 
2.5), may also have something to do with this 
process. 
In summary, intergenerational repeat 
segregation results predominantly in repeat 
expansion, which occurs at a higher rate upon 
paternal transmission. These findings explain 
both anticipation and the overrepresentation 
of nonmanifesting males in the generation 
preceding the appearance of the phenotype. 
An unknown barrier in male gametogenesis 
may limit the excessive expansion of allele 
lengths preventing paternal transmission from 
congenital DM. It is of note, however, that 
this male restriction is not absolute, as three 
paternal congenital cases have recently been 
described (Bergoffen et al. 1994; Nakagawa 
et al. 1994; Ohya et al. 1994). With the 
proposition of early embryonic mitotic repeat 
instability, instead of meiotic expansion, one 
would indeed expect such occasional con-
genital DM patients of paternal origin to 
result from rare cases of extreme expansion 
during somatic cell divisions in early develop-
ment. Finally, it should be mentioned that no 
experiments have been conducted to deter-
mine the absence of a selection process a-
gainst large repeats in oogenesis, which is 
necessary to support this explanation of the 
sex bias. 
1.6 Dynamic mutations 
Extension of a trinucleotide repeat beyond 
a threshold of approximately 35-40 uninter-
rupted repeat units results in extreme instabi-
lity in all known dynamic mutations. How-
ever, there must also be instability of "nor-
mal" alleles, in order to generate new (pre)-
mutations. As the severe forms of these dis-
eases diminish or abolish reproductive fitness, 
these would ultimately lead to the elimination 
of the disease (de Die-Smulders et al. 1994). 
Several findings and theories may explain the 
instability of trinucleotide repeats, both below 
and above the critical length: 
(I) Computer simulations for the HD repeat 
suggest that the mutation frequency of CAG 
alleles increases as allele lengths increase, 
predicting a four times greater probability of 
gain rather than loss of a single allele unit 
(Rubinsztein et al. 1994). Zhang et al. (1994) 
also reported an increased mutation rate in 
alleles with larger CAG repeats in single 
sperm typing of SBMA patients, but found 
contractions to outnumber expansions. Wheth-
er this tendency to contract is specific for 
SBMA remains to be clarified. 
(II) Apart from repeat length, "purity" of the 
13 
motif is also an important parameter. Imper­
fect repeats appear to be quite stable (Eichler 
et al. 1994; Kunst and Warren 1994; Leef-
lang and Amheim 1995), and are often found 
in normal alleles in SCA1 (Chung et al. 
1993). The expanding alleles in this disease 
contain only "pure" CAG repeats. 
(Ш) The implication of founder chromosomes 
in FRAXA (Richards et al. 1992), HD (The 
Huntington's Disease Collaborative Research 
Group 1993) and DM (Imbert et al. 1993), 
suggests that each of these diseases originate 
from one or only a few predecessors predis­
posed to expansion. Imbert et al. (1993) 
showed that DM-PK alleles with 19 to 30 
CTGs originate from certain (CTG)j alleles 
via a single mutagenic jump. They suggest 
that the (CTG)i9_M repeats constitute a reser­
voir for "new" DM mutations. What pre­
disposes certain (CTG)s alleles to instability is 
still unresolved. 
(IV) Reiss et al. (1994) reported that CGG 
alleles of similar length in unrelated FRAXA 
patients with _>46 repeats show differences in 
intergenerational instability, again indicating 
that the repeat itself is not the only factor that 
determines expansion. Neighbouring sequen­
ces have been proposed to affect stability for 
HD (Barron et al. 1994), and might also be 
involved in DM (Wieringa 1994). 
(V) Evolutionary mechanisms have also been 
implicated in DM. Meiotic drive was sug­
gested to result in the rapid spread of (pre)-
mutation alleles (Carey et al. 1994). As an 
alternative Wieringa (1994) suggested the 
fixation of the DM haplotype by repeats with 
more than 19 repeat units, which would 
contribute to the founder chromosome effect. 
(VI) An evolutionary preference has been 
proposed for the generation of CAG reitera­
tions in certain genes, based on the function 
of poly(glutamine) stretches (Green and Wang 
1994; Perutz et al. 1994). 
(VII) Finally, it is conceivable that coinciden­
tal combinations of DM alleles with impaired 
function of DNA mismatch repair, recently 
implicated in colon cancer (Bronner et al. 
1994; Fishel et al. 1993; Leach et al. 1993), 
may contribute to sudden jumps in repeat 
length, at the intergenerational or somatic 
level. 
The constant generation of new (pre)mutation 
alleles via these mechanisms compensates for 
the loss of disease alleles due to early death 
or reduced fertility of severe patients. This 
could even cause an increase in disease in­
cidence over many generations if the gene 
pool with predisposed allele lengths slowly 
expands (Kunst and Warren 1994; Rubin-
sztein et al. 1994). 
Having attained a threshold length, the 
repeat may be subjected to additional mecha­
nisms that cause extreme instability. Wang et 
al. (1994) have correlated the threshold length 
to the amount of DNA in a nucleosome (146 
bp), and found an increase in nucleosome 
formation with expanded CTG triplet blocks. 
They suggest that the generation of nucleo­
some positioning signals could induce prob­
lems during replication, or result in DNA 
polymerase pausing, slippage or idling, lea­
ding to expansion of the triplet repeat. Thus 
far, no conclusive evidence has been pro­
duced for the involvement of certain steps in 
the replication process, but two putative 
mechanisms have been proposed. The first 
hypothesis describes a model for changes in 
variable simple sequence motifs mediated by 
DNA polymerase slippage. Richards and 
Sutherland (1994) suggest that depending on 
the length of the repeat, one (small repeats) 
or more single stranded breaks are introduced 
during replication of the lagging strand. 
When an Okazaki fragment on this strand is 
flanked by breaks on either end it will not be 
anchored properly and may be free to slide 
during polymerization. This slippage might 
enable the addition of many repeat units to 
the repeat segment resulting in extreme ex­
pansion. The other model (Jansen et al. 1994) 
suggests that, when the repeat has attained a 
certain critical size, expansion is triggered by 
unequal pairing of sister chromatids in the 
repeat region, resulting in misaligned struc­
tures. Subsequent cleavage of one chromatid 
and double stranded repair using the other 
chromatid as a template would result in repeat 
expansion. Deletion of the misaligned struc-
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ture would lead to repeat regression. Ulti­
mately, the stability of the large repeats may 
be influenced by repeat length, purity and 
flanking sequences. The genetic background, 
sex of the transmitting parent and selection 
processes at the cellular level are additional 
parameters that may be involved in the mech­
anisms underlying dynamic mutations. 
1.7 Putative function of the DM-PK 
gene products 
Alternative splicing in the DM-PK RNA 
in both mouse and man predicts the existence 
of different DM-PK protein isoforms (Fu et 
al. 1993; Jansen et al. 1992b; Mahadevan et 
al. 1993; Shaw et al. 1993b). Fu et al. (1993) 
described the alternative use of exons in the 
5' region of the transcript proposed to be an 
intron by Mahadevan et al. (1993) and Shaw 
et al. (1993b), and also the alternative use of 
exon 7. These results can now most easily be 
explained as rare mis-splicing events which 
were picked up with the extreme sensitivity of 
the polymerase chain reaction (PCR). Alter­
native splicing of regions I, III, IV and V, as 
depicted in Figure 2, has never been found in 
human DM-PK mRNAs (Jansen et al. 1992b). 
Alternative splice I deletes 29 amino acids, 
including part of the last conserved kinase 
domain (see below), and cannot occur in 
human due to base substitutions in both the 
splice donor and acceptor site. Deletion of 
region III (exon 10) results in a frame shift 
and premature translation termination. Inser­
tion of region IV and V, spanning respec­
tively intron 12 and part of intron 13, both 
introduce a translation stop codon. The dele­
tion of exon 13 (in frame, region Vili; Fu et 
al. 1993) may be specific for man. It should 
be noted, however, that most splice forms 
were identified as cDNAs and reported only 
once. Moreover, preliminary data indicate 
that many of these splice variants are present 
at levels below the threshold of detection in 
most mRNA preparations, and can therefore 
be considered to be irrelevant. In contrast, 
alternative use of regions II, VI and VII has 
been reported independently by different 
groups (Fu et al. 1993; Jansen et al. 1992b; 
Mahadevan et al. 1993; Shaw et al. 1993b). 
The effects of these splices will therefore be 
discussed in more detail below. 
Several DM-PK cDNA splice variants and 
their predicted protein products have been 
used to search motif and data-base libraries. 
Computer analysis predicts the protein to 
contain a leucine-rich N-terminal sequence of 
approximately 40 amino acids, which may 
function as a protein-aggregation or routing 
signal (Fig. 3). Sasagawa et al. (1994) sug­
gest a specific role of the DM-PK protein in 
immune cells, based on an approximately 
32% identity between the N-terminal domain 
of DM-PK and thymopoietins. However, as 
the sequences of thymopoietins are 77-96% 
identical, and the homology of DM-PK to the 
thymopoietins is mainly based on shared 
leucine positions, the observed resemblance 
between DM-PK and the thymopoietins is not 
likely to be significant. Exons 2 to 8 of the 
DM-PK gene encode the putative catalytic 
kinase domain in which all eleven subdomains 
typical for the members of the protein kinase 
family can be found. Phylogenetic mapping 
by comparison of conserved motifs in these 
domains assigns the DM-kinase to the sub­
family of serine/threonine protein kinases. 
The homology to cyclic AMP-dependent 
protein kinases is most conspicuous (Brook et 
al. 1992; Fu et al. 1992; Jansen et al. 1992b). 
Recently, the predicted threonine and, to a 
lesser extent, serine specific protein phos­
phorylation activity has been confirmed in a 
functional assay with recombinant DM-PK 
produced in E.coli (Dunne et al. 1994). In 
both human and mouse the putative kinase 
domain is immediately followed by a cryptic 
splice donor site (5' to region II) that, if 
used, takes out five amino acids (VSGGG) 
(Fu et al. 1993; Jansen et al. 1992b; Mahade­
van et al. 1993; Shaw et al. 1993b). This 
peptide sequence forms an imperfect (and 
putative) glycoseaminoglycan (GAG) attach­
ment site. Following a region with no sig­
nificant homology to known proteins, a do­
main was identified with an α-helical coiled-
coil structure. Three different C-termini of 
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Figure 2. Alternative splicing of the DM-PK pre-mRNAs. Exons are depicted as open boxes, or when 
alternatively spliced, as black boxes. Numbering of nucleotides (nt) begins at the putative translation 
start. Region I spans 87 bp of exon 8 (nt 983-1069). Deletion of region II as the result of the use of a 
cryptic splice donor site removes nt 1132-1146 of exon 8. Region HI comprises exon 10 (nt 1233-1344). 
Intron 12 may remain unspliced (region IV), between nt 1606 and 1607 (exon 12 and 13). Part of intron 
13 can be included as an insertion between exons 13 and 14 (region V, between positions 1653 and 
1654). Region VI spans exons 13 and 14, deletion of which is found as a result of splicing between 
exons 12 and 15 (positions 1606-1744). The use of a cryptic splice acceptor site in exon 14 deletes four 
nucleotides (1654-1657; region VII). Finally, alternative use of exon 13 has been described (region VIII, 
nucleotides 1607-1653). 
the DM-PK protein have been predicted. 
"Normal" splicing from exon 12 to 13 and 
14, leaving the 4 bp region VII in lieu, re­
sults in a hydrophobic terminus (Brook et al. 
1992; Fu et al. 1993; Jansen et al. 1992b; 
Mahadevan et al. 1993; Shaw et al. 1993b). 
Deletion of region VII, found in mouse and 
human upon the use of a cryptic splice accep­
tor site (Jansen et al. 1992b; Mahadevan et 
al. 1993; Sasagawa et al. 1994), results in a 
frame shift. This isoform contains no hydro­
phobic stretch, but the predicted protein size 
is comparable to the previous form (approxi­
mately 70 kDa). The third C-terminal isoform 
(Fu et al. 1993; Jansen et al. 1992b; Mahade­
van et al. 1993) is smaller (app. 60 kDa), due 
to the deletion of exons 13 and 14 and the 
introduction of a premature translation stop. 
Preliminary results indicate that the different 
C-termini of the DM-PK protein are involved 
in the routing and localization of the protein 
isoforms (E. Cuppen and P. Groenen, un-
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Figure 3. Organization of the predicted DM protein kinase isoforms. All predicted DM-PK isoforms 
contain an N-terminal leucine rich stretch of approximately 40 amino acids, which may act as an 
aggregation or routing signal (AR). Exons 2 to 8 encode the kinase domain in which eleven subregions 
typical for protein kinases can be found. The alternatively spliced region II encodes a stretch of 5 amino 
acids representing a putative glycoseaminoglycan attachment site (GAG). Exons 10-12 encode an a-
helical domain that shows significant homology to protein domains capable of forming coiled-coil 
structures (Coil). "Normal" splicing from exon 12 to 13, 14 and 15, leaving in region VII yields a 
hydrophobic stretch (Hydroph.) at the C-terminus. Deletion of region VI introduces a premature stop 
codon shortly after the Coil domain. The use of a cryptic splice acceptor site 4 bp downstream in exon 
14 (region VII) causes a frame shift, and a gives the DM-PK protein a different C-terminus. The ap­
proximate amino acid positions at the start and end of each distinct domain are indicated. The resulting 
molecular weight of the predicted DM-PK isoforms is depicted to the right of the figure. 
published results). 
1.8 DM-PK tissue specific expression 
Apart from the description of the protein 
kinase activity of recombinant DM-PK pro­
tein, no experimental evidence is available 
that assigns a function to the individual do­
mains in the gene product(s). The first (Nor­
thern blot) analyses used to determine the 
tissue specific expression pattern showed high 
levels of DM-PK mRNA in heart (especially 
high in baboon, Brook et al. 1992) and skele­
tal muscle, and lower levels in smooth 
muscle-containing tissues such as intestine, 
stomach and bladder (Brook et al. 1992; 
Jansen et al. 1992b). DM-PK expression 
patterns in the mouse were determined in 
more detail using RNA in situ hybridization 
(van der Ven et al. submitted). These experi­
ments already showed expression in the myo­
tome regions of somites of 10.5 days old 
mouse embryos. During subsequent early 
development, expression is seen in smooth 
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and stnated muscle (e.g in stomach, intes-
tine, bladder, tongue, oesophagus, diaphragm 
and intercostal muscles). The onset of expres-
sion in the heart is late, but becomes more 
pronounced between 16 5 and 18 5 days post 
conceptionem Preliminary data also indicate 
that the DM-PK gene is expressed in certain 
regions of the adult brain (van der Ven et al. 
in preparation), with low but significant DM-
PK mRNA levels having been visualized in 
the granular layer of the cerebellum and in 
the dentate gyrus and pynmidal layer of the 
hippocampus and in the retina. 
Three distinct peptide antisera were used 
in comparative histochemical studies to local-
ize the DM-PK protein in more detail The 
distribution of the DM-PK protein was found 
to be developmentally regulated, shifting from 
a reticular pattern in cultured myoblasts, via a 
homogeneous staining in differentiated myo-
tubes and immature fibres, eventually to 
localize at sites of neuromuscular (NMJ) and 
myotendinous junctions (MTJ) in mature 
skeletal muscle (van der Ven et al 1993 & 
submitted). In addition, low levels of the 
protein were present in the sarcoplasm of 
predominantly type I fibers. In heart muscle, 
DM-PK was found to be localized in the 
intercalated discs. Structures appearing as 
dense plaques at cell-cell contact sites and 
ring-like structures surrounding nuclei were 
stained in smooth muscle cells These data 
suggest that the DM-PK protein is involved in 
the regulation of synaptic signal transmission 
or the assembly of junctional architecture at 
sites of cell-cell contact in skeletal, heart and 
smooth muscle This is in agreement with the 
finding of altered motor neuron excitability in 
DM, and the classification of DM as a dis-
ease of unresponsiveness to innervation, or as 
an abnormality of muscle control in cases of 
congenital DM (Harper 1989; Kobayashi et 
al. 1990). 
The results obtained when anti-peptide-
anbsera were used to detect the DM-PK 
protein on Western blot are difficult to inter-
pret One group described lmmunoreactivity 
of their antisera to a 70 kDa protein in heart, 
brain and liver (Sasagawa et al. 1994) Sur-
prisingly, all other antisera currently available 
detect a protein in muscle, heart and various 
other tissues including brain, of approximate-
ly 53 kDa (55 kDa described by Fu et al. 
(1993), 52 kDa by Brewster et al (1993) and 
53 kDa by van der Ven et al. (1993) and 
Koga et al (1994)) This size deviates con-
siderably from that predicted from the cDNA 
of between 60 and 70 kDa (or perhaps even 
larger due to glycosylation or the attachment 
of glycoseaminoglycan groups). With the 
recent development of DM-PK deficient mice 
(Jansen et al paragraph 5.1, S Reddy and D. 
Housman personal communication), the îm-
munoreactivity of the antisera to the 50-55 
kDa protein was shown to result from aspe-
cific binding As some residual staining could 
also be seen on cryosections of heart and 
skeletal muscle of DM-PK deficient mice, the 
results obtained with these antisera should be 
interpreted with caution However, using an 
anti-DM/pep2 antiserum (van der Ven et al. 
1993) and a newly developed antiserum RK-
DMK (E Whiting and R.G. Komeluk un-
published) to analyse muscle extracts of mice 
that overexpress the DM-PK gene, distinct 
isoforms (alternative splicing) of the protein 
in the 70-74 kDa molecular weight range 
were consistently seen. These bands were 
barely visible in wild type animals and com-
pletely absent in DM-PK gene deficient mice. 
1.9 Possible repeat expansion effects 
The implication of dynamic mutations in 
human hereditary diseases has introduced new 
and challenging aspects to human genetics. 
How do the expanding trinucleotide repeats 
cause the diseases they are associated with, 
and what is the effect of the expansion on the 
gene(s) involved? Several hypotheses have 
been presented 
Firstly, the presence of large trinucleotide 
repeats has been shown to influence certain 
processes at the DNA-level, such as methyla-
tion (Oberlé et al 1991), the formation of 
stable tetrahelical structures (Fry and Loeb 
1994), the timing of replication of the 
FRAXA locus in the cell cycle (Hansen et al. 
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1993), and nucleosome assembly at CTG 
repeats (Wang et al. 1994). If indeed the 
expanded repeats distort the topology of 
chromatin, this might affect the proper func-
tioning of whole gene clusters. If this is the 
case in DM the neighbouring DMR-N9 gene 
might be involved in testicular and mental 
symptoms in DM (Jansen et al. 1992b & 
paragraph 2.5). Perhaps other genes located 
downstream from the CTG repeat (Shaw et 
al. 1993b; D. Brook personal communication) 
are also involved in DM pathology. 
Secondly, repeat expansion may exert its 
detrimental effect at the RNA level. Enlarged 
trinucleotide stretches in the 3' UTR of trans-
cripts could affect RNA stability, transport or 
translation efficiency, or influence polyadeny-
lation or (alternative) splicing (Jansen et al. 
1992b; Sonenberg 1994). RNA processing of 
neighbouring genes may be hampered in the 
same way, if their transcripts reach the ex-
panding repeat as well. 
Thirdly, the unstable repeat is located in 
the translated part of the mRNA in five dis-
eases (SBMA, SCA1, HD, DRPLA and 
MJD), and will thus directly affect the protein 
product(s). As these diseases are all associa-
ted with CAG-codon reiteration, which en-
codes polyglutamine stretches, this could 
result in excessive transglutamination of the 
gene products. Cross-linked aggregates or the 
proteolytic breakdown products thereof may 
be toxic for the cell, as hypothesized by 
Green (1993). Alternatively, as poly-gluta-
mine stretches are often found in transcription 
factors, expansion of such repeats may alter 
the biological role of the protein involved 
(Chamberlain et al. 1994; Gerber et al. 1994; 
Perutz et al. 1994). 
Lastly, expanded repeats might facilitate 
binding of specific RNA- or DNA-binding 
proteins and, thereby, "titrate out" factors 
essential for other cellular functions, perhaps 
in a tissue specific fashion (Ang et al. 1993). 
All of the possibilities mentioned above, 
except the third, are applicable to DM. Sever-
al groups have tried to quantitate the effects 
of repeat expansion, by determining DM-PK 
mRNA and protein levels in cases of con-
genital and adult DM muscle. These studies 
have produced contradictory results, and 
therefore no conclusions can be drawn as to 
the effect of repeat expansion on DM-PK 
expression. Four groups found reduced levels 
of mRNA or protein, using PCR, Northern 
blotting and immunoprecipitation on tissues of 
adult DM patients, foetuses and congenitally 
affected infants (Fu et al. 1993; Hofmann-
Radvanyi et al. 1993; Koga et al. 1994; 
Novelli et al. 1993b). In contrast, Sabourin et 
al. (1993) found DM-PK transcripts to be 
present at strongly elevated levels (up to 14-
fold) in brain and at moderately elevated 
levels (2-4 fold) in muscular tissue. Possible 
misleading factors (also discussed by Roses 
(1994)) may be the difficulties associated with 
RT-PCR quantitation of mRNA levels from 
the expanded allele (Jansen et al. 1993; Sa-
bourin et al. 1993) or the aspecific reactions 
of the DM-PK antibodies (Jansen et al. para-
graph 5.1). Moreover, sampling might have 
influenced the results, as the protein is local-
ized in specific structures and more abundant 
in type I fibers (van der Ven et al. 1993), and 
can thus easily be under- or over-represented 
in a biopsy. In addition, expression of DM-
PK is developmentally regulated (van der Ven 
et al. submitted), and muscle biopsies of 
patients and controls may differ significantly 
in the actual state of fibre constitution and 
composition. Finally the quantification may 
have been hampered by as yet unknown 
factors, such as the binding of proteins or 
RNAs to the expanded CTG repeat in the 
mRNA, or the formation of (developmentally 
regulated) DM-PK protein complexes in 
inaccessible cellular structures. 
1.10 Myotonic dystrophy mouse models 
Unfortunately, the study of two mouse 
models that mimic altered DM-PK gene 
expression has also not shown clearly whether 
over- or underexpression is involved in DM. 
DM-PK-deficient mice were generated in-
dependently by two groups by deleting the 
first seven exons of the DM gene using gene 
targeting in embryonic stem cells, and repla-
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cing these segments with either hygromycinB 
(Jansen et al. paragraph 5.1) and neomycin 
resistance cassettes (S. Reddy and D. Hous-
man personal communication). Surprisingly, 
heterozygous and homozygous mutant mice 
developed no visible pathology, except for 
weak signs of myopathy which were observed 
in the muscles from the head and neck region 
in ageing homozygous mutant mice. Further-
more, mice-lacking both functional DM-PK 
alleles occasionally showed variations the size 
of the cerebral ventricles in the brain. The 
pathology found in the DM-PK deficient mice 
therefore resembles to some extent the DM 
phenotype and necessitates detailed longitudi-
nal studies during ageing. However, the 
absence of a clear muscular phenotype and 
the lack of endocrine and fertility problems in 
these mice suggests that the simple inactiva-
tion of the DM-PK gene does not provide a 
faithful model for DM. Assuming mouse and 
human DM-PK to function similarly, these 
results also support the contention that DM is 
not caused by a simple reduction in DM-PK 
expression. 
In contrast, transgenic mice that overex-
press the DM-PK gene in a correct tissue-
specific manner do show overt phenotypic 
abnormalities (Jansen et al. paragraph 5.1). 
Two mice lines with expression of the human 
DM-PK transgene mRNA up to half the 
endogenous level in leg muscle and two fold 
overexpression in heart, showed mild to 
severe cardiac myopathy, enhanced neonatal 
mortality and breeding problems upon mater-
nal transmission, but no skeletal myopathy. 
The cardiomyopathy seen in these mice re-
sembles hypertrophy, and is similar to the 
pathology seen in many advanced-stage DM 
patients (Harper 1989). Whether the cardiac 
myopathy is also responsible for the neonatal 
mortality and breeding problems is still un-
resolved. Malfunction of other muscular 
systems might be induced during periods of 
abnormal physiological stress, since it has 
been reported that pregnancy may be a pre-
disposing factor for intestinal pseudo-obstruc-
tion in DM patients (Brunner et al. 1992a). 
The absence of any signs of skeletal myo-
pathy could be explained by two observations. 
Firstly, the relative overexpression in skeletal 
muscle was significantly lower than in the 
heart, when compared to the endogenous 
levels of DM-PK mRNA in these tissues. 
Secondly, mouse muscle is generally less 
prone to the development of atrophic lesions 
than human muscle, due to a very high regen-
erative capacity and a reduced workload as a 
consequence of small body size (compare max 
mouse; Hoffman et al. 1987; Sicinski et al. 
1989; Stedman et al. 1991). As the clinical 
effects of CTG-repeat expansion in DM pa-
tients appear to be only partly mimicked in 
the overexpressor mice this is not a faithful 
model for DM. Nevertheless, it may be use-
ful for the study of molecular events involved 
in disease manifestation. Ultimately, the most 
suitable experimental context for testing the 
effects of repeat expansion on the function of 
the gene(s) involved in DM would be to 
generate a mouse model in which the human 
expanding repeat is introduced in its proper 
location in the DM-PK gene. 
1.11 Outline of this thesis 
The studies described in this thesis repre-
sent the outcome of an international research 
collaboration, with the prominent participa-
tion of the Departments of Cell Biology & 
Histology and Human Genetics in Nijmegen. 
The aim of these studies was the identifica-
tion, characterization and understanding of 
the gene(s) and mutation involved in myoton-
ic dystrophy. With the cloning of the DM 
locus on human chromosome 19 and mouse 
chromosome 7 and the subsequent charac-
terization of the gene(s) involved (described 
in chapter 2), the door towards a better un-
derstanding of DM was opened. Unexpected-
ly, the mutation introduced us to the new 
world of dynamic mutations. In close col-
laboration with clinicians and genetic coun-
sellors who provided valuable tissue samples, 
certain aspects of the strange behaviour of the 
(CTG)D repeat were examined at the DNA 
level (chapter 3). In a parallel study into the 
expression of DM-PK RNA, we showed 
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imprinting not to be involved in the enigmatic 
parental effects that characterize DM trans-
mission (chapter 4). As a prerequisite to the 
development of animal models, the specific 
cellular localization of the DM-PK protein 
was also determined (chapter 4). Our data 
indicated that DM-PK may play a role in 
signal transduction or in the assembly of the 
cellular structures involved in excitation-
contraction coupling at the postsynaptic side. 
Then, as further studies of the disease in the 
human context were hampered for logistic 
and ethical reasons, we turned to the develop-
ment of animal models (chapter 5). The 
generation of DM-PK deficient mice taught us 
that DM is not simply caused by reduced 
expression. In contrast, over-expression of the 
DM-PK gene in transgenic mice did induce 
some features reminiscent of the complex DM 
phenotype, but the full spectrum of disease 
features was again absent. Although neither 
over- nor reduced DM-PK expression resulted 
in overt skeletal myopathy, these two mouse 
strains do represent a first step towards the 
development of a more faithful animal model. 
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The mutahon involved in myotonic dystrophy (DM) has 
been mapped to the region between the ERCC1 DNA repair 
gene and the anonymous D19S51 locus on 19ql3.3. Starting 
at locus D19S112 (probe pX75b), which served as a novel 
entry site for this chromosome region, we have established a 
cosmid contig of approximately 200 kb. In the contig, a gene 
expressed in the brain and a highly informative, 12-allele 
(TC), variable simple sequence motif (VSSM) were identified. 
With this marker, designated X7!>b-VSSM, a highly charac­
teristic size distribution of alleles linked with DM, which dif­
fered significantly from that on normal chromosomes, was ob­
served. Combining our physical mapping and genetic data, we 
show that the X75b-VSSM marker is the closest distal to DM, 
thus excluding the DM mutation from the entire telomeric 
portion of the ERC01 -DI 9S51 region. . шмлгшЬписРпч.. inr 
INTRODUCTION 
Myotonic dystrophy (UM) is u slowly progressive, au­
tosomal dominant, multisystemic disease characterized 
by muscle weakness, myotonia, and a variety of other 
symptoms affecting body systems besides voluntary 
muscle With an incidence oí 1 in about 8000 individ-
uals, DM is the most common of adult muscular dystro-
phies (Harper, 1989) The onset of disease is generally 
late, but the course of the disease can vary widely, even 
within the same lamily. A rare form ol DM, presenting 
at birth, is seen solely in inlanls who acquired the dis-
ease via their allected mother (Harper and Dyken, 
1972) An association between paternal transmission 
and late onset of disease as well as an increasing severity 
of disease in successive generations has been suggested 
Sequence data troni tins article have heen deposited with the 
EMBL/CenBank Data Libraries under Accession Nos МЯЛІ0Д 
І ШЧПб 
1
 To vs hom с orrespoiidence should he addressed 
(Harper, 1989; Brunnen·/α/, 1991, HowelerW al, 19H9). 
A molecular explanation lor these features, which are 
reminiscent ol imprinting and epigenetic phenomena in 
mice (Hall, 1990). remains elusive. 
Recently, using physical and genetic analysis in paral­
lel, (he DM mutation has been mapped to chromosome 
segment 19ql3 lì At the proximal side, the closest 
known marker is the FRCCl-VSSM (TG)„ repeat 
marker, which is less than 1 cM from DM (Smeets et al, 
1991). Marker D19S63 (Brook et al, 1991) is located 
even closer to DM as linkage disequilibrium with DM 
has been demonstrated (Harley et al, 1991); however, its 
position proximal or distal to DM remains to be eluci-
dated Several other highly informative markers are at a 
slightly larger genetic distance (reviewed by Smeets, 
1991). Until now there has been a paucity ol probes the 
location ol which is unequivocally distal to DM. The 
informative VNTR probe defining locus D19S5Ü (Naka-
mura et al, 1988) was positioned at not less than 9 cM 
from DM (Korneluk et al, 1989). Just recently, a RFLP 
marker, pl34c (D19S51), has been isolated and located 
at 2.5 cM from DM by two-point linkage analysis (John-
son et al, 1990). The corresponding physical size ol the 
segment between DM and D19SM, ranging from 1 to 1 5 
Mb ol DNA, could only be estimated trom the human 
DNA content in derl9ql3 containing somatic cell hy-
brids (Brook el al. 1991, Johnson eta!.. 1990; Stallingsei 
at., 1988). Other estimates based on long-range restric-
tion mapping are seriously compromised by the presence 
of many recognition sites for rare-cutting enzymes and a 
high degree ol melhylation in the G + C-rich 19ql.'1.3 
region and are therelore equally unreliable 
We bridge these closely linked Hanking markers via 
the complete cloning ol (he DM interval. This provides 
us access to all possible highly informative markers and 
physically relevant sequences in the area. Here we de-
scribe our results with several newly cloned DNAs, in-
31 
eluding a novel (TG) repeat marker near locus D19S112 
This marker enables us to delimit the distal borders oí 
the DM area more precisely and to identify overlapping 
cosmids of the pertinent chromosome segment In this 
cosmid contig we started screening ior candidate genes 
M A T E R I A L S A N D M E T H O D S 
Farmh material and hnka^i anahsis Families suitable lor haplo 
type analvsis were selected from a large panel of previously studied 
kindreds (Brunner it al 1989) and from databases available at the 
diagnostic DNA services at the University ui Nijmegen The Nether 
lands the Insti tute of Meditai Genetics in ( arditi I К the Kleberg 
DNA Diagnostic Laborators in Houston Texas and the ( hildrens 
Hospital of Fastern Ontario in Ottawa Can ida Clinical diagnosis ol 
pat ients was based on the t nter ia established b> th( Mvotunit Dvs 
trophv Working Group (Griggs et al 1989) D \ A s trom peripheral 
blood samples were collected as published elsewhere (Mrunner it al 
1989) 
Somatic all h\bnds Somatic (ell hvbnds ?0\РТ->42 1 -I and 
2 0 λ Ι 4 Ή 2 1 fi have been described (Stallings tt al 1988 Rachinski 
and Siciliano 199Ü Schonk 1991) Somatic cell i rnd ia t iun hvbnd 
20K" was obtained trom lusion of I I P R 1 negative Chinese hamster 
Wg4 h tells and λ rav i r n d i a t e d (20 000 rads Henh im t í al 1989 
G Í not shown) 20XP3542 1 6 colls Det nis regarding the ( onstrut 
tion of the somatic cell irradiation hvbnds 2l· ~> 5B i ind ЗА i contain 
ing d e r l 9 ((¡I i) segments of h u m i n material have been reported in 
detail elsewhere (Brook it al 1991) Culturo conditions for these so 
malic cell h \ b n d s have been given previously (Schonk et al 1989) 
()ht><muiliotides\nthesi<; Oligonucleotides used is primers in pol> 
merase chain reactions (PCR Saiki it al 1988) or as SSM hybndiza 
tion probes were ssnthesi7ed on a Cvclone DNA svnthesi¿er (Rio 
search MilliGen) I he specifications lor use of the SPfi 17 Alu M 
and Alu ІЛ ohgo primers lor Alu Alu and Alu vet lor PCR amplifica 
Lion are givtn in the accompanving paper (Slimier < / al 1992) T h e 
Alu Ì3 О CTGGGATTACAGGCGTGAGÍ ( A 1) and Alu U (5 
CCC.CAC IGCACTCCAGCÍ ITxGG i ) primers are S truncated ver 
sums of P D m (5 (»( ( ICCCAAAGIGC IGGGA PTACAGGC G l 
G A G C C A Ì t and PDJ14 (5 1 GAGCCGAGA1 ( (.( G( ( ACTG 
C A C T C C A G C C I G G G 1 ) (de Jong et al 1989) 
DNA (Urning Uthnique-, Details regarding the prepar ition and 
screening of the F M B L 1 pha^e libran, of etil h \ l ind 2 U \ P l >42 1 4 
have been described elsewhere (Smtcts 1991) The prepar it ion ol the 
Charon 4U phage hbrarv Irom flow sorted chromosomes 19 has been 
reported (Yokobota t í al 1992) I he preparation ol i símil ir I awrist 
5 cosmid library has been described in a report with preliminary dat \ 
(de long tt al 1989) To increase the accuracv and speed ol cosmid 
walking multidimensional pools of 9Г» cosmids each comprising a to 
tal of 104 tosmids were arrayed in the wells of three 9b well microliter 
dishes (SO μΐ Ι В 100 μg/ml kanamvein per well) representing three 
orthogonal pooling schemes (Amemiva unpublished data) Colonies 
of replica plated cosmid pools wore grown on Gene Screen N\lun 
membrane filters (N F N DuPonl) and processed lor colony screen 
ing with probe Х75Ь insert DNA (Hermens it al 1991) according tu 
s tandard procedures Also used were eight high densit\ filters each 
containing 1440 cosmid DNA and 9b conLrol plasmid DNA (pUCl9) 
dots (de long unpublished data S h u t l e r t r n / 1992) 
l o extend the X75b contig hy ( hromusome walking insert end 
probes were generated from cosmids F142'SS ind t- )864 or from cos 
mids at their proximal and distal sides (see Fig 1Λ) using PC R with 
Alu specihe primers and vector primers (Spb or T7) as described in 
the accompanying report (Shut 1er r í al 1992) For probe preparation 
a sample ol 10μΙ ol the PC R reaction mixture was subjected to electro 
phoresis on a 2 rc low melting point agarose (Bio Rid) gel Alu veo 
tor specilu Iragmenis were excised Irom the gel and used for direct 
labeling b\ primed synthesis (Feinberg and Vogelstein 198ì) in th t 
presence ol [a 3 2 P |dCTP (Amersh im UK) Labeled Alu vector PCR 
products were boiled lor 10 min in the presence ol 100 μg sonificated 
hum in DNA and incubated lor 2 h in 2 ml hybridization solution to 
block repetitive sequences (pre issociation) For prehvbndization hv 
hr iduat ion and washing of cosmid filters standard conditions were 
used 1· or autoradiography filters were exposed to Kodak X O M A T Ь 
\ rav films lor periods ranging between 15 min to several davs at 
70 ( 
Cosmid t\pmfí Individual DNAs from each of the cosmids were 
isolated according to standard procedures digested with (combina 
tions of) restriction enzvmes tioRl H indili / 'sil P t u I I ana M lul 
(Beüiesda Research Laboratories BRL) and analy?ed by Southern 
blot analvsis using cosmid vector probe genomic insert probe 
( p \ 7 >b) or Mu vector PCR probes 1 he PCR probes were preasso 
ciated with human DNA as described in the previous section To iden 
tifv the ends ol the human DNA insert and for detection of VSSMs 
the cosmid blots were screened with the Sp6 and T7 specific primers 
specified above and with a ( I G)71 oligonucleotide (Smeets t í al 
1991) Oligonucleotides were r) end labeled with \y ^ P j A T P (Amer 
sham 1 К) and used for h\bndi7ai ion as described (Smeets it al 1991 
Smeels 1991) 
( haraiten ation and ampli) и a tion of X75b (10)
n
 V 6 S M ¡or us< as 
genetic marh г T h e DNA insert from cosmid F5864 containing a 
( T d l „ repeat was ele »ved with ScmìA restriction enzyme and I rag 
merits were subcloned in pGI M i vector plasmid (TG)„ repeat con 
taming Plasmids were identified using tolonv hvbndi7atinn and the 
segment spanning the repe it and the adjacent DNA area was че 
quenced Two unique primers H 1 l a n d H l 2 were designed to vield a 
segmtnt ol 1 iO nucleotides bracketing the ( l d l , repeal if amplified 
with the PC Ii method of Saiki or al (1988) PCR a m p l i c a t i o n oí this 
segment was performt d i n a reaction volume ol 50 μΐ containing Ι μΙ 
genomic DNA (0 > to 1 μρ) 1ΠΓ) ng ol each of the PCR amplification 
primers (HI 1 and Η I 2) >0 т Л / KCl 10 m M Tris HCl (pH 8 1 at 
2 5 4 ) 1 5 m M MgCl 0 001 gelatine and the four dN TPs at 0 2 
mM each To each reaction mixture 2 ng oligonucleotide H i 1 (see 
text) ι end labeled with [•) UP]ATP and T4 polvnuc leotide kinase 
( 10 000 cpm per reac tion) was added to lacihtate detection of tht reac 
tion products After heating the mixtures to 90°C for 10 min 2 units 
lau po lvmense was added to each reaction at 80°C The mixtures 
were incubated during Ì0 re u tion c>cles each cycle consisting of 48 s 
denalurat ion at 94°( bO s annealing \\ fi2°C and 48 s elongation at 
" ' " ( After И) tveles 1 μΐ of the reaction mixture was mixed with 2 μΐ 
s tandard formamidt/dve bufFer and after denaturation run on a b or 
8*7 it rvlannde/bisacrvlamide (19 1 w/w) sequt ncing gel until the xv 
lene cvanol dv< had migrated approximatelv ό > cm Substquentlv the 
gel was exposed onto Kodak \ Omat S film tor lb h at 7 0 4 using 
two intcnsifving screens 
D\A ΙιηΚαχι analysis Two point linkage analvsi« and haplotvpe 
reconstruction was performed as described b\ Brunner t í al (1989 
1991) and Korncluk ι í al (1989) 
Idi ntìfìcati m of < xpnssed sequent( s in coòmtd matt rial Ten mi 
crogr uns of DNA isolated Irom blood or tissue samples from human 
monkey cow pig munse rabbit hamster chicken and fish was di 
gested with / T O R I separated on a l rc agarose gel and blotted to Gene 
Screen Plus I hese zoo blots were h\bndi7ed with 32P labeled 
ftoKl cosmid insert fragments In addition f t o R I fragments ol cos 
mid У 5864 containing conserved sequences were used lor plaque hv 
bndization to a filter immobilized mouse brain cDNA phage library 
( S t n t a g e n e l ni Zap \ R ) As we anticipated no problems from ho 
molo^v between SlNb or L I N F repeats in the human genormt and 
moiist cDNA sequences (ι e cross speties DNA hopping ) we omit 
ted the optional preassociation with excess total human DNA This 
resulted in much stronger signals while the background hvbndi7ation 
was «till not signifie anil ν increased Filters were preh>bndized in I0cc 
dext ran sullate 6χ SSC aX Denhard solution and 0 lc< SDS (or 4 h 
at ljrj°C then J P labeled EcoHl insert probe wasadded a n d h v b n d i z a 
tion was perlormed for 16 h at b0°C \\ ashing was performed at fi0aC 
0 2> SSC final stnngencv All further conditions plaque purification 
01 phage clones and rescue ol phage inserts in pBluescript plasmid 
were as recommended bv S t n t a g e n e 
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DNA sequtnLinti The DNA bequemem oí the insert en<k in sub 
clones pX12i p X H 2 , p R H 2 B 5 and pRHJB4 were determined start 
ing at the SpG and 1 7 primer sequent es in iheplasmid veitur p(»FM4 
To determine the sequences of the insert ends oi cosmids small sized 
plasmid derivatives were generated To this end cosmid DNAs were 
digested with restriction enzymes HomHl, Svrl (both absent in the 
vector Lawrist ")), or Windlll (site located at the T 7 end ol the vector) 
followed by rehgation and recloning ol the vector hearing fragments 
I hen, the remaining insert ends were sequenced start ing with the Sp6 
primer lor Hindlll derived kanamvcin resistant subclones or the T7 
primer forcisfl and HamHl subclones For t DNA sequence determina 
lion either the (nmplete mouse cDNA clone 11 1 or smaller plasmid 
derivatives from whu h Apal Smal a n d / ' s i l fragments were deleted 
served ass tar t ing material In all cases the supercoil DNA sequencing 
protocol of Hattori and Sakaki (198b) was used with commercially 
available T7 I 1 nr Sp6-specihc oligonucleotides (Promegn Biolec) 
FMBL FMBL new GenHank and Vechase sequeme data 
searches were perlormed using the Intc lhOenet i ts soltw.ire package 
installed at the L'niversitv Nijmegen CAOS ('AM center 
R F S U L T S A N D D I S C U S S I O N 
Cloning of the distal edge uf the DM area Current 
estimates for the physical distance between the two clos-
est DM flanking markers, ERCC1 and D19S51, range 
from 1 to 1 5 Mb of DNA, a region far too large to di-
rectly search lor the DM mutation To identify DNA 
probes that could serve as entry points for further ge 
netic and physical delimitation of the DM region, we 
used the total Alu PCR (PDJ34 primer; de Jong et al, 
1989) reaction product from somatic cell hybrid 
20XP3542 1-4 DNA as a probe for screening the Charon 
40 phage library of sorted chromosomes 19 As is re-
ported in more detail elsewhere (Smeets, 1991), a total of 
12 different phage were isolated Three additional chro-
mosome 19-specific phages with human inserts were se 
lected directly from an EMBL3 phage library Irom 
20XP3542 1-4 genomic DNA From these phage, unique 
copy probes, pRH2B5, pRH3B4, pX75b (D19S112, Her-
mens et al, 1991), and pXI32 were derived In addition, 
we identified one subclone, pXI23, that displayed a very 
peculiar sequence organization based on the presence of 
an unusually long (>400 bp) stretch of (CA)„ and (TA)„ 
repeats To determine the localization of pRH2B5, 
pRH3B4, pX75b, pXI23, and pXI32 more precisely, 
these probes were mapped using irradiation hybrids Ini 
tially, based on their segregation in the hybrids 2F5, 
5B3, and 3A3, they were clustered in three groups to-
gether with the 19ql3 3 markers pT56-4 2 (ERCCl gene 
clone; Van Duin, 1988), pD8 (D19S62), pDlO (D19S63, 
Brook et al, 1991), andpl34C (D19S51; Johnson et al, 
1990), the order being cen- |ERCCl, pRH3B4, pDIO, 
pX75b] [pl34c, pD8J-[pRH2B5, pXI23, pXI32] ter 
(Table 1) To attain more precise ordering of the probes, 
we undertook construction of additional irradiation hy 
bnds Only one useful hybrid, 20K7, was obtained This 
cell line enabled us to place probe pX75b in between 
pDIO (D19S(H) andpl34C Furthermore, hybridization 
to blots containing an immobilized series of cosmid 
DNAs obtained by genome walking into distal direction 
from the ERCCl gene revealed that the pRH3B4 probe 
TABLE 1 
Distribution of Markers amone Chromosome 19 
Segments of der(19) Containing Somatic Cell Hybrids 
Hybrid cell line 
Probe 
pT.% -1 l (ERCCl) 
p K H l l t J 
pDIO (D19S6Í) 
FlBbiS hpß 
pX7Sb (D19S112) 
F170S8 Spfi 
p l14( (D19S51) 
pD8 (IH4SG2) 
pRH2Hr> 
p \ I 2 t 
ρ \ Π 2 
>F=, 
| 
+ 
1 
+ 
1 
+ 
4 
+ 
1 
1 
1 
5R3 
+ 
+ 
+ 
+ 
+ 
Η 
-
-
-
J A I 
+ 
+ 
+ 
+ 
+ 
+ 
4 
+ 
-
-
20K7 
+ 
-t 
+ 
4 
-
-
-
-
Nate ( ι I Marker present or I ) marker absent on Southern blot 
analvsis I'robe DNAs were b « K l / / V I (XI23 and X132) or EcoRl/ 
HindlII (RH2B5 and RH IM4) subclones ol КМИІ.1 phage t h a t were 
derived Irom the 19der segment in somatic cell hybrid 20XP3542 1 4 
(Mailings et al 1988) 
was positioned at approximately 30 kb telomenc from 
ERCCl Likewise, pDIO (D19S63) was positioned at 
200-250 kbp from ERCCl, exactly at the site deter 
mined by probe pKBEO 8 (D19S119, for details about 
the ERCCl cosmid contig see Shutler et al, 1992) X75b 
could be excluded from the entire "walk segment" of 
0 35 Mb distal to ERCCl (results not shown), placing it 
distal topDIO (D19SM) in keeping with the results from 
the irradiation hybrid mapping panel On the basis of 
crossover analysis, we know that the unique locus deter­
mined by probes pDIO and pKBEO.8 (D19S63/ 
D19S119) maps immediately adjacent to the proximal 
border of the DM area (Shutler et al, 1992). Similarly, 
pl34C forms the distal border (Johnson et al, 1990, 
Tsilfidis et al, 1992) We can therefore exclude all 
probes located outside the pDIO to pl34C interval as 
being relevant for the identification of the disease locus 
Based on this evidence, probe pX75b was considered to 
be the only promising candidate to serve as a molecular 
entry site lor further cloning 
Therefore, using the 1 2-kb SacII/PstI insert of 
pX75b as a probe, two overlapping cosmids from the 
X75b locus, F5864 and F14255, were isolated from the 
sorted chromosome 19 cosmid library A partial restric­
tion map of cosmid F5864 and the region just adjacent to 
pX75b is shown in Fig 1A The cloned area was further 
extended by the isolation of several more overlapping 
cosmids, once genetic data that served to position the 
X75h probe area more precisely with respect to the DM 
locus became available (see below). As illustrated in Fig 
1A, the entire region now cloned is defined by 12 par 
tially overlapping cosmids, spanning 200 kb of DNA 
Except for the cosmids designated 1 4 in Fig. 1A, all 
cosmid members in the contig were identified by walking 
using Л/u-vector probe hybridizations A detailed de-
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B s-i 
GGCCTTGGCTGGTTCCAGGATGCACGTTAAATGATGTTGCCGGGAATCTGCGTCTCTTGCCTCTCGTATTGTCTGTGTTCCCTTCTOTCTCiUGCACCTT 
10 20 30 40 50 60 70 80 90 100 
S-2 
TGAGAACTACCTGGTGAGCICCGGGCCGGGGTGACTAGGAAGAGGGACAAGAGCCCGTGCTGTCACTGGACGAGGAGGTGGGAGAGGMGCTCIAGGATT 
10 2 0 3 0 4 0 5 0 6 0 7 0 8 0 9 0 100 
S-3 
ATCATAGATCTTTCTAGTCTCATGTAGICMTGGCCTCTACGATTTCTCCCTAGAGTGTCCCAAGGGCATCTCACACTTaaaaiiaaiiaaatcctacaatg 
10 20 30 40 50 60 70 SO 90 100 
-А 
ATTCTTCATTGTTGTCGTGTGAGGTACTAGTTCGTTTTTTATTGCTCAGTAGTATTCTGTCATA1GAA1ATACAATCATTTGTTTATCCACACCGGTAT1 
10 20 30 40 50 60 70 80 90 100 
S-5 
AAGTTGGGGGCAGGTATCGGGGTGTGGGCTCACATGGAGCAGGGACTGGTTGTGGGTTCAAATGGAGGCAAAGGCGTCTACTTGGGCAGCCGAGGAAC1G 
10 20 30 40 50 60 70 80 90 100 
S-6 
GTTATCCCTGAT1GAAGTGAGCTACTTCCTGTCCATCCACCATCCCCAGCTAGAAAGGAAGCTCTGAGAGTGGAGTTCAGTATTTTATTCACTGCTG1AT 
1 0 2 0 3 0 4 0 5 0 6 0 7 0 8 0 9 0 1 0 0 
FIG. 1. Physical characterization of the cüsmid contig containing probe pX75b (Al Preliminary restriction map oí 12 overlapping cosmids 
The t»pen bars represent YAC derived cosmids [ 1, Ycl00259. 4, Y с 100263, Aslanidis vt nl ( 199'2)| or cosmids from sorted chromosomes 19 (1. 
F18894, 2 F18411.S, F1662Ä, 6, F23948, 7, F25609, 8, F14255, 9. K2S240. 10, F5864, 11.F18029. 12, Fl 7058) hpb or T7 end» of the cosmids are 
inditaled by an open or black end, respectively The chromosomal orientation and relat ive positioning of the cosmids are at the top T h e arrows 
at (S 1 to S-6] represent the locations of six end sequences of these cosmids (given in B, below) A more detailed restriction map of cosmid 
F5Hb4, including the approximate positions ol probe pX75b (D19S112, open bar), the X75b-VSSM (TG)„ repeat (black bar), and the mouse 
cDNA ( Urne 11 1 (hatched bar), is given at the bottom M, Mlul, К h.uiRl, H, ЯілаІІІ (В) Sequences of six cosmid ends spaced JO-40 kb apart 
across the X75b contig Sequences homologous to L I N E sequences are underlined, sequences pr inted in lowercase are homologous to Lhe h u m a n 
Ліи с cinsensus sequence 
senption of the isolation and characterization of cos­
mids 1-4, which involved YAC cloning, has been given 
elsewhere (Aslanidis et al, 1992). A conspicuously high 
number of rare-cutting sites, including at least four Sfi\ 
(not shown), one Noti (proximal to X75b), and four 
Miul sites (three proximal and one distal to pX75b; Fig. 
1A), are present within the cloned segment. Within the 
contig we have sequenced six stretches of anonymous 
DNA, each 100 bp long (S-l to S-6, Fig. IB) and spaced 
approximately 30-40 kb apart. Upon comparison to se­
quences in EMBL and GenBank databases, no signifi­
cant homology was found, except for S-3 and S-4, that 
contain parts of Alu and LINEI repetitive elements 
However, the S-4 sequence shows less than 70% homol­
ogy to known human and mouse LINE sequences, and 
S-3 consists ol only a small part of the Alu sequence. 
Therelore we expect that all sequences can be used as 
molecular anchor points or sequence-tagged sites (STS; 
Olson et al. 1989). 
The chromosomal orientation of the X75b cosmid 
contig was determined by mapping the A(u-Sp6 PCR 
fragments oí cosmids F16625 and F17058 and the origi-
nal X75b probe on the irradiation hybrid cell lines listed 
in Table 1 As the Sp6 end oí cosmid F16625 maps on all 
four cell lines and X75b and the Sp6-end oí cosmid 
F17058 are no longer present in 20K7, the orientation 
34 
was established to be cen-F18894-F16625 X75b 
F17058-tel The orientation and integrity of the cosmid 
walk was validated in several ways Recent findings 
based on YAC cloning of a significant portion of the 
ERCC1-D19S51 interval demonstrated that the Alu 
vector PCR products spanning the S 1 to S 6 sequences 
indeed were all contained within the YAC inserts Irom 
19q Furthermore, walking into centromenc direction, 
starting at cosmid 1 (Fig 1A), and using YAC derived 
tosmid libraries enabled us to bridge the gap between 
our X75b contig and a more proximal 19q cosmid contig 
starting at the ERCCl gene (Aslanidis et al 1992) Un 
fortunately attempts to confirm our results by long 
range physical mapping in analogy to strategies em 
ployed for the proximal segment of the ERCC1 D19S51 
segment (Shutler et al 1992), failed This is most likely 
due to the abundance of rare-cutting sites within the 
cloned area 
Identification of a (¡0)„ repeat marker To explore 
the relevance of the cosmid contig for DM, we sought to 
define the DM mutation between the narrowest possible 
crossover borders in patient families As the only previ 
ously identified marker in the cloned area is a rarely 
informative Mipl polymorphism detected by pX75b 
(Hermens el al 1991), we had to rely on the identifica 
tion of a more informative probe Simple sequence mo 
tifs (SSMs) constitute a rich source of such highly poly 
morphic elements (Weber, 1990 Smeets, 1991 Smeets 
et al 1991) Upon screening the cosmid DNAs that were 
originally isolated using pX75b, only cosmid F5864 
yielded a positive signal with the radiolabeled SSM 
probe (TG)7T, indicating the presence of a (TG)„ motif 
By restriction enzyme cleavage and hybridization analy 
sis, we positioned this motif within 10 kb from the 
pX75b site (Fig 1A) Next, this (TG)„ motif was sub 
cloned (clone pHl) , and its sequence was determined 
Based on the sequence shown in Fig 2A, two unique 
copy primers were designed for PCR amplification to 
yield a unique PCR product of 130 nucleotides encom 
passing the (TG)„ motif PCR amplification of total ge 
nomic DNA cosmid F5864, and subclone pHl DNA 
yielded a similar distinct band on a 4% agarose gel, indi 
eating that our PCR primers indeed were unique and 
specific for the X75b VSSM locus PCR products of 
various individuals were analyzed on sequencing gels 
On the resulting autoradiograms, examples of which are 
shown in Fig '2B we can discern altogether 12 alleles 
Linkage analysis Mendehan inheritance of the 
X75b specific VSSM marker was confirmed by testing 
its segregation behavior in various pedigrees many of 
which carried crossovers in the DM relevant area Alto 
gether, 392 normal and 101 phase known DM chromo 
somes were analyzed, including Dutch, British, and 
Northern American families The allele frequencies as 
determined from a random sample of nonaffected indi 
viduals in the Caucasian population are given in Table 2 
As shown a hiphasic distribution of allele lengths with 
overrepresentation of alleles 5 to 8 and 0 is observed 
Strikingly, in the 101 disease carriers tested, DM is 
found in combination with a narrower range of allele 
sizes involving only alleles 4 to 9 and 0, with a conspicu 
ous overrepresentation of alleles 5 and 6 Using the Kol 
mogorow-Smirnov test, which can be used to compare 
two random distributions, we found the distribution of 
alleles on DM carrying chromosomes to differ signin 
cantly from the distribution of "normal alleles" (P < 
0 001) Our data point to the existence of a strong link 
age disequilibrium between the X75b VSSM and the 
myotonic dystrophy locus Linkage disequilibrium, to 
differing extents, is seen over a vast region of the 
ERCCl D19S51 interval on chromosome 19ql3 3 (Наг 
ley et al ,1991 Ί silfidis et al, 1992) Because the marker 
systems used for these observations were conventional 
RFLP markers, however we cannot draw direct compari­
sons between the significance scores at other loci and the 
X75b VSSM 
Provided that a significant portion of the DM muta 
lions are related we can explain our observations by 
assuming that the originally DM coupled (TG)„ repeat 
length underwent changes over a shorter evolutionary 
time span and did not attain the broad variability as seen 
for normal chromosomes Ultimately, once the DM gene 
has been identified we will perhaps be able to test this 
hvpothesis by analyzing whether alleles other than 5 or 
6 e g allele 0, are associated with the new mutations 
Further support may also come from the analysis of 
X 7 % VSSM alleles in families of highly different ethnic 
backgrounds 
In spite of the narrower size distribution of DM al 
leles the X75b VSSM marker was found to be informa 
tive in most of the Caucasian DM families On the basis 
of the distribution of allele frequencies in normal individ 
uals, we established the polymorphism information con 
tent (PIC) value of the new locus to be 0 85 (Botstein et 
al 1980), whereas for DM individuals, a value of 0 62 
was calculated Previously we had identified one family 
that shows recombination between DM and the closely 
linked proximal gene ERCCl (Smeets et al 1991), as 
well as seven families that show recombination events 
between DM and the distal locus D19S50 (Brunner et 
al, 1989, Tsilfidis et al, 1992, van Oost, personal commu 
nication) The haplotype analysis of a subset of these 
and other families for which the X75b VSSM marker 
was informative is shown in Fig 2B In all families ex 
cept one, the X75b VSSM locus cosegregated with loci 
within the ERCCl D19S50 interval, containing the DM 
locus The only exception found thus far was observed in 
the French Canadian kindred whose pedigree structure 
and marker typing data are given in Fig '¿C Apartfrom 
the family described by Johnson et al (1990), this pedi-
gree is the second family known to have an established 
recombination between the distal marker D19S51 and 
DM plus the more proximal 19q marker loci ERCCl, 
apoC2 and BCL3 Our data are compatible with a cross 
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FIG. 2. Characterist ics and use of the X75b-VSSM marker. (A) Partial DNA sequence of" clone p H l containing the X75b-(TG)
n
 repeat and 
location of the target regions for primers used in the PCR amplification of the (TG)„ repeat (underlined). T h e forward primer 5 -GCCAGC-
C A T T C A G T C A T T T G A A G - 3 ' and reverse primer 5-CTGAAAGACACGTCACACTGGT-3 were synthesized as described under Materials 
and Methods. (B) Autoradiogram illustrating the variability in allelic signals of the X75b VSSM in two DM pedigrees. In the family shown to 
the left, six alleles can be identified. In t h e family to the right, five distinct alleles can be observed. DM segregates in both families with allele 5. 
Allele numbers refer to the lengths of the P C R products, allele 0 being 120 bp. Consecutive higher numbers correspond to the number of 
dinucleotide units differing between a given allele and allele 0 (see also Table 2). (C) Haplotypes of all relevant markers from the 19q 1ΓΪ area 
tested in the French-Canadian DM-X75b crossover family (for detailed information about marker designations see Smeets (1991) and Shutler 
e ía í . (1992)]. 
over in this family that separates DM from the X75b 
locus, since DM segregates with allele 7 in individuals 
.018, .016 and their mother .112 and with allele 5 for 
individuals .110 and .013. This result places DM proxi-
mal to D19S112 and renders X75b-VSSM the closest 
known distal marker to DM (for further details on this 
family we refer to Tsilfidis et αϊ, 1992). As will he re­
ported elsewhere (Smeets and Jansen, unpublished 
data), the X75b-VSSM marker, together with a struc­
turally similar marker motif in the ERCCl gene (Smeets 
et al., 1991), is highly useful for a simple presymptomatic 
DM carrier diagnosis based on PCR technology and 
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TABLE 2 
Distribution οΓ X75b-VSSM Allele Lengths over 
Normal and DM Carrying Chromosomes 
Allele Normal chromosomes DM chromosomes 
No 
0 
1 
2 
з 
1 
τ 
ь 
7 
8 
q 
10 
π 
Length 
120 
122 
1?4 
12b 
128 
130 
1 Ì2 
134 
1 lb 
П 8 
140 
142 
Occurrence 
r>7 
1 
3 
29 
21 
f>6 
b 
44 
)5 
22 
1U 
1 
l· requencv 
0 IS 
0 0 1 
001 
0 07 
0 0=i 
ο ί­
ο 14 
0 П 
0 14 
0 0b 
0 03 
0 001 
Occurrence 
r, 
0 
0 
0 
" 
IS 
11 
6 
Ì 
1 
0 
0 
Frequency 
0 0) 
0 0 
0 ь 
0 44 
0 0b 
0 0 1 
0 01 
laser activated detection of fluorescently labeled alleles 
using an automated DNA sequencer 
Identification of expressed sequence·, in the X75b 
luntig We started screening tor evolutionanlj con 
served or expressed DM candidate sequences in cosmids 
F5864 and F142V3 that span the Х7ГЛ VSSM marker 
and the original X75b probe region Upon using a 700 
blot assay, two fragments oi cosmid F5864 with highly 
conserved sequences were identified (not shown) These 
then were used directly as probes for screening a mouse 
brain cDNA library As brain is particularly rich in ex 
pressed sequences and in view of the impairment oi 
brain function in the clinical picture of DM, we antic 1 
pate any DM candidate gene to be expressed in this tis 
sue Our strategy involved both genomic versus cDNA 
and cross species homology detection, which has previ 
ously been used successfully for the detection of ex 
pressed sequences from chromosome 11 (P Little, per 
sonai communication) Furthermore as the whole clus 
ter of svntenic genes spanning the DM gene area ol man 
is one oi the largest evolutionary conserved chromo 
some segments in mammals (Cavanna el al 1990 
Saunders and beldin 1990) we assume that DM gene 
homologues may exist throughout the mammalian king 
dom Out of l'îOOOO clones screened eight positive 
phage were purihed and their inserts were rescued All 
eight DNAs detected the same three FtoRI fragments— 
the larger of which is human specific - i n somatic cell 
hvbnds 2Fi ->BS and ìAMFig ЗА) We therefore con 
sider it likely thai all cDNAs are derived from the same 
transcriptional unit Four of the eight cDNA clones con 
lained repetitive sequences Whether or not this is due 
to the presence ol intron sequences containing S I N b or 
LINE elements is presentK not known Of all clones 
onlv clone 11 1 containing the largest insert (2 1 kh) 
with no repetitive sequences was taken tor lurther anal 
\sis It maps to an 18 kb ¿coRI Iragment situated near 
thcT7endofcosmidsF I i864andF2)240 (Fig 1A) 1 he 
11 1 cDNA insert sequence did not reveal any significant 
homology to sequences present in databases and there 
tore did not yield a clue as to the function of the protein 
product A partial restriction map of the insert in 11 1 is 
shown in Fig 3B 
As can be seen in Fig 1A, the 11 1 locus is positioned 
slightly distal to the X75b VSSM region This renders 
gene I l i a less likely candidate for DM, but we cannot 
at this moment exclude any eis regulatory position ef 
fects of the causative mutation Therefore we may ulti 
mately have to type all expressed elements in and just 
around the entire area bracketed by crossover events 
We have demonstrated here that it is feasible to use 
large fragments of human cosmids directly as probes on 
a mouse brain cDNA library to identity such sequences 
In summary by the development of a novel 12 allelic 
(TG)„ marker system and the identification of a cross 
over m a French Canadian family we have established a 
new distal genetic border for the area in which the DM 
mutation resides The new marker forms a highly valu 
able diagnostic tool for DM Recently using a strategy 
•г 
о 
о 
•г-
# * 
i? « 
• -
с? 
о 
ι-
я в . • 18 КЬр 
С 
_U_I 
Psií 
ι 
»ιοί 
Smai £Vt>RI Apai 
- I M - L _ J 
FIG 3 Chromosomal loiali7dtion and restriction md|> ol mouse 
brain c D \ \ clone 11 1 (Al Vitoradiogr lm showing Southern h \ b n d 
i/ition signais ol / inRI digested DNAs from human and r n m s i e r 
ci ntrol and somatic cell h\hrids 2 F ) Г>111 md 1A 1 using the 'IMd 
hi led insert f c D N A l l 1 as ι probe IB) Par t i l i restricliun m ipol the 
insert ul m use br in i i D \ Λ ( 1 ne 111 Гпе open bars represent ν e( 
tor DNA 
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involving cosmid walking and convent lonal RFLP anal> 
sis, several new useful markers were identified in the 
proximal segment of the DM area (Shutter el al, 1992) 
This enabled us to determine the location of a proximal 
ERCCl DM crossover in a Dutch family with high pre 
cisión On the basis of YAC cloning data ( Asian idis*>f al, 
1992), we now estimate the physical length of the seg 
ment separating these crossovers to span not more than 
0 25 Mb oí DNA The 130-kb contig centromenc to the 
X75b-VSSM anchor locus forms the hrst characterized 
distal segment herein and is ideal starting material for 
attempts to clone candidate cDNAs for DM 
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CHAPTER 
2.2 
Cloning of the essential myotonic dystrophy region 
and mapping of the putative defect 
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M Y O T O N I C dystrophy is a common dominant disorder (global 
incidence of 1:8,000) with variable onset and a protean nature of 
Symptoms mainly involving progressive muscle wasting, myotonia 
and cataracts1. To define the molecular defect, we have cloned the 
essential region of chromosome 19ql3.3, including proximal and 
distal markers2 7 in a 700-kilobase contig formed by overlapping 
cosmids and yeast artificial chromosomes (YACs). The central 
part of the contig bridges an area of about 350 kilobases between 
two new Hanking crossover borders45. This segment has been 
extensively characterized through the isolation of five YAC clones 
and the subsequent subcloning in cosmids from which a detailed 
f t « H I, Hind I I I , Vf/ul and Vori restriction map has been derived. 
I wo genomic probes and two homologous complementary DNA 
probes were isolated using the cosmids. These probes are all 
situated within —10 kilobases of genomic DNA and deled an 
unstable genomic segment in myotonic djstrophy patients. The 
length variation in this segment shows similarities to the instability 
seen at the fragile X locus". The physical map location and the 
genetic characteristics of the length polymorphism is compatible 
with a direct role in the pathogenesis of myotonic dystrophy. 
As j prerequisite to the isolation and characterization of the 
defect causing myotonic dystroph) ( D M ) , vve have prepared 
cosmid conligs by chromosome walking in our chromosome 
19-ennched cosmid l ibrary9 starting from polymorphic markers 
I To whom correspondence should be addressed 
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FIG 1 Physical and genette map for the DM region of chromo 
some 1 9 q l 3 3 The map shows the pos tion of various genetic 
loci relat ve to the position of overlapping YAC cones and a 
proximal 350 kb (A) and distal 150 kb IB) cosmid contig The 
cosmid contigs (solid back bars were prepared by chromo 
some walking start ing from the proximal ERCC1 locus and 
the distal D19S112 locus as described*15 New polymorphic 
loci have been derived from the proximal contg D19S118 
(ref 121 D19S119 irei 13) and D19S195 ¡ref 21 Marker 
D19S63 represents the pos tion of an independent y isolated 
polymorphic marke r 2 2 2 3 revea ing the same poymorphism 
as D19SÎ19 The region designated as essential is flanked 
by the nearest crossover markers The location of the elusive 
DM locus s restricted to this essential area ERCC1 and 
D19S51 were the previously closest flanking markers6 7 YAC 
clones used here are indicated by grey bars The cross 
hatched regions in one οΓ the YACs indicate uncertainties 
with respect to the origin of the ends based on the fnding 
that this YAC (101F2) maps to multiple human chromosomes 
as scored by in situ hybridization (MV unpublished results) The dashed 
areas η two of the YACs (483E7 С and 4 8 3 11) indicate regions deleted 
in the highly unstable origina clone (manuscript in preparation) The clones 
231G8 215B3 and 168D1 are unstable showing multiple bands in the range 
of 180 2 5 0 kb The YACs are designated as for the St Louis YAC l ibrary 1 4 
ERCC1 D19S118 D19S119 D19S195 
D19S63 
LL145 
LL146 
E s s e n t i a l r e g i o n 
LL147 D19S51 
LL148 
except that plate numbering is different 1 0 1 F 2 - A 1 0 7 F 2 1 6 8 D 1 A51D1 
215B3 B5B3 2 3 1 G 8 - A 2 5 G B a n d 4 8 3 E 7 B136E7 CEN and TER ndicate 
the centromere and l e o m e n c directions PCR primers derived from the 
vector insert j u n c t o n s of YAC 231G8 are md cated as LL145 146 and 
LL147 148 'manuscr pt η preparation) 
flanking the DM region We thus established a cosmid contig 
extending ISO kilobases (kb) towards DM from the proximal 
flanking marker ERC С 1 (refs 2 4) a small cosmid/YAC contig 
around the distal marker* 1(l and a 150 kb cosmid contig around 
locub DÌ9S112 (refi S 11) Several new polvmorphic markers 
thai were informarne in DM families were derived from the 
proximal cosmid contig4 These markers have permitted the 
mapping of a proximal crossover in between D19S1ÌS (ref 12) 
and DÏ9SÏ19 (ref П) hence eliminating about 200 kb from 
the proximal side of the DM candidate region4 A highlv infor 
mative marker X7SbVSSM has been developed which lies 
within a few kb of D19SÍÍ2 (ref 5) This marker is informati\e 
in a distal crossover familv so is the nearest distal marker 
flanking the DM candidate region On the basis of the orientation 
ofthe two flanking cosmid contigs and the positions of the new 
DM flanking markers, we estimate that about 220 kb of the 
candidate region is represented in the two contigs established 
by chromosome walking"1 * Figure 1 shows a map of the DM 
region including the location of various markers and contigs 
To characterize the region between the distal and proximal 
cosmid contigs we isolated and mapped cosmid clones from 
the central DM region We could not extend the contigs b> 
chromosome walking because we were unable to find lurther 
o v e r l a p p i n g c l o n e s in the e i g h t f o l d r e d u n d a n t c h r o m o s o m e 19 
c o s m i d h b r a r v W e t h e r e f o r e s e a r c h e d a Y A C l i b r a r v u h ν s c r e e n 
i n g w i t h ρ « I % rnerase c h a i n r e a c t i o n ( P C R ) p r i m e r s f o r the X 7 ^ b 
V S S M ( f o r D19S112 ( r e f s S ] 1 ) a n d D19SH9 ( r e f M i l w h i c h 
are d e n \ e d f r o m t h e d i s t a l a n d p r o x i m a l c o s m i d c o n t i g s respec 
t i v e l v L s e o f t h e D19SÌI9 p r i m e r pa i r r e s u l t e d in t h e i s o l a t i o n 
o f а "ЬО k b c h i m a e n c Y A C 1 0 1 F 2 w i t h i n s e r t s e q u e n c e s s p a n 
n i n g - 2 0 0 k b o f t h e p r o x i m a l c o s m i d c o n t i g ( F i g 1 ) W i t h t h e 
d i s t a l \ 7 5 b V S S M p r i m e r s t h r e e new Y A C c l o n e s w e r e i s o l a t e d 
T w o o f t h e s e Y A C s ( 2 H B 1 2 4 1 G 8 ) w e r e a n a l > s c d i n m o r e 
d e t a i l r e v e a l i n g b o t h c l o n e s t o be n o n c h i m a e n c a n d u n s t a b l e 
U s i n g A l u P C R p r o d u c t s f r o m 2 Ì 1 G 8 to p r o b e the c h r o m o s o m e 
19 c o s m i d l i b r a r v a s m a l l c o s m i d c o n t i g c o n s i s t i n g o f c l o n e s 
H S S 9 4 a n d F l 8 4 1 1 was e s t a b l i s h e d in the c e n t r a l g a p r e g i o n 
( C A , u n p u b l i s h e d d a t a a n d F i g 2) N e w PC R p r i m e r s d e r i v e d 
f r o m the v e c t o r / i n s e r t l u n c t i o n s f r o m 2 1 1 G 8 w e r e used to i so la te 
v a r i o u s n e w Y A C s i n c l u d i n g the h i g h l y uns tab le 4 8 1 F 7 c l o n e 
( F i g 1) T h i s Y A C o v e r l a p s w i t h the p r o x i m a l Y A C 101F2 a n d 
the d i s t a l Y A C 2 И В Ч T h e e x t r e m e i n s t a b i h t v o f t h i s b r i d g i n g 
Y A C c l o n e w a s e v i d e n t f r o m the m a n y r e l a t e d Y A C b a n d s 
r a n g i n g f r o m И 0 2S0 k b w i t h o n l y a m i n o r t r a c e o f the 120 k b 
u n d e l e t e d f o r m ( n o t s h o w n ) T w o s t a b i l i z e d d e l e t i o n f o r m s 
( 4 8 1 F 7 С 180 k b a n d 4 8 Ì F 7 11 24> k b ) a n d Y A C 2 И В 1 w e r e 
FIG 2 Cosmid contig map for the central DM region Cosmids 
derived f rom the chromosome 19 library are shown as black bars 
and their identification numbers are preceded with F cosmids 
obtained by subclon ng from YACs are shown as white bars 
F cosmids on the left (proximal contig) or right (distal contig) 
were originally round by chromosome walking in the chromosome 
1 9 c o s m i d library as d e s c r i b e d 4 5 Cosmids between the proximal 
and distal contigs were found by hybridization with Alu PCR 
products from YAC 231G8 (for cosmids F18894 and F18431) or 
were generated by subcloning f rom YACs 483E7 С (identification 
number preceded by Ya) and 231G8 (preceded by Yc) The YACs 
were subcloned in the Lawnst 1 3 vector following partial Mbo\ 
digestion of total yeast plus YAC DNA Clones with human inserts 
were screened by colony hybridization with human repetit ve DNA 
probes using standard techniques Cosmid overlaps were estab 
lished using chromosome walking as before" 1 5 and by fluorescent fingerprint 
ing of cosmid D N A s l b 1 6 Overlaps were also confirmed by the construction 
of an EcoRI and H/ndlll restriction map for the entire contig Only the central 
part of this restriction map is depicted (Fig 3) The restriction map was 
used to locate sites for two rare cutting restriction enzymes relative to the 
EcoRI and Hind\\\ sites The location of Noti and Mlu\ s i tes are indicated 
along the hor zontal bar showing the DNA length in kb from locus D19S119 
the s tes are designated as N or M with subscripts indicat ng the iden 
Y-i CP o"j 
Sa OC 7 ^ ^ ^ _ 
D19S119 
D19S63 
N j N 5 M 6 
D19S195 
M a 
D19S201 
M 9 
D19S112 
X75 VSSM 
t fication number of the part cu ar site starting from the more proximal 
ERCC1 locus Sites with lower subscript numbers have been described as 
part of the próxima cosmid contig4 Note the high frequency of occurrence 
within the 700 kb contig 9 /VoiI sites and 10 Mlu sites Also md cated are 
the precise locatons derived f rom the FroRI Hind II map for various loc 
D19S119 (ref 13) DÎ9S63 (refs 22 23) D19SÎ95 (ref 21) D19S201 
(ref 17) and D 1 3 S Î 1 2 (ref 11) The location of the EcoRI fragment conta ning 
the var able length po ymorphism is designated by VLP 
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FIG 3 Restriction map of the central DM region Restriction 
siles for fcoRI and Мл dill are indicated along the overlap 
ping cosm ds and along a horizontal bar indicating the 
distance m kb starting from the Dl9S119 locus13 Amplified 
portion of the map shows the locations of probes discussed 
m the text and used to detect the variable length polymorph 
ism (VLP) in DM patients 
Yd 00259 b - ¡ -
Yc 100263 ^" "^ 
У ι V , A° ι У , 1P° , ' i " 
Fl6625 l· j l l -
F2394B "—T-
.1.« . 1JW» , 
- ι — Ί " - m "-π—i—г-
45H9 
pDMR B15 
pQPI S 
Y 
„ „ <L_L 
pGB2 6 
LT—Г ГГ 
pDMR N9 
_ VLP fragment 
subcloned into cosmids lor detailed genorrm analysis (see H g 
2 legend) The resulting cosmids were ordered I Fig 2) bv 
chromosome w a l k i n g ' s and b\ cosnud fingerprinting1^16 I o 
help with ihe localization ol candidate genes a restriction map 
for f t í í R I , Hinâlll, \1lu\ and \ o r I sites was made for the 
central D M <irea (Figs 2 and 1) 
To isolate candidate genes lor D M we searched for cDNAs 
corresponding to \anous cosmids from the central D M region 
Two dis l tnu cDNA clones ( p D M R Н И .mei p D M R N9) were 
found in a mouse brain lambdaZAP L D M A hbrar\ using the 
o\erlapping cosmids H 8 8 4 4 and Val(H)26^ as probes, respec 
lively ( G J , manusenpt in preparation) In addit ion, using a 
cosmid (Ya 100172) largely overlapping with I 1H894, a 700 base 
pair (bp) ς truncated c D N A (45H9I was isolated Irom a human 
fetal brain c D N A library' Comparison ol partial 1 c D N A 
sequences Irom p D M R В И and 4^H9 indicates that these 
c D N A s represent the murine and human lorms ol the same 
FIG 4 Pedigree and Southern blot analysis of a three generation DM family 
The pedgree il ustrates affected males (black squares] and females (black 
circles! that show clinical manifestations of DM The DM affected md viduals 
in generations l and II show both clinical and electromyographic evidence 
of myotonia using the criteria defined in ref 24 Three affected individuals 
born with the congenital form of the disease (designated by с I are shown 
in generation III Southern blot analysis with probe pGPl 5 was done on 
Hindlil digested DNA from peripheral blood leukocytes for all individuals 
Normal members of the family (open squares and cire es) display polymorph с 
/-/indili fragments of 8 5 and 9 8 kb The DM affected grandfather (individual 
I 1) shows enlarged Мл dill bands «segregating with the DM chromosome 
The affected individuals of generation II have all inherited expanded alleles 
slightly larger than those seen m individual I 1 All three congenital DM 
patients of generation III show even larger DM associated Нти\\\ alleles (up 
to 15 0kb) Note that the hybridirahon signals of the expanded alleles 
appear blurred implying variability in the size of the enlarged Hmdlll bands 
and suggest ng nstabil ty of the DM region w th somat с cell heterogeneity 
gene (G J unpublished results) 1 his conclusion is corroborated 
h\ the mapping of the two c D N A s lo (he same 10-kb EcoK\ 
Iragment in F l 8 X 9 4 a n d 9 kb Fa>R\ fragment in Ya 100261 (Fig 
*l The / t o R I fragments in (hese iwo cosmids have been derived 
from different mdi\ iduals and correspond to allelic lorms which 
have also been delected using p D M R HI'S as a probe on genomic 
f-<"Rl blots from normal individuals (not shown! Surpnsingh 
p D M R B h detects a \er\ unusual variable length pol>morph 
ism (VLP) in E i f i R I or K/î/iI-digested D N A from D M patients 
with allele sizes ranging between 1 0 - И к Ь (not shown) This 
haN also been observed using various genomic probes derived 
from the same segment o( cosmid Ya 100261 on Soulhern blots 
ol D N A Irom D M patients digested with f t u R l . H i n d l l l or 
Kpn\ Probe pGIM \ containing a 1 S kb genomic AVI fragment 
( hig 1) reveals the identical F U J R I variable length polvmorph 
ism Inol shown) and also detects a H r n d l l l p o k m o r p h i s m in 
D M patients ( h g 4) In the normal human populat ion (over 
1(H) individuals analysed), two H r n d l l l allele sizes of 8 S and 
У ^ kb have been lound using the p G P l ^ probe In contrast a 
survev ol - 2 0 0 D M affected individuals reveals increased Hin 
d i l l allele sizes in the range of 9 S to И kb in nearly 70% of 
the molecularlv diagnosed D M individuals This is illustrated 
in a three generation D M familv I h g 4) Stnkingl>, the allele 
sizes appear to increase in successive generations of this D M 
familv correlating with an increased seventy o f the disease The 
individuals in generation I I I , which suffer from a severe con 
genital form of the disease, also have the largest ( 1 S kb) H i n d l l l 
alleles We are m the process of analysing all our D M families 
I η - 200) to establish whether there is a strict positive correlation 
between the expanding allele size and the seventy ol ihe disease 
The same variable length polvmorphism patterns have been 
observed lor probe pGB2 6 which is shghtlv more distal than 
p G P l s (Fig Ì ) , and for cDNA2S (ref 18) cDNA2S hvbndizes 
to our cosmid F1K894 (K. J unpublished results) and so may 
be homologous to our cDNAs Н И and 4^H9 
Through the use of YAC and cosmid cloning strategies and 
novel mapping approaches, we have identified a segment of 
10 kb D N A containing a highly unstable genomic sequence B\ 
Southern blot analysis, this instability appears to be similar to 
the genomic events ьееп in fragile X syndrome* ' ' : u and in 
spinal and bulbar muscular atrophy 1 The sequence tends to 
increase in size only in D M affected individuals and is situated 
ad|acent to a transcribed region Other transcribed regions are 
in the immediate vicinilv ol this gene Although we have no 
proof thai expressed sequences are directly involved, we now 
have the lools to studv (he genetic eyenls that result in the 
development and transmission ol the compie* clinical features 
in mvotonu dystrophy С 
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CHAPTER 
2.3 
Characterization of the myotonic dystrophy region 
predicts multiple protein isoform-encoding mRNAs 
Nature Genetics 1: 261-266 (1992) 
Characterization of the myotonic 
dystrophy region predicts multiple 
protein isoform-encoding mRNAs 
Drpartmnit of ( ill 
liiolag) and 
Histology Iaculi) 
of Meditai Sc it ма 
i т ігъЯ) of 
Лі;ш<лім 1' О Box 
9101 ЬМЮПН 
\./шіііп ¡he 
\etherland 
lh\i>wn ol 
(struttili С liililnris 
Ho pita! ol bucini 
üllfttno ami 
Depart пи ш of 
MurobioU\\ ami 
¡тпшпоіоч) 
I ni\a<it\ of 
Ottawa Ottawa 
( amida 
Human (jinonit 
( entir lìiotntiliuil 
Vf( mi * Пи ¡itoti 
¡aw η ми I i\trriiore 
\atwnal 
{abaratan 
11\ erniari 
( tiliforrna 94^0 
L S 4 
Department of 
Human (nmtw. 
Ьш,егыІ) of 
Leiden Leiden ¡lu 
Netherlands 
( or respondí me 
ilwulil bea Ыге^еіі 
to BW 
G. Jansen', M Mahadevan , С. Атстіуи\ N Wormskamp1, Б Segers1, VV Hendriks, 
K. 0 'Hoy\S Bdird , I Sabounn,G I e n n o n \ P I Jap',D lies1, M. Cocrwinkel1, M. 
Hofker^A V Carrano\P J de Jong\R G Korneluk & В Wiennga1 
The mutation underlying myotonic dystrophy (DM) has been identified as an expansion 
of a polymorphic CTG-repeat in a gene encoding protein kinase activity Brain and heart 
transcripts of the DM-kmase {DMR-B15) gene are subject to alternative RNA splicing in 
both human and mouse The unstable [CTG]530 motif is found uniquely in humans, 
although the flanking nucleotides are also present in mouse Characterization of the DM 
region of both species reveals another active gene {DMR-N9) in close proximity to the 
kinase gene DMR-N9 transcripts, mainly expressed in brain and testis, possess a 
single, large open reading frame, but the function of its protein product is unknown 
Clinical manifestation of DM may be caused by the expanded CTG-repeat 
compromising the (alternative) expression of DM-kmase or DMR-N9 proteins 
M v o t o n i c c h s t r o p h s is an a u t o s o m a l d o m i n a n t 
multisystemic disorder char.icten/ed b\ <i highK \ in iblc 
clinical phenotype Rccuulv the mutation undcrkmi» 
DM was localized lo a small segment in chromosome 
19ql3 1 (refs 2 ί) I Ins DNA legion displays extiuru 
kngth variation' due to changes within а С 1 (J 
trinucleotide repeal ' Long, expanded repeats which 
seem to be unsi ihlc both muolicalb and nitoticalb an. 
found uniquch in DM indmduals and prehmin ir\ 
evidence points lo л torre! it ion bttween clinic il s t u n t s 
and length ot this simple sequence motif' " I he unstable 
С IG motif tornis part ot the last exon of a gene encoding 
a putative serine threonine protein kinast product 
Although it was icportcd that this gene is expressed in 
tissues affected by the disease no details on the pat hologu al 
effects of the mutation haveemeiged Asa first approach 
to study the molecular and cellular events involved in 
DM, we undertook to resolve the tunctional org mi/ ilion 
of transcribed sequences in and around the DM locus b\ 
taking advantage otlhe evolutionär) conservation ol ihe 
relevant chromosome area in man and mouse 
Genomic organization in the D M area 
Bv using pooled LcoRi fragments of the two hum m 
cosmids that span the ( Τ Π repe il region as probes on 
mouse brain or human letal brain and heart libraries we 
isolated a variety ol clones with inserts ranging belwtui 
1 1 and 2 6 kilobases (kb) Restriction analysis indicated 
that these clones fall into two classe s which represent ihe 
products of two distinct transcribed regions DMR Hl^ 
(that is, the DM kinase gene) and DMR N9 (Fig 1) 
Hvbndization on Southern blots from human and mouse 
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Fig 1 Maps of the essential myotonic dystrophy regions 
and the transcribed sequences m human and mouse a 
Only the relevant EcoRI Ηιηύ\\\ and SamHI genomic 
restriction fragments ot human and mouse are given (open 
bars) The posilion of the variable CTG repeat sequence is 
md caled by a pair of interrupted vertical lines Regions 
with homology to the human [hDMR B15) or mouse 
{mDMR B15 and mDMR N9) cDNAs that is the two 
distinct transcribed reg ons are given as closed black bars 
beside the restriction fragments Sequence identity was 
based on hybridization assays and the positions of introns 
is not specified further The actual sequences are given in 
Figs 2 and 3 The transcriptional orientation of both genes 
is indicated by arrows b Partial restrict on maps of the 
longest mouse DMR cDNAs DMR B15 (2 6 kbp) and 
DMR N9 (2 1 kbp) including the adjacent vector 
sequences В SamHI E EcoRI N Nco\ Ρ Psfl and X 
X/iol 
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more detail, the entire (.DNA sequences were determined 
.... .« ... « « „ „ . « « , „ „ , « « , .«« ,„ , f „ ™ • = « - 3 T h e m u n n c D M R . | V 9 t D N A s c o n t a i n a j ingle large 
? " * 1 " ? ΐ Τ Ϊ ? ί " ! Τ ? 7 ΐ ΐ 7 " ϊ ϊ ϊ ΐ 'S consensus open reading frame (ÜRF) consisting of 568 
Τ'!c*5T c!' ΐ * ί * " ' * ! ( ΐ Τ ' « * ' ! ( ' î * Τ * ΐ Ύ Τ ( " Τ ΎΎ f Τ f 'ίί codons which starts at the second base in the longest 
» « « д н и » . ι « ι « » ι < ι · κ > « ϋ ΐ « ι · > · ι > » a· cDN'A (2160 hp. Fig 2) A search of the NBRF and 
LLLLLLLtL...'.,L LLLL... LLLLL«....... Ζ bwissProt databases wi th the predicted D M R - N 9 amino 
1
 • • ' "
 l
 '" acid sequence revealed no significant sequence homology 
MS ISC CU Kt «M t u SU iet CU HC CM CCI ICI CM «С Ml CCC UC CCI I1C CIC HC IIC GIC UB ' ° ' У 
• « . · · • ι • . • ι · • • ι ι с . с . . . . . tu
 t o a n v 0 ( t n c known protein sequences except for the 
isc см ac tec ice tec MC cci ccc см u t M I etc eie u i см «ci ем ecc i n eel etc u i cci u i
 c I L L С _ . . 
• • ' с ι ι ι . > . • ι с ι • . e . e . ι » . ι ut presence of an unusual h igh content or p u t a t i v e 
"
,
Τ ' , Τ ? ? ' , " " . , ; ' Τ " ι > , ί " ! " ί ' ϊ ΐ " " Γ " " ! " : " . " i ghcosslation sues PoU(A) tails were identif ied at two 
мс tei cet u t ecc cu eie t u e « tei etc ice uc eit see tee cu en etc ме uc m eie ice cu a l t C m a t l \ C Sl tCS 4 1 2 a n d 4 5 0 Ь р d o w n s t r e a m o f t h e S t o p 
ite ем ets est e« etc ne ne ш t u i t i ecc еет eie eu tei eie ice ice ice cet eit eec ece τι» c o d o n I h e s e p o K ( A ) t a i l s a r e p r e c e d e d Ь \ T a t h e t U n U S U a l 
. M eie etc u i eci ссе ем с . ем t u cc « . cu tee ι . ne ме ем eet cei eu eie ее. cc m S e q U C l l C C I l l O t l l s , A A A T T A a n d Α Τ Τ Ί A 1 A , w h i c h a r e , 
ш
 however, at the appropriate polyadenylalion signal 
ccc c«t ecc eie ме tee tee etc ш « ι eu eec m « ι ece і м ке м і ссс cet ем ем ecc ссе t u г г г г / / с? 
' " ' " " ' " ' " ' ' · ' * ' ' ' ' • ' • • " · ™ location Pre l iminar) data on h u m a n D M R - N 9 c D N A s as 
tei ecc Mt cet eit cci eit ccc « t cet ем uc CM CM eet u i cu ice ice t u uc i u cu ece eie ,, ^ . , , , . . . . . л 
• • • • • ' · ' • с ι ι e ι > ι . ι • e e ι e • JM well as g e n o m i c D N A s revealed that these motifs are 
eu eie tee cu cu ce. u . ce. eçc tee ne Me . . . ece . . . ece , u е.. ш ем uc u , eje ... , »
 m ¿ e L ¿ c o n s e r v e d b e t w e e n m O U S e a n d m a n W e S U r t T l l S e 
.ее cu .ее uc cc ic i si i sit se etc tee eet eu eec lei cu ecc cet ice ece ice eii ece ece ieri t h . i t t h e ) a r e U s e d r a t h e r i n e t f l L i e i i t l v a S W C h a V C i d e n t i f i e d 
ic i cet cet ccc .ce eu eu cet ici est ici te. ccc ecc eu ем M I u t su ecc ece ets eec eec , i>. p a r t i a l C O N A s t h a t СЭГГ l o n g e r 3 U n t r a n s l a t e d S e g m e n t i 
•ce cu « ι ce ce uc M I CU CU UC CU « ι eci set ccc I M set u t uc eet u . ec· .ce i.e ,!» I h e s e c D N A s h a v e t e r m i n i c o r r e s p o n d i n g t o a s t r e t c h o f 
2 I A residues that is located at 720 bp further downstream 
us cc. ccc i . i cu ..с ме п . ecc ссе ... ecc M I eu мс cu см ue ces ccc uc cu eu ce. .ne r 1
 ' • ' ' • · ι s . ι • . ι . ι . ι • • e • e • u m t h c g e n o m ic D N A ( data not shown ) Interestingly, this 
uc us u i см u i ccc .м u . ice cu sei cu ite мс ccc eet ем M I cu ccc u . мс мс u . .uc , , , , i r . ι . . 
• • с e . ι ι . e e . с e • ι • • .» genoiinc|A| , streich isonlva lew hundred bases upstream 
ue us eie ist sc. е.. se. eçc eu ме eu t u см eu « ι us su . . . u . мс eu cu •« ce, u »
 o f , η ( . b e g i n n i n g θ ! t h e k i n a s e d o m a i n 1П О Ц Г l o n g e s t 
cçc ire u t eie eie eu eu c.e ue cet eu su tee us us l i t cet eçc u · ese cíe ice eje eu i m c D N A , 1П k e e p i n g W i t h O U r Ь у Ь Ы і / а І І О П m a p p i n g d d t a 
eu ne eu см u t ut ne ne M I ecc tec см см ecc cu ne ice uc ι α ccc uc α ϊ esc uc n u * i l l O W I l 111 F i g I 
ses ne м . e« u s uc ме ue ccc ем ее. cec ем eu м. .cc ccc MS l u ccc мс u s t u е.. . « . F o i t h e a i i a l v S C S O Í t h e C S S e i l t i a l C o d i n g i n f o r m a t i o n 1П 
с e ι ι . о . s · . · . > . . > . . ι ν ». ^ DMR B15 transcripts, we compared mouse c D N A 
е.. uc see >ic ice ice см cu ccc »cc tec uc Mt все M I SIS SIS I U M tciecneic tnc r ' 
' ' ' ' ' · · ' ' ' ' ' ' ' ' " " ' "· sequences and human sequences determined from both 
UTCIICCCe CCCICCtMC UIMCCCIC CCCUIUCC lUMMtU CISIllIlM IMMIMIC І І Я , . . . . . • • tl L 1 /Г-
i i u i e u M uciecieu мсссмес t c u u u t . „ « c c c , « ее,«.,.« есемеиіе , - Р З Г " а І C D N A c l o l l C S Л П І i m M g d l O m i C S U b c l o n C S ( F l g 
ccuisiMisiccicisu«cites«euieetceMcuei«eMeucutueciei ieicis i n i l i l a n d d a t a p u b l i s h e d p r e v i o u s l y " ) T h e 2 , 5 6 1 Ь р 
uic.iCMi eiuMCiii tcecieic« MuieicM uiicMicc icccMicM ч м а с і и zot» C O I I S C I I S U S S C q U C I l C C O f t h e l o i l g C S t І П и Г І П е DMR-B15 
eiiccccc eiuueecc месемм. еик.ссм , « . « « M «ecu,.« „ « i . i c c , » . ^
Ν Μ r c , v c a l c d a n 0 р С П r e a d i n g frame ( O R F ) o f 4 4 1 
ciciu.Mi uMCisi i i eciuiscc. «cciue« cceicciici rccccieue ciciiiTMi neo ' тч ι ι 
¡сепией смеси«.·] ' ...м ammo acids, starting at position 2 Preliminary results 
f r o m p r i m e r extension experiments indicated that 
approximately 400 nucleotides upstream of the first base 
are missing Irom our longest (2 6 kb) mouse DMR-B15 
Fig 2 Consensus sequence of the murine DMR N9 cDNAs
 c D N A ( n o t shown) 1 he human clones, although longer 
The composite sequence assembled from overlapping
 m , , ) l r e c , l u n , w e r e . i l s o m . s s . n g l h e A T G s t a , t c o d o n a n d 
cDNA clones is shown above the deduced ammo acid . , , . . ° . ,
 c , 
sequence Nucleotides are numbered starting with the first t h c r c S ' ° " encoding the N terminus Similar findings 
base of the sequence and specify an open reading frame w c r e reported for a c D N A (C28) f rom frontal cortex 
(ORF) of 568 codons The putative polyadenylation signal n iRNA and we have recently found that the largest c D N A 
sequences are underlined the last nucleotide before the published (3186 bp)" contains a large stretch of in t ron 
two possible poly(A) tails are indicated by an arrowhead sequence (710 bp, not shown) at Us 5 terminus As all our 
Throughout the putative protein sequence four attempts to isolate the relevant sequences f r o m other 
glycosylation sites N-X-S/0 are predicted ' . , , , . . , Λ . , . 
cüNA libraries have tailed we decided to predict this 
informat ion by sequencing the appropriate segments in 
human and mouse cosmids As yet, roughly 1,500 bp of 
genomic DNAs and a chromosome 19q specific somatic human sequence and 600 bp of mouse genomic sequences 
cell hybrid panel ' revealed that thc transcribed regions are have been determined (sequencesavailable upon request) 
unique and do indeed map to 19ql3 2-13 3 (not shown) Although thc sequence data conf i rm the close prox imi ty 
Using the appropriate 5' and 3' specific segments from of the DMR Bi">and DMR-N9 genes as outl ined above, 
both cDNAs (not shown) we established, in both species, weobtained nocluesabout the location of the translational 
that the transcriptional directions were identical and the or transcriptional start sites of DMR-BI5 w i th in the 
t ranscr ipt ion i in i lsarewi th inasegnientof ro i ig l i l ) 20 26 intergenic region 
kb o l genomic DNA (Fig Π In humans, where the Farl ierwcandothers Reported the identif ication of up 
chromosomal orientation ol the cosmici contig is knov\n, to 4 0 % identity between thc putative translation product 
the genes have a telomere to centromere pola π t\ W o r k is o f DMR Β/τ and the conserved catalytic core c o m m o n to 
currenlls inprogrcsstocstabl ishthcoricntat iononmousc serine threonine specific protein kinases This family of 
chromosome 7 which, f rom genet к data' v%e expect to be kinases includes the S6 specific kinases, с A M Ρ dependent 
in the opposite direction kinases and protein kinases С ( in decreasing order of 
homolog\ ) and is phvlogeneticallv related to the family of 
Putative functions of gene products protein η rosine kinases A protein homologvcompanson 
In order to .indisse the strutture ol the cloned DNAs in revealedthalapproximateh 7%of theaminoacidresidues 47 
Fig 3 Sequence alignments of partial cDNAs and genomic 
DNA subclones and deduced ammo-acids sequences for 
the putative DM kinase (DMR-B15) m mouse and human 
a, The composite sequence assembled from overlapping 
cDNA clones is shown above the deduced ammo-acid 
sequence Nucleotides and amino acids are numbered 
starting with the first base of the determined sequence for 
each species The murine sequence of 2,561 nucleotides 
contains an ORF of 1,323 residues, specifying 441 amino 
acids The human sequence extends further 5' and 
specifies 621 amino acids It is a consensus of several 
sequences of partial cDNAs and genomic DNA subclones 
and has been partially published elsewhere9 Only variant 
nucleotide positions are shown in the human sequences 
which are shown underneath the consensus mouse cDNA 
sequence As in these clones, except for the length of the 
CTG-repeat (shaded area, [CTG]S in the cDNAs and 
[CTG],,
 ûr2Q in the genomic DNAs) sequences were 
completely identical, only one sequence for the entire 
region in humans is given Shaded area I (mouse cDNA 
positions 636-722), containing 87 nucleotide residues, 
encodes 29 amino acids and was absent in some cDNAs 
It presumably corresponds to an alternatively spliced 
exon Additional cDNA clones, in which the shaded intron 
regions II (mcDNA positions 7 5-79Э due to alternative 
use of 5 splice site), III (mcDNA positions ΘΘ6-997) IV 
(mcDNA positions 1260-1430) or V (1478-1606) are 
absent, have been identified Human cDNAs with shaded 
areas II or VI missing were also isolated The 3 
untranslated region of all mouse cDNAs now typed 
includes the 5'-CTGCTGCAGCAGCTG-3 motif, which is 
the homologue of the human expanding [CTG]n repeat 
(see text) Poly(A) tails in the various clones were of 
variable length (17-2Θ residues) The putative 
polyadenylation signal is underlined, the CTG-like segment 
is boxed Intron-exon boundenes are indicated with 
arrows For the sake of clarity, some alternative C-terminal 
reading frames have been omitted b, Structural diversity in 
DMR-B15 transcripts of mouse and human Alternative 
combinations of coding information in various cDNA 
inserts are shown The numbering of the black blocks 
corresponds to the numbering of the shaded areas in Fig 
3a The 3 ends of the inferred ORF's differ m length and 
codon usage between cDNAs for both species Four 
different mouse cDNA types and three different human 
cDNA types were found Mouse cDNA type A is missing 
area V, В is missing IV and V, С is missing I and D is 
lacking area II, III, IV and V In human cDNA type A region 
VI is deleted, m В region II is missing Additional cDNAs 
contain both regions 
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in the domain with putative kinase activity, that is, 18 of 
the first 240 residues determined, differ between mouse 
and human (Fig. Зя). The highest conservation is seen at 
the N-terminal side. The -GTPDYLSPEIL- sequence at 
mouse amino acid positions 117-127, which has the 
characteristics of a kinase site involved in the regulation of 
kinase activity through phosphorylation ot the threonine 
residue, is absolutely conserved between both species. 
The conserved DIKPD-sequence motif (mouse residues 
79-83) is a strong indicator of the enzyme's serine/ 
threonine specificity". Only the human sequence is long 
enough to include the -G-G—G/S- amino acid motif. 
This motif is also known as the P-loop domain and 
invariantly found in nucleotide binding proteins and 
kinases12 n (Fig. 3). Following the kinase domain in the 
predicted amino acid sequence, a less well conserved 
domain with significant homology to the α-helical (coiled-
coil) segment of myosins and other myofibrilar or 
filamentous proteins (mouse residues 296-413; up to 
26% identity) was found. This domain ends in an overall 
hydrophobic region which is predicted to be remarkably 
different in mouse and man (see below). 
Alternative splicing of kinase ¡soforms 
A further comparison between all DMR-Bi5cDNA clones 
revealed the existence of several mRNA ¡soforms in mouse 
and human. An 87 bp nucleotide sequence (shaded area 
1, mouse cDNA positions 636-722; Fig. 3) flanked by 
consensus 5' and 3' splice sites and identical to genomic 
DNA sequence, was found absent in some murine cDNAs, 
probably as a result of alternative splicing. This stretch has 
biological significance as it encodes 29 amino acids that 
contribute to the homology to protein kinases. Suprisingly, 
due to an A to G change at position 721, the human 
sequence does not contain the 3' splice site consensus (-
CAG/) of this cryptic intron. This might explain why we 
have not identified human UMR-BJ5cDNAs which lack 
the cognate segment. Other regions that are differentially 
expressed in both human and mouse involve the short -
VSGGG- amino acid motif situated between mouse 
positions 785-799 (due to alternative use of an 5' splice 
site; Fig. 3a, shaded area II) and the stretch of codons 
between nucleotides 886-997 (shaded area III). 
Comparison to genomic sequences of both mouse and 
human revealed that exon-intron junctions are indeed 
present precisely at these positions (see Fig. 3a). 
Furthermore, by using a panel of oligonucleotides 
distributed equally over the DMR-B'5cDNA sequence as 
probes, several murine cDNAs were found that failed to 
hybridize to a primer specific for the translational stop 
sequence at position 1325. Primer sequences both 5' and 
3' to the stop codon region were present and comparison 
of several independent cDN As as well as genomic subclones 
revealed a complex use of intron-exon information around 
and just downstream of this region (shaded areas IV and 
V). Alternative splicing of the 3' segment in human ÜMR-
B15 mRNAs, albeit different from the mouse situation, 
was also observed (shaded area VI). 
A scheme of all mRNA isoforms identified is shown in 
Fig. ib. These mRNAs carry ORFs ending in regions 
which differ in length and use of reading frame. As a 
consequence, different hydrophobic tail pieces are 
predicted for the putative kinases in both species. Most 
cDNAs typed so far originate from brain or heart mRNA 
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Fig. 4 Northern analysis of the tissue expression of DMR-
B15 and DMR-N9 transcripts. The mouse tissues are given 
above the lanes, the DNA probes used were mDMR-B15, 
mDMR-N9, and GAPDH, shown below each panel. The 
position of the mouse 18 and 28S rRNAs are indicated by 
arrows. Glyceraldehyde phosphate dehydrogenase 
(GAPDH) mRNA is shown as a qualitative and quantitative 
control. 
preparations and it is not known whether cell- or tissue 
type is important in the expression of the mRNA variants. 
The finding of alternatively spliced and species specific 
mRNAs with different 3' coding information does not 
necessarily imply that isoproteins with different C-termini 
are produced. Yet, it is tempting to speculate that the 
variable C-terminus of the protein has a regulatory 
function as a kinase inhibitor site14 or functions in the 
differential anchoring of the kinase to cellular structures. 
A situation which issimilar to the findings presented here, 
including (i) various distinct modes of differential RNA 
splicing, (ii) use of donor site GC-dinucleotides, (iii) lack 
of absolute conservation of exon borders and (iv) 
differential use of stop codons in the alternatively spliced 
RNA products, has been shown for the muscle myosin 
heavy-chain gene1'. 
T h e C T G - r e p e a t is transcribed but untranslated 
As seen in Fig. 3, sequences at the 3' end of the human and 
mouse mRNAs are almost identical and colinear with 
genomic sequences. Immediatelyaroundthepolymorphic 
stretch of CTG-trinucleotides, the partial human cDNAs 
and the genomic DNAs of different human individuals' 
show perfect identity whilst there is a relatively poor 
match to the mouse cDNA. Upstream of the CTG-repeat, 
around the area of the stop codons (murinecDNA position 
49 
]8->2) and further з the homolog\ between the human 
and mouse sequence* is conspicuouslv stronger In all 
mouse and human DMR B Ì J L D N A S the repeat or repeat 
like motif is preceded by stop codons in ill three reading 
fnmes indicating ih it the CTG repeU forms part ot the 
} untranslated regionof thegene transcripUsl Inmouse 
the motif is interrupted b\ tuo A residues and contains 
onlv τ trinucleotides In the D\A ot healths human 
individuals onK relativelv short vanints of the repeat 
with variable lengths r inging be tu ten ь-30 trinucleotide 
elements "aresecn Yctherealso the [CIC,] repeatsi/e 
is*by far the most prominent (frequency > 40%) in 
keeping with the hypothesis that this represents the most 
ancient motif from which all other allelic repeat lengths 
have evolved 
Tissue specific expression of DMR-B15 and DMR-N9 
We analysed the tissue distribution oí normal expression 
of the genes from the DM region hxprcssion was assessed 
b\ northern analysis of RNAs from various mouse tissues 
usingthelargestDW? BbandDMK V9cDNAsasprobes 
(Fig 4) DMR ßbcDNAdetectcdasignalofroughlv λ ì 
kb which is predominant in skeletal and he irt muscle and 
in ι few other tissues containing smooth muscle (lung 
bladder) A low level or expression was found in almost ill 
tissues examined bul si/e heter ogencity as expected trom 
the cDNA analysis was not immediatelv apparent Also 
from RT PCR experiments which are far more sensitiv e 
it was difficult to give a precise estimate tor the frequencies 
of occurrence of the alternatively spliced transcripts 
Although all murine DMR B / T C D N A derivatives originate 
from brain the level oí transcription in this tissue is low 
compared to the expression levels in m useular tissue This 
is in stark contrist to the findings for DMR N9 where 
expression of a 3 kb m R \ A is mainh restricted to brim 
and testis Strikingly the combined pattern ot tissue 
specific expression of these two genes trom the DM region 
corresponds exactly to those sites where ihe clinical 
manifestations in DM patients arc most prominent 
Whether or not the abnormal expression of both genes 
contributes to the functional impairment ind degeneration 
of neuromuscular tissues in DM patients remains to be 
seen It is not inconceivable that other as > et unknown 
genes in the immedialevicinitvoftheC TG repeatarealso 
affected at the level of expression 
Discussion 
Our results show the existence of two genes in the region 
containing the expanding CTG repeat seen in DM 
individuals The unstable motif is situated within the 
DM kinase gene OMR BI5 and forms part of the 3 
untranslated region of all mRNA transcripts now typed 
Less than 1 kb of DNA separates the beginning of the 
kinase encodingdomain of DMR ßi5fromanothergene 
DMR N9 whichencodesaproductofunknovvnfunction 
Sequencing of the complete intcrgcnic region did not 
shedlightontheactual5 endofDMK 1Ì15 hencewemiy 
have to consider the possibility that [he promoter ot 
DMR BJ5andlhe3 end of DMK N9arc overlapping or 
even more speculativelv that DMR N9 exists within a 
large S intron of DMR Віэ Further functional DNA 
studies will be needed to demonstrate that these genes are 
indeed separate genomic entities DMR BI5 the most 
likely candidate for involvement in the clinical 
manifestation of DM is predicted to encode multiple 
protein isotorms that possess kinase activitv and mosth 
differ at their С terminus The putative kinase(s) mav 
pia) a specific role in the regul ition of excitation 
contraction eouplmgor maintenance otcellularphysiolog) 
vu regulation ot protein protein interactions m ion 
channels orinsulm receptor signalling " Abnormihties 
in phosphorvlation ot membrane proteins have indeed 
been reported to be a characteristic finding in DM ч and 
application of prolein kinase ( modifiers can evoke 
myotonia in mouse muscle n 
The manifestation of locus expansion as a cause of 
disease is highly reminiscent of fragile Xsvndrome(FraX) 
and spinal and bulbal muscul ir atrophv i In Fra X a 
correlation between the genetic instabilità and a reduction 
in the level of the Fra X gene (/-VÍK 1) transcripts has 
been demonstrated However the fact that the repeat 
does not form part of a translated sequence in DM m ikes 
it difficult to explain the dominant phenotype and the 
phenomena of anticipation ind potentiation " ς From 
the results presented here it is conceivable that the level of 
expression of the DM kinase isoforms and/or the DMR 
\9 product(s) is regulated b> as influences on 
transcription translation or mRNA si lbility is affected 
differentially by variation in the length of the repeat Such 
differential ch in ges in expression mav have more severe 
effects if the allelc(s) on the unaffected chromosome are 
subject to imprinting ° or cpigcnctic downregulation 
Alternativel) the presence of abnormallv long simple 
sequence motifs may also lead to disturbances in the 
complex patterns of alternative splicing for the DMR ВI5 
kinase gene If regulated splicing does not occur peptide 
coding 3 segments of some mRNA forms mav be 
abnormallv interrupted by translation termination codons 
derived from intron sequences (Fig Зл b) As a 
consequence dominant abnormal production of prolein 
kinase isotorms could ensue I hese issues and other 
mechanistic inferences for the protein kinase can now be 
iddressed in both man and mouse 
Methodology 
Characterization of cosmids and cDNAs Hit isolation ol osmid 
and \east arufiei il chromosomes (\ AC ) UN Ль Irom iht essential 
DM region has heen described Restriction cnzvme maps of the 
inserts in cosmids ST 18894 and Yal002b3(rcf:>3 5) were generated 
and theappropr ire TcoRI fragments used to screen a mouse brain 
lambda 7APII eDNA phage libran (Stratagem) as described 
prcMOusK In total 10 and 6 dilferenuloius were obtained from 
the DMR flii and DMR \9 region rtbpeUivelv Sim hrK 
screeningofhuman teulbrainandhearuDN MibrancsU lonrcch 
-indStntagenehielded:>diIIerent/niK ü ^ c D N A clones Inserts 
were rescued in Uluescripl SK vector plasmids (manufacturers 
protocol) and either subcloncd or used directly for hybridan ion 
and sequencing experiments aceoidiii^ to standard protocols A 
pooled mix ol [a P] dLl Ρ labelled mouse cDlSA fragments uas 
used as probe [o screen a mouse genomic DNA cosmid librar\ 
( M i l unpublished data) tour o\crlapping cosmid clones 
mDMRc3 rnüMReö mDMRcl 1 and mDMRc'2 were puntied 
and used to generale a map of ¿tiiRI HindHIandBamHI restriction 
1 ragmen is in the immediate region of the DMR BI^andDMR V9 
transcribed sequences follow ng standird procedures 
Sequence determinations and computer analysis \pprnpr ate 
subclone* ol human ind mouse c l ) \ \s md human genomic DNA 
wereusedlorsequenceanahsis In add tion igradcdsenesofcDNA 
demandes uuh mere ising deletions trom the ~> end was generated 
b\ exonuclca^e 111 treatment Sequence dcterminationwasbasedon 
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ABSTRACT 
The mutation causing myotonic dystroph} (DM) has recently 
been identified as an unstable CTG trinucleotide repeat 
located in the 3' untranslated region of a gene encoding for 
a protein with putative serine-threonine protein kinase 
activity. In this report we present the genomic sequences of 
the human and murine DM kinase gene. A comparison of 
these sequences with each other and with known cDNA 
sequences from both species, led us to predict a translation 
initiation codon, as well as determine the organization of the 
DM kinase gene. Several polymorphisms within the human 
DM kinase gene have been identified, and PCR assays to 
delect two of these are described. The complete sequence and 
characterization of the structure of the DM kinase gene, as 
well as the identification of novel polymorphisms within the 
gene, represent an important step in a further understanding 
of the genetics of myotonic dystrophy and the molecular 
biology of the gene. 
INTRODUCTION 
Myotonic d>strophy (DM) is the most prevalent inherited 
neuromuscular disease in adults (1) The DM mutation, localized 
to ihe long arm of human chromosome 19 (19ql3 3), has recently 
been identified as an unstable trinucleotide CTG repeal in the 
3' untranslated region of a gene encoding for a protein with 
putative serine-threonine protein kinase activ iry (2 - 4) Although 
quite polymorphic, the CTG repeat is both meiotically and 
mitotically stable in the normal population In affected individuals, 
the repeat exhibits instability with copy number ranging from 
a minimum of approximately 50 to greater than 2000 (2) 
Increasing amplification of the CTG repeal is correlated with 
increased disease severity (2,5,6) In all populations studied thus 
far, the amplification of the CTG repeat seems to be the sole 
mutation responsible for DM (2,7,8), with the rare exception, 
in one study, of two clinically affected families which exhibit 
no amplification of the trinucleotide repeat (2) 
The sequence of the coding region of the DM kinase gene, 
determined from clones isolated from heart, brain and muscle 
cDNA libraries, has been reported by various groups (3,4,9) 
All of the sequences were missing the initiation codon The 
translalional products deduced from the various sequences have 
also differed, but clearly have domains coding for a serine-
threonine protein kinase in all cases Recently, we reported on 
the characterization of the DM region in both the human and 
mouse genomes, and have provided clear evidence for a variety 
of alternatively spliced mRNAs encoding the DM kinase, in both 
species (9) 
In this report, we present the complete genomic sequence and 
structure of the human DM kinase gene, starting with the 
sequence of the 3' end of the DMR-N9 gene, which is 
immediately telomeric to the DM kinase gene (9) Most of the 
genomic sequence of the munne gene, with the exception of some 
intron sequences, was also determined Precise sequences for 
intron and exon boundaries of all known exons of the DM kinase 
in both mouse and human genomes are described As well, the 
genomic sequence of the 5' end of the DM kinase gene from 
both species, and the location of a putative translational start site 
are presented Furthermore, the position of several polymor 
phisms within the human DM kinase gene and polymerase chain 
reaction (PCR) based assays to detect two of them are detailed 
These polymorphisms will be very useful in studying the linkage 
disequilibrium patterns of these markers with respect to the DM 
mutation The sequence information should be useful in further 
characterization of the DM kinase as well as be of great value 
in detecting possible, additional mutations within the gene 
RESULTS AND DISCUSSION 
To determine the structure and genomic sequence of the human 
DM kinase gene, a detailed restriction map of the relevant regions 
of the chromosome 19 cosmid clones Yal0O263 and F18894 (10), 
was obtained Similarly, the relevant regions of the mouse 
genome were mapped (9) The DM kinase gene mapped within 
a region of approximately 14 kb contained within five contiguous 
BamHI fragments in cosmid Ya 100263 (Figure 1) The sequence 
of 13747 bp (GenBank accession no L08835) begins from the 
* To whom correspondence should be addressed dt Chüdren s Hospita] of Eastern Ontano Molecular Genetics Laboratory 401 Smyth Road OtUwa 
Ontario K1H 8L1 Canada 
GenBank LÜ8B3S EMBL Z21503 - Z21506 linci 1 
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Figure 1. Structural organization of the human DM kinase gene. The gene maps within a 14 kb genomic region contained in five contiguous BamHI fragments 
The positions of relevant restriction sites are given: B, BamHI; E, EcoRl. The orientation of the gene is from telomere (TEL) to centromere (CEN). The exons 
are depicted as boxes and exons 1, 2, 9 and 15 are numbered. Exons 2 - 8 (black boxes) encode the protein kinase domains, exons 9 - 12 (stippled boxes) encode 
the a-helical(coiled coil) domains, and exon 15 (striped box) encodes the hydrophobic, possibly transmcmbranous domain and contains the CTG repeat 
tCtOacIQAAOCCCAQQTQQÎCTCTA 
DMRN9 «op codon 
ААС1ССССОАОЮОСАСАаТОатфО^ОССАТ(МАТАТСОйОССС 
lACTOOTCACTCCTQGQOAQACACTCfccCOCCCCTbcCAC 
MRF. CS« 
CCt!CQCCCQOCCCC):ACCCCAOCTOCCCTTOCTAT I 'Л с 
humen 
mous· 
humen 
mouse 
moue· 
human 
mouse 
human 
mous· 
mouse 
human 
mouse 
mouse 
1 ооАтссолсААааАсгттаАттАгтосатоАААагосгоАСТоссАООАСАаОААостАостААвАтвСААОтісссАосстАОАасАотоосстстоао 
101 ааатстАааасааАсссААааасААОэссАоаатоасАасАэсттаоаоАстстаастоастссстссссто, 
201 АССССТСССАТСТСТСССТСТСАТСГТССССАОЭаСАІСІССТСССААІ 
X 1 ССССААССССАТОСССССАОССТССТАОССАТААСССТСССТОСіаАССТСАСАОАТСААСОТАТТААСААвАСТААССАтаАТООАТОаАСТаСІССАО 
401 тссссссАССгасАСААААіттааоаоссссссАаАстаасссааАСАсаохісаАтатААТАасссттаіоасстсАассттаісссссАсссАсіассА 
501 АаТАСААТОЛССТСТТССТСТОАААСАТCAOTOTTACCCTCATCCCTOTCCCCAOCATO' 
601 ААОАОссссАоотстосАотатосссстсАаттаАатаоосАооассооаоотаотссАі 
701 TOTOCTTTTOAAOAQTQTIAAATTATQQAAOCCCCICAaOIICClCCCIQICCCaCAQaACCICIIAIIIATACTAAAQTTCCCTaTTTTCTCAOCOQOI 
βΟΐ стотссссттсовАООАОАтОАтатАаАООАсстотатототАстстотоогтстАаосАОтссастттссссАОАааАооАотасАоосстастсссАо 
901 сссдососстсссАссссттттсАТАОСА(10ААААассаоАох:ссАОООАЭоаААСэаАсстосаАатсАСАСААстаатаАсссАСАссАскоастаоА 
1001 ОСАОаАСССТСТТООООАОААОАОСАТССТОСССОСАОССАОаОССССТСАТСАААаіССТСООТОГТТТГТАААТГАТСАОААСТОСССАОаАССАСОТ 
1101 ТТСССАООСССТ«ССАОСТОЛОАСТССТСаОТССТТОССТССТАаТТТСТСАОЖ:СІООСССТСТСААОГКССАООСАССССАООССООТТОаАаОССС 
1201 COACTTCCACTCroaAOAACCOTCCACCCIOaAAAOAAOAOCICAOAITCCiCIiaQcrCTCOQAaCCtlCAÍlQOAQTQTOTCTTCCCOCOCCACCCTCCA 
1301 ССССССОАААТОТТТСТаттТСТААТСССАОССтаООСАООААГОТООСТССССО<У:САа<к«КСААОаА(КТАТТТТООООТСТСОТТТОСс|«аоХ1АО 
САР __ΑΡΐ ЛР2 
1401 о х ю т т о о с т с с А с ^ г т Т Т :о7ссеаСА(^фттозоу:Ао<:АаотсАсссстаттсАоох:тстаАЬ(ютассссЬісстаатсстатссгсАссАсссст 
I l I I І і Г і П И Ύ ί ΐ Ι Η Η Η i l ι ι I I I I I I I I I I и ι T r T i i i M M I I I I I 
I ооАТССАссАСТіосфсссссАаофааоосеАасАааісАсссстаоссстоасохістаАОСАААСтстс T C C T O A T C I I C C T I 
ОАОтсаалАтссАтст 1501 тссссАсстсстоооААААААААДАААААААААААААААастаатттАААОСАалаАосстаАааастАААтттААстатсс 
87 с т А с с т с с т а с сААААААтоволааасааотААТАсАосАаосАСАаооостАААттгААстатсссАААотсаоААтссАтта 
A f ) А>2 
1599 CffaA&r i^cCCAAaAAOCTOCCCTOOCCTCCCOTCCCCTTCCCAOOCCTCAACCCCITTCTCCCACCCAncCCCAjiiCCCCCAGCCCfTCACCCCCTAaCCC 
Ι Ι Ι Ι Ι Ι Ι Ι Ι Ι Μ ι I 1 Ι Μ I I I I I I I I I I I I I I I I I M l I l l l l ι И I m i M i l l I I I 
171 CfOAOTCAj CQAAQAAOCTQCC CCTQOCCTTTOCCCCCCCCCACTACCCCCTCACCCCCTOTTQCCCAOQCATCAOCCCTTTCCCCCAACCC 
ОТ Τ CAOCAAT QOOCAOaTT CT TCT Τ QAAAT Τ СА 
Ι Ι Ι Ι Ι Ι Ι I I 
АостсталатстлтАаАстаастстсстоаосАста ACACC 
1699 CCAQTTCTQOAQCTTOTCQeQAaCAAOOOQQTOQTTOCTACTauQTCACTCAOCCTCAAT 
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ото 
1799 TCACACCTQTQQCTТССТCTQTОСТСТАССТ ТТТТАТТаоавТаЛСАататаАСАОСТалаЛТТСТССАТЭСАТТСССССТ АСТСТАОСАСТОЛА 
308 ТСССАССТОТААСТСССТОТОСТСТСТТТАТООаТОООТАОАООСАДТООООаОООаСАДСССТОаАаТАТТАСТСТОТССССТОАСАТТаООСТСТОАА 
1994 ваоттстаААолассстооллоалволлосттоаоооосіовсітатаАйоааіт А А о а с т а м 4 а ^ И а > а а а а а а с т о о л с с л А а а а а т о а а а л а л 
I I I I I I I І М І М І М І М Н И М I I M I I I I М Н И М I I I I I I I I M H T M I I I I I Ι M I M I I I I I I M I I I I 
408 аАаттттададоассстоадАа»АаооАОттасоототтс^хстсАаоАОООЮттАААААстаооА|оосаоо{АаааааастоаоссААоооотопАОААА 
1993 АоаааАаоАа<кстсаассаол:со£АаАаАаААатоассАаАаАао«ссАООх>аАСАОсСАЭоаАСАаосАаАСАтасАОссАааостссАаоох;стаоА 
508 AOAOOAOOAOOCCTTAAOC ATAOAACTOOCCAOAaAOACCCAAOOOATAOTCl 
2093 cAoaa<KTi«cA5MCfcTOTaACAoaAaoAccccaAOcccccaocccaoaQAOOQOccATi 
600 сАоооосА|оссАоосфтатаАсооаАлаАссссоАО стссаасссодааАаоаоссАТоотаттасстасссААСІАтфсАассдААатосоостоАО 
A E V R L R 
2193 OCOOCTCCAUCAUCTOaTaTTOaACCCUOaCTTCCTaQQOCTQQAQCCCCTOCTCaACCTTCTCCTaOOCOTCCACCAGGAGCTCGGCOCCTCCaAACTO 
Μ Ι Μ Μ Ι Ι Ι Ι Μ Ι Ι Ι Ι Ι Ι Ι Ι Ι Ι Ι Ι I l l l l l l l l l l M l I I I I I I I I I I I I I I I I I I I M M I I I I I I I I I I I I Ι Μ I I I I I I M i l l t I I 
690 осАОстссАОСАастоотостоо>сссАОЛсттсстою<іАсіваА(кссстастсаАсстісісетаоосатссАссАаоАОСтоаатасстстсАсстА 
Q L Q Q I V L D P C F L C I E P L L D L L L C V H Q E L C A S H L 
AGACATocAGCTAOGaTTCTooaacciooA 
DMK j u r t codon 
отссААаАтфсАоссоАоатосоастаАЭ 
human 2293 OCCCAGGACAAGTACGTGGCCOACTTCTTOCAaTQaa 
M I M I I I I I I I I I I I I I I I I M M l I I M I I I I I I 
mous« 799 асссАоалсААатАтотаоссалсттсттасАатоао 
A Q D K Y V A O F I Q W V 
Figure 2. DNA sequence of the 5 ' region of the DM kinase gene from human and mouse genomes. The human sequence of 2329 bases begins from the most telomeric 
BamHI site of the five BamHI fragments containing the gene. Similarly, the murine sequence of 835 bases begins from the most telomeric BamHI site of the four 
BamHI fragments containing the murine DM kinase gene. The depicted sequences terminate at the 3' end of the first exon in both species. Several putative transcription 
factor binding sites are boxed with the respective transcription factors indicated above the sequences. The 5' end of the last exon of the human DMR-N9 gene, 
at position 234, is indicated by the vertical arrow, and the stop codon for the DMR-N9 gene, at position 279. is boxed and indicated above. The two putaUve polyadenylation 
signals for the DMR-N9 gene (9) are underlined. The most telomeric putative transcriptional start site for the human DM kinase gene, at position 1394, is indicated 
by a directional arrow. A second transcriptional start site was identified, at position 1414. corresponding to a consensus CAP site Alignment of the genomic sequences 
from the two species enabled the determination of the DM kinase (DMK) start codon. The putative amino acid sequence is presented below the DNA sequences 
Variations in the mouse peptide sequence arc presented below the consensus peptide sequence 
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most telomeric BamHI site of the five BamHI fragments and ends 
at the position of the poly A tail of the cDNA It contains the 
sequence of the last exon of DMR N9, and all of the DM kinase 
gene Except for the presence of two Alu repeats preceding exon 
9 and three Alu repeats following it the rest of the sequence 
is unique 
In order to ascertain the putative translational start site ot the 
DM kinase gene, we did a comparative analysis of the sequences 
from the 5 ' region of the murine and human versions of the gene 
(Figure 2) The sequence depicted in Figure 2 terminates at the 
last base of the first exon of the DM kinase gene The last 92 
bp or 31 codons overlap with the sequence of the 5' end of the 
Table 1 Splice Junctions and Sizes Ol Exons of the Human DM Kinase Gene 
Exon 
1 
2 
3 
4 
5 
6 
7 
8a 
8b 
9 
10 
11 
12 
13 
14 
15 
Nucleotide 
No 
1-936 
3268-3359 
3615-3698 
3778-3873 
4496-4644 
4918-5011 
5265-5471 
5548-5796 
5548-5811 
7134-7219 
9346-9457 
10173-10330 
10436-10533 
10705-10751 
11041 - 11 Π0 
11461-12154 
bp 
936 
92 
84 
% 
149 
94 
207 
249 
264 
86 
112 
158 
98 
47 
90 
894 
Amino Acid 
No 
1-53 
54-84 
85-112 
113-144 
145-194 
195-225 
226-294 
295-377 
295-382 
383-411 
412-448 
449-501 
502-533 
534-549 
550-579 
580-629 
3 Splice 
Junction 
cccag CGG 
ctcag'G ΓΑ 
tgcag/GTG 
ctcag/TAC 
tgcag/GGA 
lecag/GTG 
agcag/GAG 
agcag/GAG 
cgcag/GAG 
cccag/GGA 
cacag/GCT 
cacag/TCA 
tccag/CTG 
tccag/CTA 
cgcag/GTC 
5 
Junction 
GGG/glgdg 
GAG/glaag 
GAG'glgag 
CTG/glgag 
CAG'gtggg 
ACG/gtgag 
AAG/gtgag 
ATG/gtgag 
GGG/glagg 
CAG/glaag 
ACA/gtaag 
CAG/glcgg 
CAG/gtgag 
CAT/glaag 
AGG/glacg 
Note Exon 8a a shortened version of exon 8b is generated by the use of a cryptic 
splice sue within the exon and results in the loss of the last five codons (15 bp) 
The clone containing dus alternatively spliced exon was isolated from a human 
brain frontal cortex cDNA library The nucleotide position starts from the putative 
transcriptional ilart sue of the DM kinase gene This is position 1394 of the 
submitted sequence (GenBank accession no L08835) A schematic ol the various 
spliced regions of the human gene is presented in Figure ЗА 
longest cDNA reported for the human DM kinase gene (9) The 
longest reported murine cDNA began in exon four (9), but new 
cDNA clones as well as murine genomic clones spanning the 
first three exons have since been isolated and sequenced At the 
3 ' end of the sequence presented in Figure 2 the strong sequence 
homology between species was clearly evident In the 5' region 
of the sequence the sequence homology, though present, was 
scattered with sequence gaps and base deletions Therefore due 
to the loss of sequence homology and the known proximity of 
the DMR-N9 gene (9), the putative translational start codon was 
identified based upon the maintenance of the open reading frame 
for cDNAs previously identified in both species The sequences 
flanking the translational start site (CCAACATGT), though not 
identical, are similar to the Ko?ak consensus sequence (CC 
A/GCCAUGG) (11) A computer search of the sequences 
revealed no clear TATA or CAAT box motifs in either species 
The predicted translational product of 629 amino acids, for the 
longest human cDNA, has a molecular weight of 69 370 Daltons 
A computer search for binding sites of transcription factors 
identified a variety of putative sites (including a metal responsive 
element (MRE CS4) (12) Sp 1 AP1, AP2 binding sites and CAP 
sites (13)) in the sequence depicted in Figure 2 Ongoing studies 
in our laboratories to detect promoter activity within the 5' region 
ot the human DM kinase gene, have mapped putative 
transcriptional start sites In the human situation, the 
transcriptional start site of the DM kinase gene may in fact be 
5' to an unusual stretch of 24 adenines located approximately 
550 bp proximal to the start codon (Figure 2) This transcription 
initiation site is actually within the 3' untranslated region of a 
cDNA clone isolated for the human DMR-N9 gene (though this 
clone could represent a readthrough mRNA, as it has been 
suggested that the polyadenylation signals of the DMR N9 gene 
may be used inefficiently) (9) The predicted full length mRNA 
of the human gene would be approximately 3 4 kb These results 
are concordant with previously reported data from Northern blot 
analysis (3,9) which showed that the full length transcript was 
between 3 to 3 3 kb Future studies utilizing this sequence, will 
A Human 
В Mouse 
- П 
•Ητ-Ι] 
3 2 1 
l i ι 
•Ή 
1 kb 
Figure 3 Schematic apre sentati on of the human and murine DM kinase gene The open boxes represent the 15 exons of the DM kinase gene The stnped boxes 
are exon regioni deleted in various isolorms ol the gene The stippled regions in the mouse gene represent intron regions used to generate truncated isoforms of 
the gene The numbered arrows indicate the position of translational stop sites used by various isoforms A Human DM kinase gene Slop codon 1 is used by 
the full length transcript Slop codon 2 is utilized bv a hean cDNA isoform in which exons 13 and 14 arc deleted В Murine DM kinase gene Stop codon 1 
is used by the full length transcript Stop codon 2 is emplo>cd b> an isolorm which utilizes exon 14a Stop codon 1 is utilized by an isoform in which intron 
12 is used 
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Table 2. Exon Splice Junctions of the Murine DM Kinase Gene 
Exon 3' Splice Junction 5' Splice Junction 
1 
2 
3 
4 
5 
6 
7 
8a 
8b 
9 
10 
11 
12" 
13 
14a 
14b 
13 
cccag/TGG 
tttag/GTA 
cacag/GTG 
cccag/TAC 
cacag CiGA 
cacag/GTG 
aatag/GAA 
aatag/GAA 
cctag/GAG 
ctcag'AGA 
gacag/GCT 
cccag/CCA 
tccag/CCA 
gclag/ATG 
llcag GCT 
Cgcag/ATC 
GGG gtgag 
GAG gtgag 
GAG gtgag 
CTG/gtaag 
CAG glggg 
ATG gtaag 
AGG gtgag 
ATG/gtgag 
GGG/gtacg 
CAG gtgag 
GTG gtgag 
CAG gtcag 
CAG/gcgag 
CAT gtaag 
AGG/gtatg 
AGG/gtatg 
-
Noie. An 87 bp segment (encoding amino acids 328 to 356) within the longer 
versions of" cxon 8 (8a and 8b) is deleted in some murine isoforms (9). This 
fragment, which extends the homology to protein kinases, is flanked by consensus 
5' (GAG/gtggg) and 3' (accag'ACT) splice junctions. Exon 14 utilizes two different 
3' splice junctions. The longer version (14b). found in some cDNA clones, results 
in the use of an earlier translational stopcodon. The shorter version (14a). though 
similar to the human version of exon 14. has the 3' splice junction offset by 4 
bp. thus resulting in a different 3' termini for the translated product. The intron 
between exons 12 and 13 was present in some cDNA clones. This resulted in 
a different and shorter 3 ' end for the translated product. A schematic of the various 
spliced regions and translational stop sites of the murine gene is presented in 
Figure 3B. 
•Exons with nonconsensus 5' splice junctions. 
Table 3. Sequence Polymorphisms within the DM Kinase Gene 
Nucleotide Position 
3892 (G or T) 
4650 (C or T) 
6764 (1 kb ins./del.) 
9300 (G or T) 
10387 (G or T) 
11188 (G o r T ) 
11837 (CTG repeat) 
Location in 
the Gene 
intron 4 
intron 5 
intron 8 
intron 9 
intron 11 
intron 14 
exon 15 
Polymorphic 
Enzyme Site 
HphI 
Hhal 
N/A 
Hinfl 
Fnu4HI 
DOM 
Ν Λ 
N/A—not applicable 
Note. The nucleotide position is relative to the putative transcriptional start site 
of the DM kinase gene. ie. position 1394 of the submitted sequence (GcnBank 
accession no. L08835). 
clarify the importance of the 5' region with respect to the 
expression of the DM kinase gene and factors controlling it. 
The precise positions of intron-exon boundaries were 
determined by comparison of the genomic and cDNA sequences 
(Table 1). The human gene has fifteen exons. varying in size 
from 47 bp to 936 bp. The introns vary in size from 2331 bp 
(the first intron), to 76 bp (the seventh intron). The highly 
conserved kinase domain is encoded by exons 2 through 8. A 
region showing significant homology to the α-helical (coiled-coil) 
domains of myofibrillar and filamentous proteins is encoded by 
exons 9 through 12, with the strongest homology being contained 
in exons 11 and 12. Exon 15. the last exon. contains a relatively 
short region encoding for a hydrophobic, possibly 
transmembranous domain, and also contains the CTG repeat in 
the 3' untranslated region. Exons 13 and 14. which show no 
strong homology to any proteins or protein domains, are 
-4 91 
-4 19 
- 2 5 3 
- 1 S 1 
Figure 4. PCR based assays to detect two sequence polymorphisms in the DM 
kinase gene. In each figure, the first lane contains the 123 bp DNA size marker, 
the next lane contains the uncut PCR amplified product and the remaining lanes 
contain the digested PCR products from a representative DM pedigree. The sizes 
of the uncut, and digested products arc indicated. A: Hhal Polymorphism. B: 
Hinfl Polymorphism. 
alternatively spliced out in several cDNA clones isolated from 
a human heart cDNA library. As a consequence of a shift in the 
open reading frame, an earlier termination codon (5 bp after the 
beginning of exon 15) is used. This results in the loss of the 
hydrophobic region. The predicted translational product of this 
isoform has 535 amino acids with a molecular weight of 59.790 
Daltons. A schematic of the various human isoforms is presented 
in Figure ЗА. 
The presence of multiple protein-isoform encoding mRNAs 
has been well documented (9). Though the genomic sequence 
of the murine DM kinase gene is incomplete due to gaps in some 
intron regions, we were able to determine the sequences of all 
known splice junctions for the gene, in the mouse genome (Table 
2) (EMBL accession nos Z21503-Z21506 (incl.)). It is clear 
that the myriad of alternatively spliced mRNAs (Figure 3B) 
isolated from a mouse brain cDNA library resulted from the use 
of cryptic splice sites. In the mouse, nonconsensus 5' splice 
junctions (exons 12) are used in some cDNA clones. Also a 
comparison of the genomic sequence between species, identified 
nucleotide changes in the human situation, which have led to a 
loss of the consensus 3' splice junction utilized by the mouse 
to generate alternatively spliced mRNAs containing exon 14 or 
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deleting an 87 bp fragment in exon 8 Interestingly only one 
human cDNA clone which has the last five codons of exon 8 
deleted by the use of an alternate 5 splice junction within the 
exon showed the use of crvptic splice sites This clone was 
isolated from a human brain frontal cortex library A similar clone 
has been isolated from a mouse brain cDNA library 
In the course ot sequencing the human gene numerous 
sequence polymorphisms were identified within introns and 
noncoding regions ot the gene (Table i) No polymorphisms have 
been identified within the coding region thus far The majority 
of these sequence poly morphisms are due to a single base change 
For those which have altered a restriction enzyme recognition 
sequence and were amenable to simple detection we have 
developed PCR based assays (Figure 4) The larger of two alleles 
tor the Hhal polymorphism (fig 4A) located in the fifth intron 
has an allelic frequency ot 0 55 Of the two alleles detected by 
the Hinfl polymorphism (tig 4B) located in the ninth intron the 
larger allele has an allelic frequency ot 0 47 Also a 1 kb 
insertion/deletion polymorphism previously noted to be in total 
linkage disequilibrium with the DM mutation (2 7 8) has been 
characterized and a PCR based assay to detect this flanking 
marker has been developed ( 14) The larger of these two alleles 
on which the DM mutation always occurs is found in 53% of 
normal chromosomes This polymorphism is contained within 
the region of the two Alu repeats that precede exon 9 We have 
utilized all of these polymorphisms as the primary tools in 
documenting a rare gene conversion event which resulted in the 
loss ot the DM mutation in an offspring who inherited the DM 
chromosome trom her affected lather (15) The polymorphisms 
should be of significant value in studying linkage disequilibrium 
patterns in the region of the DM mutation and may assist in 
determining the ancestry ot the DM mutation in various 
populations 
The determination of the complete genomic sequence and the 
structure of the DM kinase gene represents an important initial 
step in further characterization ot the gene and a better 
undei standing of the disease Presently it is unclear how the 
presence of an unstable trinucleotide CTG repeat in the 3 
untranslated region ot a gene encoding a lañase could result in 
the clinical outcome of myotonic dystrophy an autosomal 
dominant disorder No clear evidence has been provided to 
indicate that the product ot the DM kinase gene is the affected 
protein in DM though the expression patterns of the gene (9) 
suggest it is the most likely candidate The presence of a gene 
(DMR N9) expressed in brain and testes (9) in the immediate 
vicinity of the DM kinase gene along with speculation on the 
effects of the unstable CTG repeal on neighbouring genes and 
chromosomal structure has led to suggestions that multiple genes 
are involved in the clinical manifestation of DM 
The amplification of the CTG trinucleotide repeat has been 
identified as the mutation responsible tor DM in over 98% of 
affected families (2) The provision of the complete sequence 
of the gene is essential for the detection of novel mutations within 
the DM kinase gene in the few affected families which 
demonstrate no amplification ol the CTG repeat This would 
prove that deleterious effects on this one gene are solely 
responsible for DM Also it would lead to a better understanding 
ot the functional importance of the \anous domains in the gene 
and may provide ideas for therapeutic strategies to treat DM 
The elucidation ol the structure and sequence ot the DM kinase 
gene will aid in the development of in vitro and transgenic 
models These models can be used to studv the effects of the 
unstable CTG repeat in DM as well as gain a broader 
understanding of the properties of heritable amplified trinucleotide 
repeats which have now been clearly implicated in three major 
genetic disorders (2-4 16 17) 
MATERIALS AND METHODS 
DNA mapping and sequencing 
The isolation and detection of chromsomc 19 cosmid and yeast artificial 
chromosome (YAC) clones as well as the characterization ol cDNA clones have 
been detailed elsewhere (9 10) Restriction maps of the relevant regions ofcosmids 
Ydl00261 and F18894 as well as mouse genomic DNA (9) were generated 
after hybridization with the cDNA clones Appropriate subclones of mouse and 
human genomic DNA were generated for sequence analysis As well a shotgun 
cloning strategy was usui to generate dones from cosmid Yal00263 Also PCR 
amplified products of human genomic DNA were directly sequenced to confirm 
much of the sequence generated from the clones Sequencing strategics included 
ϋκ direct sequencing of subclones with vector pnmers sequencing with synthesized 
oligonucleotides and sequencing of a graded series ol clones with increasing 
deletions I rom the 5 end generated b> e\onucleasc III treatment Sequencing 
was performed using standard protocols with 3<iS and 3 2 P labeled dNTPs In 
addition sequencing was performed with an ABI 373A automated sequencer using 
either fluorescent dye labeled pnmers or didcoxytermination sequencing reactions 
with fluorescent dye labeled ohoeonucleotides Assembly analysis and alignment 
ol DNA sequences was done with the IG SUITE 5 35 package (Intelligenetics) 
David Ghosh s Transcription Factor Database (Rel 4 5) (18) was scanned using 
SINGAL SCAN 3 0 (19) As well the sequence alignment was done using the 
GAP program in the GCG package (20) 
PCR based assays of polymorphisms 
Hhal poKmonphism Genomic DNA (2μ§) was PCR amplified with 50 ng each 
of primers 445 (5 GACCTGCTGACACTGCTGAGC 3 ) and primer 472 (5 
GTGCCTTCCATCCCTtATCAC 3 ) by a standard protocol and 30 cycles 
of amplification ai94 a C for I min 60°C for 1 5 min and 72°C for 1 5 min 
Amplified products were digested with Hhal for one hour and subsequently 
separated b> electrophoresis usine 1 xTBE buffer in 1 % agarose 1 % NuSicvc 
gels containing ethidmm bromide 
Hinfl polymorphism Genomic DNA (1μ%) was PCR amplified with 50 ng each 
ol primers 45Я (5 CTGCAGAAGGTTTAGAAAGAGC 3 ) and primer 424 
(5 CATCCTGTGGGGACACCGAGG 3 ) by a standard protocol and 10 cycles 
of amplification at 94°C for 1 mm 60°C for I 5 min and 72°C for 1 5 mm 
followed by 25 c>cles of amplification at 94°C for 1 mm 55°C for 1 5 min 
and 7">°C lor 1 5 mm Amplified products were digested with Hinfl for one hour 
and subsequently separated by electrophoresis using IxTBE buffer in \7c 
agarose 2% NuSieve gels containing ethidium bromide 
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CHAPTER 
2.5 
Structural organization and developmental 
expression pattern of the WD-repeat gene DMR-N9 
immediately upstream of the myotonic dystrophy 
locus 
submitted 
S T R U C T U R A L ORGANIZATION A N D D E V E L O P M E N T A L 
EXPRESSION P A T T E R N O F T H E W D - R E P E A T GENE D M R - N 9 
I M M E D I A T E L Y U P S T R E A M OF THE M Y O T O N I C D Y S T R O P H Y 
L O C U S 
Gert Jansen, Dietmar Bächner1, Marga Coerwinkel, Nicole Wormskamp, Horst 
Hameister1 & Bé Wieringa 
Department of Cell Biology and Histology, Medical Faculty, University of Nijmegen, P.O. Box 9101, 
6500 HB Nijmegen, The Netherlands and ' Department of Medical Genetics, University of Ulm, 
Germany. 
The diverse biological consequences of size-expansion of the unstable (CTG)n repeat in 
the myotonic dystrophy protein kinase (DM-PK) gene at chromosome region 19ql3.3, are 
still poorly understood. Abnormal (CTG), length may affect either DM-PK mRNA fate or 
function, or alternatively, compromise gene transcription by distortion of chromatin 
configuration. In the latter model involvement of neighbouring genes in DM upon extreme 
expansion of the repeat cannot be discarded as a possibility and should be studied further. 
Here we report on the elucidation of the complete genomic structure and expression 
pattern of the DMR-N9 gene in mouse (called 59 gene in man), which is at 1.1 kbp 
upstream of the DM-PK gene. This gene contains five exons spanning seven kbp and codes 
for a protein of 650 amino acids. Two regions of the predicted protein show significant 
homology to WD-repeats, highly conserved amino acid sequences that have been found in 
several distinct proteins with regulatory functions. The start site of transcription has been 
determined and we have identified putative transcription factor binding sequences in a 400 
bp putative promoter area immediately upstream of the transcribed unit. Northern blotting 
analysis and RNA in situ hybridization revealed ubiquitous low expression in all tissues of 
the embryo and enhanced expression in adult brain and testis. The onset of transcription is 
phased early in embryogenesis, before or at day 9.5 of gestation. From day 14.5 onwards 
DMR-N9 mRNAs were detected in all neural tissues, especially in the telencephalon and 
mesencephalon. Later, mRNA presence is evident in distinct tubules of the mature testis, 
restricted to secondary spermatocytes of stages Ш to ΧΠ of the spermatogenic prolifera­
tion cycle. We conclude that the DMR-N9 gene is a candidate for being involved in the 
manifestation of mental and testicular symptoms in severe cases of DM. 
Introduction 
Myotonic dystrophy, the most common 
form of muscular dystrophy in adults (1), is 
caused by the expansion of an unstable CTG 
trinucleotide repeat (2-4). Manifestation of the 
DM phenotype is correlated - but not tautly -
to the repeat length as determined from blood 
DNA (5-7). Generally, patients with 40-150 
CTGs show no or only very mild symptoms 
(cataract) and carriers of repeats up to a 
thousand CTGs are more severely affected, 
with muscular dystrophy, atrophy, myotonia 
and variable multi-organ disfunctioning. In 
the most severe form of DM, seen in con­
genital and early onset cases which carry even 
larger alleles, additional involvement of men­
tal retardation and serious defects in endo­
crine functions are commonly observed. 
The expanding (CTG)
n
 repeat is located in 
the 3' untranslated region of the DM protein 
kinase gene (DM-PK) in a gene-dense area on 
human chromosome 19ql3.3. Elucidation of 
the structural organization and expression 
60 
latçcacatggaggaeggc acttggctccctctgacctc tacatgctcgttcacgcaca aatacacgcaaaaataaatg cattttttttttttattatt 100 
taaaaaacaaaaccaagaat cgcccggagtcagctgtaac Bacacgaggcttctgaatag gctttgaggcttctccgttg ctgggcaaacggttcCCaSB 200 
ApZ 
gCgctgttgttagggtctag gggcgttcccaacegtcato. cctcgtagccaaccaaacgc gegggtctgtcgcgttgacc acacccacatattgcctccg 300 
"Spi 
cccacagccccagaaccgtt acctcagcaactgtctcggc ttctccgcctccggctctgg gtgícaáicgtagaggcgtc acccggacgacgaccctacc 400 
CAAT box 
|-> |-> transcription start 
cct tccggtgctaoCCCCTC AACTTCCCGCTGGGGGGTCT GGCGGTGGGCGGTCGGGCTG CGGTGCGGCCCGGGGGGCGG CCAAGATGGCGGCGGGCGGC 500 
<- P . " . ' p r i m e r 
Nhel 
M G D С A Ε Ι К S О F R Τ R E G F V K L L P G D 2 4 
GCGGAGGGCGGCCCGGGttC OJCCGCCGCCATBGGCGACT GCGCGGAGATCAAGTCGCAG TTTCGCACCCGCGAGGGCTT CTACAAGCTGCTCCCCGGCG 6 0 0 
Ap2 DMR-MÏ e l a r t codon | - > s t a r t cONA c l o n e 1 .4 
Ncol 
A T R R S G P T S A Q T P A Ρ Ρ Ο Ρ Τ 0 P P P G P A A A S G P G A 5 7 
ACGCGACGCGCAGGTCGGGC CCGACCTCCGCTCAGACCCC GGCGCCGCCTCAGCCCACTC AGCCCCCGCCCGGGCCCGCC GCAGCCTCCGGGCCCGGCGC 7 0 0 
A G Ρ A S S Ρ P P A G P G P G P A L P A V R L S I V R L G D P D G 9 0 
CGCGGGTCCCGCGTCGTCCC CGCCGCCCGCCGGCCCCGGG CCCGGGCCCGCGCTGCCCGC CGTCCGCCTCAGCCTGGTGC GCCTAGGCGACCCGGATGGC 8 0 0 
| - > s t a r t cDNA c l o n e 9 . 1 
A G E P P S T P S G L G A G G D R V C F N L G R E L Y F Y P G C C R 1 2 4 
GCTGGGGAGCCGCCCTCCAC GCCCTCCGGACTGGGCGCGG GAGGAGACCGCGTCTGCTTC AACCTGGGCCGGGAGCTTTA TTTCTACCCCGGCTGCTGCC 9 0 0 
| - > s t a r t hunan cDNA 59 
exon 1 lexon 2 
S G S 0 R |S I D L N K P 1 D К R [ ï К G T Q P T C H D F Ν О F Τ A 1 5 7 
GCAGCGGGAGCCAGCGGTCC ATCGATCTCAACAAGCCCAT CGACAAGCGGATCTACAAGG GGACCCAGCCCACCTGCCAC GACTTCAACCAGTTCACAGC 1 0 0 0 
exon 21 
A T E T I S L L V G F S A G Q V Q Y L D L I K K D T S К L F Ν E E 190 
TGCCACAGAGACCATTTCCC TGCTGGTGGGCTTCTCTGCC GGCCAGGTGCAGTATCTGGA CCTCATCAAGAAAGACACCA GCAAGCTATTCAATGAAGAG 1100 
exon 3 
R L I D K T K V T Y L K U L P E S E S L F L A S H A S G H L Y L Y N 2 2 4 
CGGCIGATTGACAAGACCAA GGTGACATATTTGAAGTGGC TGCCTGAGTCAGAGAGTCTG TTCCTTGCTTCTCACGCCAG TGGCCACCTGTACCTCTACA 1200 
V S H P C T S T P P Q Y S L L K Q G E G F A V Y A A К S Κ A Ρ R N 2 5 7 
ACGTCAGCCACCCCTGCACC TCCACCCCACCCCAGTATAG TCTGCTGAAACAGGGTGAGG GCTTTGCTGTCTATGCAGCC AAAAGCAAGGCACCCCGCAA 1300 
P L A K W A V G E G P L N E F A F S Ρ D G R H L A C V S О D G С L 290 
TCCACTAGCCAAGTGGGCAG TGGGTGAGGGGCCCCTCAAT GAGTTTGCATTCTCACCTGA TGGCCGACACTTAGCCTGTG TCAGCCAGGATGGCTGCCTG 1400 
R V F H F D S M L L R G L M К S Y F G G L L C V C W S P D G R Y V V 3 2 4 
CGTGTCTTCCACTTTGACAG CATGCTTCTGCGTGGGCTCA TGAAGAGCTACTTTGGGGGT CTGCTGTGTGTGTGCTGGAG CCCTGATGGCCGCTACGTGG 1500 
Τ 6 S Ε Β О L V Τ V W S F T E G R V V A R G H G H K S U V N A V A 357 
TGACAGGAGGGGAAGATGAC TÎAGÎCACTÈTÛTÛGTCCTT CACGGAGGGTCGTGTGGTGG CTCGAGGCCATGGCCACAAG TCCTGGGTCAACGCTGTAGC 1600 
F D P Y T T R A E E A A S A S A D G D P S G E E E E P E V T S S D 390 
CTTTGATCCCTACACCACTC GCGCAGAGGAGGCGGCGTCA GCCAGTGCTGATGGAGATCC CAGTGGTGAAGAGGAGGAGC CTGAAGTCACCAGCTCAGAC 1700 
T G A P V S P L P K A G S I Τ Y R F « » A fi « D Τ Q F С l V 0 L Τ E 424 
ACAGGAGCCCCAGTGTCCCC ACTGCCCAAGGCTGGCTCCA TCACGTACCGCÎÎÎGGCTCA GCTGGCCAGGACACACAGTT CTGCCTGTGGGACCTCACAG 1800 
D V L S P H P S L A R T R T L P G T P G A Τ Ρ Ρ A S G S S R A G E 457 
AAGATGTGCTCTCCCCTCAT CCGTCTCTGGCCCGTACCCG CACCCTTCCGGGCACACCTG GTGCCACCCCACCAGCTTCT GGTAGTTCTCGGGCCGGAGA 1900 
T G A G P L P R S L S R S N S I P N P A G G G 1С A G G Ρ К A S M E 490 
GACAGGTGCAGGCCCCCTGC CCCGCTCCCTGTCTCGTTCC AACAGTCTCCCACACCCAGC TGGTGGTGGCAAGGCTGGTG GGCCTAATGCATCGATGGAG 2000 
P G 1 P F S I G R F A T L T L Q E R R O R G A E K E H K R Y H S L G 5 2 4 
CCTGGCATACCATTCAGCAT TGGCCGC1TTGCCACACTGA CCCTGCAGGAGCGGCGGGAC CGGGGAGCTGAGAAGGAACA CAAACGCTACCATAGCCTGG 2100 
N I S R G G S G G N S S N D K L S G P A P R S R L D P A K V L G T 557 
GAAACATCAGCCGCGGTGGC AGTGGGGGCAATAGCAGCAA TGACAAGGTCAGTGGTCCTG CTCCCCGAAGCCGATTGGAC CCAGCTAAGGTGCTGGGCAC 2200 
A L C P R I H E V P L L E P L V C K K I A O. E R Ι Τ V L L F L E D 590 
GGCACTGTGCCCTCGGATCC ATGAGGTGCCACTGCTGGAG CCTCTCGTGTGCAAGAAGAT TGCTCAGGAACGCCTGACCG TGCTACTGTTCCTGGAGGAT 2300 
exon 3lexon 4 
C I I T A C O E G L I C T U A R P G K A F T D E E T E A Q A G Q A S 6 2 4 
TGTATCATCACTGCCTGCCA AGAGGGCCTCATCTGCACCT GGGCCCGGCCAGGCAAGGCG TTCACAGAGGAGGAGAGCGA GGCCCAGGCAGGGCAAGCAA 2400 
61 
exon 4 lexon 5 
U P R S P S K S V V E G I S S O P G S S P S G T V V 650 
GTTGGCCCAGGTCACCCAGC AAGTCAGTTGTAGAGGGCAT CTCCTCCCAACCAGGCAGCT CCCCCAGTGGCACTGTGGTG TGAAATGTGGATGTCCCATG 2500 
TTCCCGGCCTCCTAGCCATA ACCCTCCCCGCTGACCTCAA GAATCACTGTATTAACAAGA CTAATCATGATGGAAGGACT GCTCCAAGCCCCACGCTGCA 2600 
CACATACTGGGGGTCCCCTA GGTTGGCCCAGCCATGGGGA TGTAGTGTCCTGTGTGGCCT TGGCCCTTGGTTCCTCCACC CACTGCCAAGTACAATGACC 2700 
TGTTCTCTGAAACATCAGTG TTAACCATATCCCTGTCCCA GCATGTGACTGTTCACTCCT GGGAGAGACTTAGCCCACAG TACCCCTGGGTGAGAGGGCA 2800 
GGGCAGGGGCCATCCCCACT CCTGCCCAAACCCCACCCCT TGCTATGGTCTGTGATTTTG AAAGTGTTAAATTATGGAAG CCCTGAGGGCCCTCCTTGTT 2900 
polyA signal 
CCCCTGGACCTCTTATTTAT ACTAAAGTCCTTGTTTGCAc agtgtttctgtcccctgggg cagggtagggtgggggttgc agtacttggcctccaagctg 3000 
polyA signal 
tgcactgaccaaaggaagcc caatcttagctgtatcccca tccctagccctgagcagaga gccctctgaaagatgagtct cgacccccaaagtcaagagg 3100 
ctgagatggccttcctacta ggtccttggagatgtttgaa acttgttttaaacaccagga ctatccaagctagctctcct tggggagaggaggatgctgg 3200 
aatttactgcactccctgcc tcctctgaacatgcctttgc agtctgctgcccctggceca tttatgactggccatctagt gccagctggaggtcatgatt 3300 
tcctccccagagaactggcc accctagaaagaagctaact tgtcgcctggcttgctgtcc aggcacgtccgccctcaacc cctaaaatgtttctgtctct 3400 
aatcctagcccaggcaggaa tgtggctgccccggcctgtg gccaaggagctattttgggg ttctcttttgcttaaggagg gcctggatccaccacttgcc 3500 
tcccccaggctggggccagc aggtcscccctggccctggc ggctgagcaaactctctcct gatcttccttctacctcctg ccaaaaaatgggggggeggg 3600 
taatacagcaggcacagggg ctaaatttaactgtcccaaa gtcggaatccattgctgagt cacgaagaagctgcccctgg cctttgcccccceccactac 3700 
cccctcaccccctgttgccc aggcatcagccctttccccc aacccctcccagctctgagt ctatagactggctctcctgg gractgacacctcccacctg 3800 
taactccctgtgctctcttt atgggtgggtagaggceatg ggggggggcaaccctggagt attactctgtcccctgacat tgggctctgaagagttttga 3900 
ggggccctggaagaagggag ttggggtgttggcctcagga ggggttaaaaactgggaggc gggaggggggctgggccaag gggtggagaaaagaggagga 4000 
ggccttaagcatagaaCTGG CCAGAGAGACCCAAGGGATA GTCAGGGACGGGCAGACATG CAGCTAGGGTTCTGGGGCCT GGACAGGGGCAGCCAGGCCC 4100 
j-> putative DM-PK transcription start 
TGTGACGGGAAGACCCCGAG CTCCGGCCCGGGGAGGGGCC ATGGTGTTGCCTGCCCAACA T6TCAGCCGAAGTGCGGCTG AGGCAGCTCCAGCAGCTGGT 4200 
DM-PK translation start 
Figure 1: Essential sequences across the mouse DMR-N9 gene region. Sequences of the 5' end of the 
mouse DMR-N9 gene, the cDNAs, the predicted primary structure of the gene product, and the 3' end 
up to the DM protein kinase translation start are given. The two partial WD-repeat units are shaded. 
Transcribed sequences are in capitals. The ВатШ, Nhel and Ncol sites used to generate probes for the 
SI nuclease assays are double underlined and the primer used for the primer elongation is indicated 
(P.E. primer). The putative CAAT box and several putative transcription factor binding sites are shaded 
with the respective transcription factors indicated underneath the sequences. Transcription initiation sites 
and ATG start codons (shaded) are depicted, as well as the 5' end of the 1.4, 9.1 and human cDNA 
clones. Boundaries of exons are shown by vertical lines, with beginning and end of each exon numbered. 
The two polyadenylation signals are underlined. 
pattern of this gene in human and mouse have 
revealed interesting clues about its possible 
role in muscle functioning (2-4, 8-12), but it 
is still unclear if the DM-PK gene is the only 
gene involved in DM. Both over- and under-
expression, as well as unaltered DM-PK 
expression have been reported (11, 13-18; M. 
Siciliano, personal communication). Until 
now, no changes in the level and nature of 
mRNAs or protein products of other genes 
from within the DM critical area have been 
described. Theoretically, we may expect such 
changes to result from titration of DNA or 
RNA binding proteins (19), or alterations in 
the chromatin structure around the expanded 
repeat (20). 
A possible candidate gene which might be 
involved in severe manifestation of myotonic 
dystrophy, the DMR-N9 gene (8, 9) or 59 
gene (10), was identified when the search for 
the DM mutation culminated. This gene is 
located very close to the DM-PK gene, at 
approximately eleven hundred bp upstream, 
and is prominently expressed in brain and 
testis, two tissues which are commonly af­
fected in DM patients. Here we report on 
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Figure 2: Structural Organization and restriction map of the mouse DMR-N9 gene. The DMR-N9 exons 
are depicted as open boxes, the translation start codon is indicated with an arrow, the translation stop 
codon with a star. The first exon of the DM-PK gene is given as a black box. Restriction sites: B, 
Ватт; Η, «indili; Ν, Ncol; S, San; X, Xhol. 
the characterization of the complete DMR-N9 
transcription unit, including the promoter, 
transcription start site and intron/exon boun­
daries. The expression distribution of the 
DMR-N9 gene during development was stud­
ied in detail by Northern blot analysis and in 
situ hybridization on mouse tissues. We dis­
cuss the significance of these data for the 
understanding of the complex clinical picture 
of DM. 
Results 
Genetic characterization of DMR-N9 
Upon screening of a mouse brain cDNA 
library with the 5' end of the previously des­
cribed DMR-N9 cDNA (clone 9.1; ref. 8) a 
new clone was isolated which extended the 
transcribed region to 205 bp further upstream 
(clone 1.4; Fig. 1). However, as this se­
quence did not contain a putative translation 
start codon, we concluded that clone 1.4 still 
did not represent a full length transcript. 
Unfortunately, attempts to isolate full length 
cDNAs from other sources have not been 
successful until now. 
In order to fully characterize the DMR-N9 
gene, a detailed restriction map of the rele­
vant region of cosmid mc8, located on mouse 
chromosome 7 (21) was generated (Fig. 2). 
The DMR-N9 gene maps within a region of 
only 7 kbp, of which several overlapping 
subclones were partially sequenced (EMBL 
accession numbers Z38011-Z38013 and 
Z38015). By comparing the genomic and 
cDNA sequences we were able to delineate 
five exons (Figs. 1 and 2), which range in 
size from 75 to 1260 bp. The exon-intron 
boundaries, which flank introns between 280 
and 1830 bp in size, comply with the GT/AG 
rule for 5' and 3' splice site sequences (Table 
1). As the cDNA analysis failed to indicate 
the gene's 5' end we extended our genomic 
sequence to 570 bp upstream of the longest 
cDNA. In this region, which is extremely 
C/G rich, we found a putative translation start 
codon at only 40 bp upstream of the 5' cDNA 
end (CCGCCATGG). Because the sequence 
flanking this possible start codon is identical 
to the Kozak consensus sequence (22), com­
puter prediction strongly favours this ATG 
over a second ATG start codon, located 45 bp 
further upstream (CCAAGATGG). If true, 
the DMR-N9 gene encodes a protein of 650 
amino acids, with a molecular weight of 
68,660 Daltons. 
Also the gene's 3' side, in the region be­
tween DMR-N9 and DM-PK (or DMR-B15 
as designated in ref. 8) was sequenced com­
pletely (positions 2940 to 4016 in Fig. 1; 
EMBL accession number Z38015). The most 
downstream DMR-N9 polyadenylation site as 
deduced from mouse cDNAs is positioned at 
only 1240 bp upstream of the DM-PK transla­
tion start codon. As we have preliminary 
evidence that the 5' UTR in the mouse DM-
PK gene spans approximately 140 bp, which 
is significantly shorter than the 5' UTR in the 
human situation (9), we conclude that the end 
of DMR-N9 and the start site of transcription 
in the DM-PK gene in mouse are 1077 bp 
apart. 
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Table 1. Splice junctions and exon sizes of the DMR-N9 gene. 
Exon mRNA Nucleotide Amino-acid 
No. No. 
1 1-502 1 - 129 
2 503 - 685 130 - 190 
3 686 - 1945 191 - 610 
4 1946-2020 611-635 
5 2021 - 2524 636 - 650 
DMR-N9 transcription 
To verify the computer predictions and to 
determine the length of the putative first exon 
more precisely, an SI nuclease protection 
assay on DMR-N9 mRNA was performed. To 
avoid interference from the extremely high 
frequency and patchy distribution of C/G's in 
the relevant region (87% C/G in the 100 bp 
5' to the ATG; Fig. 1) we used two different 
probes and tested various hybridization tem­
peratures. Probe A, generated from a geno­
mic ВатШ - Ncol subclone which spans the 
complete cloned region upstream of the ATG, 
including the C/G rich area, yielded a doublet 
signal of protected fragments of 112 and 118 
nucleotides (Fig. 3) in mouse brain, liver, 
intestine and testis RNA, but not in E.coli 
control RNA. The signal intensities varied 
with the expression levels as seen on Nor­
thern blots (see Fig. 4). We can exclude 
artifacts due to preferential domain melting of 
our probe, as we saw no signals from probe 
portions hybridizing to another C/G rich 
clamp area (65% C/G) 100 bp further up­
stream. Also when the location of the start 
site of transcription was verified with an end-
labelled probe, probe B, which ends at the 
Nhel site at position 410, no SI resistant 
fragments could be seen after test hybridiza­
tions between 55 and 65°C. Likewise primer 
elongation experiments (primer overlapping 
the Nhel site in probe B) did not yield ex­
tended signals. 
From these results we tentatively conclude 
that the actual start site of transcription is 
located around nucleotide positions 416/422 
of the sequence shown in Fig. 1, just up-
64 
3' 5' 
Splice Junction Splice Junction 
CGG/gtgag 
tcaag/TCC GAG/gtgac 
tgcag/CGG GCG/gtgag 
cctag/TTC GAG/gtagg 
cccag/GGC 
stream of an extremely C/G rich region. A 
computer search identified a putative CAAT 
box (position 364-368; Fig. 1), but no TATA 
box in the upstream region. Also several 
putative binding sites for transcription factors 
were identified, including an Spi site (posi­
tion 235-244) and two Ap2 sites (positions 
195-202 and 518-524) (23). Taken together, 
our data indicate that transcription of the 
DMR-N9 gene starts at position 416 or 422 
(Fig. 1) and yields a mature mRNA of 2524 
nucleotides, with an ORF of 1950 nucleotides 
and 5' and 3' UTRs of 115 and 459 nucleo­
tides, respectively. The 3' UTR may vary in 
length because, as described earlier (8), poly-
adenylation of the DMR-N9 transcripts occurs 
at two adjacent positions (positions 2900 and 
2939 in Fig. 1), due to the presence of two 
rather inefficient polyadenylation signals 
(AATTA and ATTTA, underlined in Fig. 1). 
DMR-N9 homology 
Recently, the human homologue of the 
DMR-N9 gene, called the 59 gene, was iso­
lated (10). The corresponding human cDNA 
clone is a partial copy of the mRNA which 
starts at position 840 of the mouse (Fig. 1), 
corresponding to our amino acid position 104. 
The predicted amino acid sequences of the 
human 59 and mouse DMR-N9 gene are 
highly homologous. Over the published se­
quence, 92.7% of the amino acid positions in 
the proteins of these two species are identical, 
95.1% of the positions are similar. Also the 
genomic structure of the human and mouse 
59/DMR-N9 genes is very similar (D. Brook, 
personal communication). The human gene 
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ligure 4: Northern blot of total cellular mouse 
RNA. In each lane approximately 10 μg RNA was 
loaded. The blot was successively probed with the 
DMR-N9 cDNA clone 9.1 (8) and with glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) 
cDNA as a control probe. 
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Figure 3: SI nuclease assay for the determination 
of the transcriptional start site. Probe A was 
hybridized with 25 μg RNA from mouse brain, 
liver, intestine and testis, and with E.coli RNA as 
a control. The controls consist of: Non hybridized 
and non digested probe (Probe -SI) and digested 
and non digested E.coli hybridization mixes 
(E.coli +S1 and -SI, respectively). All other 
hybridization mixes were digested with SI nucle­
ase. Marker fragment lengths are indicated at the 
right. Two specific fragments of approximately 
112 and 118 bases can be seen in the mouse tissue 
lanes, representing two transcriptional start sites. 
In brain and liver also an aspecific band of ap­
proximately 210 nucleotides is visible. 
spans approximately 11 kbp of genomic se­
quence and comprises 5 exons of the same 
approximate length as the corresponding 
mouse exons. Computer searches with the 
putative DMR-N9 protein sequence revealed 
significant homology of amino acid segments 
323-337 and 408-422 (shaded in Fig. 1) to the 
last half of WD-repeat sequences (reviewed in 
ref. 24 and 25). Less well conserved repeat 
units are present in the DMR-N9 protein at 
positions 210-225 and 282-297. These highly 
conserved repeating units are found in several 
distinct eukaryotic proteins with regulatory 
functions, such as the /3-subunit of G pro­
teins, neurogenic Groucho-related proteins 
and the PR55 and CDC55 phosphatase sub-
unit proteins. 
Tissue specific DMR-N9 expression. 
In a preliminary study, using Northern 
blot analysis on a limited series of tissues (8), 
we have reported that expression of the 
DMR-N9 gene is mainly restricted to brain 
and testis. Analysis of a more elaborate series 
of mouse total cellular RNAs (Fig. 4) con­
firmed this finding, but shows also significant 
expression levels in heart and lung. In order 
to refine the expression pattern, RNA in situ 
hybridization analyses were performed on 
mouse embryo's and adult mice. Already very 
early in embryogenesis, 9.5 days post concep-
tionem (d.p.c), expression of DMR-N9 could 
be detected in all parts of the embryo (Fig. 
5a, b). Also the placenta shows expression 
within the fetal parts, whereas no expression 
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Figure 5: RNA in situ hybridization of mouse 
embryos with a DMR-N9 antisense riboprobe. 
Bright field (a,c,e) and dark field (b,d,f) images 
of cryosections through a 9.5 d.p.c. embryo and 
placenta (a,b), 14.5 d.p.c. embryo (c,d), and 
16.5 day old embryo (e,f) are shown. In all 
embryonic stages DMR-N9 was found ubiquitous­
ly expressed in neuronal tissues. Abbreviations: 
dec, decidua; e, embryo; g, gut; li, liver; me, 
mesencephalon; my, myelencephalon; pi, placen­
ta; r, ribs; re, retina; te, telencephalon; sc, spinal 
cord; to, tongue. Bar = 1 mm. 
of DMR-N9 is seen in the decidua. Midges-
tation embryos (14.5 d.p.c.) showed high 
expression of DMR-N9 in all neural tissues 
e.g. telencephalon, retina and the spinal cord 
(Fig. 5c, d). In the 16.5 day old embryo 
(Fig. 5e, f) high expression is visible in the 
telencephalon and the mesencephalon, where­
as the myelencephalon shows a significant 
lower level of expression. Also some non-
neural tissues with significant expression, for 
example muscle tissue of the tongue and 
around the ribs, were seen. 
In the postnatal mouse highest expression 
was observed in the brain and in testis. In situ 
hybridization of frontal sections through the 
head of a two day old mouse shows expres­
sion in all parts of the olfactory bulb and the 
granular layer of the neopalhc cortex (Fig. 
6). There is also some expression visible in 
the retina and the olfactory epithelium of the 
nasal cavity. In the mature testis expression 
of DMR-N9 is visible only in some tubules of 
distinct stages of the spermatogenic prolifera­
tion cycle. Staging of the tubules according to 
Oakberg (26) revealed that expression is 
restricted to tubules of the stages ІП to ХП 
(Fig. 7a, b). Within the tubules expression is 
located over the layer of the secondary sper­
matocytes (Fig. 7c, d). No hybridization 
signals were observed using the sense control 
probe (Fig. 6c, not shown). 
Discussion 
Using a combination of DNA sequencing 
and SI mapping analysis, we have delineated 
the DMR-N9 transcription unit. This gene can 
be considered the closest upstream, distal, 
neighbour of the DM-PK gene in which the 
expanding CTG-trinucleotide repeat is loca­
ted. Though there is circumstantial evidence 
that there are also several genes located close­
ly downstream of the DM-PK gene (i.e. 
proximal on 19ql3.3; D. Brook, personal 
communication; 10), none of these has been 
characterized in detail. 
We know that DM is caused by an un­
stable (CTG)D trinucleotide repeat in the 3' 
UTR of the DM-PK gene. What then is the 
rationale to study genes that have no apparent 
link to this repeat? The first argument comes 
from the complex clinical manifestation of 
66 
co 
v v 
ob 
ПС 
re 
le 
to 
\ 
Figure 6: In situ visualization of DMR-N9 expression in postnatal head. Bright field (a) and dark field 
(b,c) images of frontal sections through the head of a two day old mouse. Hybridization with a DMR-N9 
antisense probe (b) showed high expression in the olfactory bulb and the granular layer of the neopallic 
cortex. The control hybridization with the sense probe revealed no specific signals, only non specific 
light reflection by lens fibres (c). Abbreviations: co, cortex; le, lens; nc, nasal cavity; ob, olfactory bulb; 
re, retina; to, tongue. Bar = 1 mm. 
DM (1) and the tissue specific expression of 
the DM-PK gene (2, 8, 11, van der Ven et 
al., submitted). CTG-repeat expansion has 
dominant and length-dependent effects which 
manifest themselves mainly in muscle. Yet, in 
the more severe cases of DM there is a com­
plex involvement of endocrine abnormalities, 
male sterility (testicular atrophy) and mental 
impairment which cannot be simply explained 
by disbalance in the functioning of a putative 
protein kinase expressed in muscle and cer­
tain brain areas only. 
The second argument originates in the fact 
that, although more than two years have 
passed since the discovery of the CTG-expan-
sion, the molecular etiology of DM has re­
mained an enigma. From studies of human 
materials we even do not know whether over-
, under- or ectopic expression of DM-PK is 
involved in DM (11, 13-18 and see ref. 27). 
Also, recent studies on mouse models did not 
really clarify this problem. Our group, as 
well as the group of D. Housman and S. 
Reddy at MIT (personal communication), 
have found independently that DM-PK "knock 
out" mice show no phenotypic abnormalities 
except for minor and variable changes in the 
muscles of the head and neck region in old 
mice and thus are not a faithful model for 
DM. Furthermore, overexpression of DM-PK 
in a transgenic mouse model (Jansen et al., 
submitted) results in cardiomyopathy, en­
hanced neonatal mortality and breeding prob­
lems. Again no clear affection of skeletal 
muscles as in DM patients were seen. If we 
may compare the situation in mice and man, 
we can tentatively conclude that the complex 
picture in DM is indeed caused by more 
parameters than disregulation of DM-PK 
alone. 
The last argument comes from the study 
of the genomic organization around the CTG-
repeat. The DMR-N9 gene is in the same 
transcriptional orientation as the DM-PK gene 
and its 3' end in the mouse is located only 
1077 bp upstream of the DM-PK start site of 
transcription. In humans the genes could be 
even closer, as start of transcription of the 
DM-PK gene 630 bp further upstream has 
been reported (9), leaving only a 600 bp 
intergenic region. Also, human 59/DMR-N9 
read-through transcripts were found ending in 
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Figure 7: Expression of DMR-
N9 in mature testis. Bright field 
(a,c,d) and dark field (b) images 
of a section through a 6 week 
old testis hybridized with a 
DMR-N9 antisense riboprobe 
are shown. Expression is obser­
ved in seminiferous tubuli of the 
stages VIII to XII of the sper-
matogenic proliferation cycle. In 
tubuli of the stages I to П only 
low expression is detected (a,b). 
The grains are predominantly lo­
cated over the layer of the sec­
ondary spermatocytes (c,d). 
Abbreviations: Roman numbers 
(I - XII) indicate the stages of 
the tubuli according to Oakberg 
(25); rs, round spermatids; sc I, 
primary spermatocytes; sc Π, 
secondary spermatocytes; sg spermatogonia; sp, mature sperm. Bar: a,b = 100 μτη; c,d = 10 μπι. 
a genomic poly-A stretch that is located even 
closer to the DM-PK gene's 5' end (8-10). It 
is known that transcription of a gene may 
proceed thousands of base pairs beyond the 
poly (A) addition site (28). Thus it is con­
ceivable that transcription of the 59/DMR-N9 
gene runs through the DM-PK gene and that 
the actual termination of transcription does 
not occur before the CTG-stretch is reached. 
If the expanding repeat alters chromatin fol­
ding in the DM-locus, as recently described 
by Wang and coworkers (20), and therewith 
affects progression of RNA polymerase II, 
the expression of the DMR-N9 gene is very 
likely altered. Alternatively, if CTG-repeat 
expansion alters chromatin domain topology 
and transcription initiation efficiency, not 
only DM-PK and DMR-N9 but also genes 
downstream of the DM-PK gene could be 
affected. 
Ultimately brain and testicular biopsies of 
DM patients will be needed to study altera­
tions in DMR-N9 mRNA or protein levels, 
but these are difficult to obtain. For the time 
being, therefore, DMR-N9's involvement in 
DM is purely hypothetical and our specula­
tions are based only on its chromosomal 
position and expression pattern. The latter is 
particularly intriguing in view of the typical 
cataract, mental impairment, testicular atro­
phy and oligospermia (1). Highest expression 
of DMR-N9 was found in neural tissue and 
testis. Already early in development (from 
day 9.5 p.c. onwards) expression could be 
detected in the central nervous system, es­
pecially in telencephalon and mesencephalon, 
after birth in the olfactory bulb and the gran­
ular layer of the neopallic cortex. Also, ex­
pression was evident in retina and the olfac­
tory epithelium. Unfortunately the neuropath­
ology in DM is still poorly understood, and, 
therefore, comparisons with DMR-N9 expres­
sion are speculative. In mature testis the 
DMR-N9 expression was found restricted to 
secondary spermatocytes of stages VIII to XII 
of the spermatogenic proliferation cycle. 
Within these stages proliferation of the pri­
mary spermatogonia is evident and the secon­
dary meiotic division takes place (26). The 
expression of DMR-N9 in secondary sper­
matocytes during the second meiotic division, 
in combination with the presence of the two 
(or four) WD-repeat units in the protein, 
indicates a specific regulatory function of the 
gene in this step of the meiosis. Therefore, 
disfunctioning of DMR-N9 during spermato­
genesis of DM patients could be involved in 
the testicular atrophy, which consists of a 
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primary tubular degeneration with fibrosis 
and hyalinization along with a relative hyper-
trophy of Leydig cells. In addition, we have 
reported recently that large (CTG)„ repeats of 
more than 1000 triplets are not found in 
sperm of male carriers (29). Whether this 
selection is biased by disfunctioning of DMR-
N9 or due to pause or arrest of DNA replica-
tion (30) is currently not known. 
As the genomic organization of the DM 
critical area is largely similar in man and 
mouse, perhaps the best hope for the future is 
in the generation of an animal (mouse) model 
for DM in which an unstable (CTG)„ repeat 
has been engineered in the appropriate posi-
tion of the mouse genome. Also, the elucida-
tion of DMR-N9's biological function and 
testing of patient material is necessary to 
draw conclusions about the involvement of 
the gene in DM. Some clues may be expected 
from further study of the role of members of 
the WD-repeat protein family, to which 
DMR-N9 belongs. At the same time a further 
search for other genes in close proximity of 
the DM-locus is warranted to obtain a better 
understanding of the complex phenotype of 
myotonic dystrophy. 
Materials and methods 
Characterization of cosmids and cDNAs. 
The isolation of mouse cosmid and cDNA 
clones has been described elsewhere (8). Using 
the 5' end of a fully characterized DMR-N9 
cDNA clone (clone 9.1; ref. 8) as a probe, ad-
ditional cDNA clones were isolated from the 
original mouse brain cDNA library (Stratagene). 
Restriction enzyme mapping and sequencing using 
the supercoiled DNA sequencing method (31) 
identified several cDNAs with longer 5' exten-
sions. The longest cDNA clone (clone 1.4) was 
used as a probe to map DMR-N9 exons on previ-
ously isolated mouse cosmids, and to identify 
genomic subclones by standard hybridization 
detection assays (32). Briefly, exon containing 
genomic clones were generated by shotgun sub-
cloning of random Sau3A fragments or by speci-
fic subcloning of hybridizing restriction fragments 
of cosmid mDMRc8 (8) into plasmid vectors 
pGEM3 and pGEM4 (Promega) and pBluescript 
(Stratagene). Intron-exon boundaries in these 
clones were determined by sequencing and com-
parison to cDNA sequences. Commercially availa-
ble T7, T3 or Sp6 transcription start site oligonuc-
leotides or DMR-N9 specific synthetic oligonucle-
otides (Pharmacia) served as sequencing primers. 
Assembly, analysis and alignment of DNA and 
protein sequences were done using IG-SUITE 
S.3S package (Intell¡genetics). Genbank (release 
83), EMBL (release 40), PIR-Protein (release 42) 
and SwissProt (release 30) databases were 
searched for homology using the BLAST program 
(33). The DMR-N9 sequences have been de-
posited in the EMBL database, accession numbers 
Z38011-Z38013 and Z38015. 
Determination of transcription start site. 
The transcription start site of the DMR-N9 
gene was determined using standard SI-nuclease 
mapping or primer elongation assays. Several 
different probes were used in the SI nuclease 
mapping. A BamHl-Ncol genomic fragment (bp 1-
534 in Fig. 1) was subcloned in pGEM4 and used 
to generate a single stranded randomly labelled 
probe A. To this end, 4 μg of supercoiled plasmid 
DNA was denatured and dissolved in 22 μΐ reac­
tion mixture, containing 30 ng T7 primer and 3 μΐ 
lOx buffer (70 mM Tris-HCl pH 7.5, 70 mM 
MgCl2) 200 mM NaCl, ImM EDTA, 15 mM 
DTT). After 10 min at 65°C and 30 min at 37°C 
for primer annealing, 5 μΐ a-,2P-dCTP (Amers-
ham, 3000 Ci/mmol), 1 μΐ 20 mM dATP, dGTP 
and dTTP and 2 μΐ Klenow enzyme (Boehringer 
Mannheim, 2 units/μΐ) were added. The reaction 
was run for 15 min at 37°C and then chased twice 
by the addition of 1 μΐ 250 μΜ and 1 μΐ 20 mM 
non-radioactice dCTP, respectively, at 15 min 
intervals at RT. After heat-inactivation of the 
enzyme the reaction mix was incubated with 
EcoRl to linearize the double stranded reaction 
product and the probe was run on a 6% denatur­
ing Polyacrylamide gel. The radioactive fragment 
of the appropriate length was excised and the 
DNA eluted in TE (10 mM Tris-HCl pH 8.0, 1 
mM EDTA) at 65°C. Probe В was a shorter 
genomic fragment, bracketed by the BamUl (at bp 
position 1) and the Nhel site (at bp position 410). 
This probe was end-labelled with γ-32Ρ-ΑΤΡ 
(Amersham) and T4-polynucleotide kinase (BRL) 
at the Miel site and purified from LM agarose. 
The SI nuclease protection assay was performed 
essentially as described by Berk and Sharp (34) 
and Weaver and Weissmann (35). Briefly, 0.01 -
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0.03 pmol probe (30,000 cpm of probe A, or 
10,000 cpm of probe B) was hybridized to 25 μg 
total cellular RNA (mouse brain, liver, testis or 
intestine, or E.coli RNA) in 80% FAHB (0.907 g 
formamide/ml, 400 mM NaCl, 40 mM PIPES pH 
6.4, 1 mM EDTA) at 55°C. After 16 hrs hybridi­
zation the DNA-RNA complexes were digested 
for 45 min at 30°C with 75 units Sl-nuclease 
(Pharmacia) in 250 μ\ digestion buffer (0.25 M 
NaCl, 0.03 M NaOAc pH 4.5, 1 mM ZnS04, 12 
ßg single-stranded carrier DNA per ml). Diges-
tions were stopped by phenol xhloroform (1:1 
v/v) extraction and protected DNA/RNA hybrids 
were alcohol precipitated and redissolved in 5 μ\ 
of 90% (v/v) formamide, 1 mM EDTA, 0.05% 
Bromophenol Blue and Xylene Cyanol. After 
denaturation by heating, reaction products were 
resolved on a 6% denaturing polyacrylamide-urea 
sequencing gel (acryl:bisacryl 20:1) and visualized 
by exposure to Kodak X-OMAT film, for 16 hrs 
to 2 weeks with one intensifying screen. 
The primer elongation assay was performed as 
follows. The N9 specific primer, 5'-
GGA.AGT.TGA.GGG.GCT.AGC.A-3·, was 
located 200 bp upstream of the 5' end of cDNA 
clone 1.4 (see Fig. 1). One ng of 5' MP endlabel-
led primer was mixed with 25 μg total cellular 
RNA, in distilled water and denatured for 15 min 
at 65°C. Annealing and elongation was carried 
out in 50 mM Tris-HCl pH 8.3, 75 mM KCl, 15 
mM MgCl2, 0.01 mM DTT, 1 mM of each of the 
dNTP's and 100 units MoMLV RT (BRL) for 1 
hr at 37°C. The reaction product was precipita­
ted, loaded onto a 6% denaturing Polyacrylamide 
gel and visualized as described above. 
Total cellular RNA used for these analyses 
was isolated from various tissues from adult mice, 
using the LiCl-Urea-SDS method (36). 
RNA in situ hybridization. 
RNA in situ hybridization was performed as 
described by Bächner et al. (37) and van der Ven 
et al. (submitted). MS-CTP (Amersham) labelled 
transcripts were generated from the previously 
described cDNA clone 9.1 (8), linearized with 
EcoRI (anti-sense), or Kpnl (sense). T7 RNA 
polymerase (a kind gift of R. Hoet) or T3 poly-
merase (Promega) were used to transcribe the 
anti-sense and sense probes under standard con-
ditions (32). 
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CHAPTER 
3 
Identification and characterization 
of the dynamic mutation involved 
in myotonic dystrophy 
CHAPTER 
3.1 
Myotonic dystrophy mutation: An unstable CTG 
repeat in the 3' untranslated region of the gene 
Science 255: 1253-1255 (1992) 
Myotonie Dystrophy Mutation: An Unstable CTG 
Repeat in the 3 ' Untranslated Region of the Gene 
M A N I M A H A D F V A N , C A T H F R I N E T S I L U D I S , L U C S A B O U R I N , 
G A R Y S H U T L E R , C H R I S A M L M I Y A , G E R Ì J A N S L N , C A I H L R I N L N h v i i . i t-, 
M O N I C A N A R A N G , J U A N A B A R C L L Ó , K I M Ο Ή Ο Υ , S U Z A N N I - L U Ì I O N D , 
J A N E E A R L E - M A C D O N A L D , P I E I E R J. DÌ- J O N C , Β ί W I E R I N C . A , 
ROBERT G KORNEIUK* 
Myotonic dystrophy (DM) is the most common inherited neuromuscular disease in adults, 
with a global incidence of 1 in 8000 individuals. DM is an autosomal dominant, multisys-
temic disorder characterized primarily by myotonia and progressive muscle weakness. 
Genomic and complementary DNA probes that map to a 10-kilobase Eco RI genomic 
fragment from human chromosome 19ql3.3 have been used to detect a variable length 
polymorphism in individuals with DM. Increases in the size of the allele ín patients with DM 
are now shown to be due to an increased number of trinucleotide CTG repeats in the 3' 
untranslated region of a DM candidate gene. An increase in the severity of the disease in 
successive generations (generic anticipation) is accompanied by an increase in the number of 
trinucleotide repeats. Nearly all cases of DM (98 percent or 253 of 258 individuals) 
displayed expansion of the CTG repeat region. These results suggest that DM is primarily 
caused by mutations that generate an amplification of a specific CFG repeat. 
M YOiONic ms iRo i 'm (DM) is <in autosomal dominant disorder characterized primarily by myoto-
nia and progressive muscle weakness, al 
though (.entrai nervous system, cardio\ascu 
lar, and ocular manifestations also frequently 
occur (Í) The disease shows a marked vari-
ability in expression, ranging from a severe 
congenital form that is frequently fatal just 
after birth to an asymptomatic condition 
associated with normal longevity burther-
more, the progression of DM in a H cued 
families may exhibit genetic anticipation, an 
increase in the seventy of the disease in 
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" Го whom e orre sponde пес should bc addressed 
successive generations (2) 
We have cloned the essential region of 
human chromosome 19ql3 3 that contains 
the DM locus ( i-5) We isolated genomic 
and cDNA probes that map to this region 
and that detect an unstable, 10-kb beo RI 
genomic fragment in individuals aficcted 
with DM This variable length polymor­
phism is similar to the liistabihn at the 
Ir agi le X locus (6-8) The physical map 
location and generic characteristics of the 
variable length polymorphism are consistent 
with it being the cause of DM We now 
further characterize the variable length poly­
morphism segment to determine the molec­
ular basis of the unstable genomic region 
We identified, using Southern (DNA) 
blot anaKsis, two different DNA polvmor 
phisms mapping within the 10 kb Eco RI 
genomic fragment (Fig 1) The polymor­
phisms are detected by two genomic probes 
fpGB2 6 and pGPl 5) that map ro this beo 
RI fragment In normal individuals, these 
probes detect an 8 5- or 9 5-kb Hind 111 or 
a 9 0- or 10 0 kb hco RI insertion polymor­
phism This variation is due to a 1 -kb inser­
tion within a 150-bp Pst I Rgl I fragment 
(Fig 1) The second DNA polymorphism 
maps to a 1 5 kb Bam HI fragment located 
4 0 kb centromene to the insertion poly 
morphism and is associated exclusively with 
chromosomes from individuals with DM. 
DNA sequence analysis of' this genomic frag­
ment revealed a trinucleotide CTG repeat lo­
cated approximately 300 bp distal to the cen-
tromeric Bam Ш site (Fig. 1). Chromosome 
19 cosmids F18894 and Y100263 (5) con­
tained 20 and 11 CTG repeats, respectively. 
We have used the 1.5-kb Bam HI frag­
ment, as well as other genomic probes from 
the DM region, to isolate human and mouse 
cDNAs from brain, muscle, and heart librar­
ies. Sequence analysis shows that some of 
the isolated cDNAs contain the variable 
CTG repeat (Fig. 1). Multiple stop codons 
are found in all three reading frames 5' to 
the trinucleotide repeat. Furthermore, a 
polvadenvlation signal and polyadenvlated 
tail are present in these clones approximately 
500 bp downstream of the repeat region. 
Therefore, the CTG repeat is contained 
within the 3' untranslated region of this 
DM candidate gene. 
We investigated the relation of both DNA 
polymorphisms to DM by Southern blot anal­
ysis. Genomic DNA from a total of 280 nor­
mal and 258 affected individuals from 98 DM 
families were used in the study. The insertion 
polymorphism in normal individuals can be 
detected with a variety of restriction enzymes 
(Fig. 1). In all of our affected families, the DM 
chromosome segregated with the larger iaser-
tion allele, which has a frequency of 0.60 in the 
normal population. This strong linkage dis­
equilibrium suggests that there exists a limited 
number of DM mutations. Alternatively, the 
larger 10-kb Eco RI allele may be somehow 
predisposed to DM mutation. 
Increases in the size of the variable length 
polymorphism (5, 9, 10) up to 6.0 kb and 
greater were detected (Fig. 2). Nearly 70% 
of individuals with DM (180 of 258) show 
distinct increases in the size of the variable 
length polymorphism by Southern blot 
analysis. Furthermore, almost all DM fami­
lies (96 of 98) have at least one individual 
with expanded DM alleles. Normal individ­
uals (280 analyzed) do not exhibit allelic 
expansion. 
Expanded alleles often have a blurred 
appearance on Southern blots (Fig. 2). This 
suggests a somatic cell heterogeneity in the 
size of the expanded alleles similar to that 
seen in the fragile X mutation (6-8, 11). 
Furthermore, preliminary results suggest 
there is a tendency for the DM variable 
length polymorphism alleles to increase in 
size in successive generations of a family and 
that the greater the expansion of these vari­
able length polymorphism alleles, the great­
er the clinical severity of the disease. There­
fore, genetic anticipation may, Ín fact, be a 
real phenomenon in DM (2) and may not 
simply be due to ascertainment bias, as 
originally suggested (12). 
To determine whether an increased num-
ber of CTG repeats is responsible for allelic 
expansion, primers for the polymerase chain 
reaction (PCR) flanking the CTG repeat 
region were derived from the DNA se-
quence in Fig. 1. All primer combinations 
produce similar patterns of amplification in 
normal individuals. A substantial variability 
in the size of normal alleles can be seen with 
agarose gel electrophoresis and ethidium 
bromide staining. Polyacrylamide gel elec-
trophoresis (Fig. 3) revealed that the sizes of 
normal alleles corresponded tí) variability in 
the number of CTG repeats, ranging from 5 
to 30 (124 normal chromosomes analyzed). 
CTG repeat numbers of 5 and 13 are the 
most common in the normal population 
Bg 
~zr 
pGB26 pGPI.5 
Fig. 1. (A) Restriction map 
of the genomic segment 
containing the variable 
length polymorphism de-
tected at the DM locus. The 
map was constructed by the 
analysis of subclones derived 
from the cosmid Y100263, 
a genomic clone previously 
described (5). The normal 
insertion polymorphism and 
the variable length polymor-
phism (triangles 1 and 2, 
respectively) are detected by 
two sequence probes, 
pGB2.6 and pGP1.5. The 
orientation of the map is 
given from telomere (TER) 
to centromere (CEN), and 
the position of relevant re-
striction sites are given: B, 
Bam HI; Bg, Bgl I; E, Eco 
RI; H, Hind III; and P, Pst 
I. (B) Nucleotide sequence 
of the 3' region of a cDNA 
clone. The clone was isolat-
ed from a human heart 
cDNA library (Stratagenc, 
Inc.) with the 1.5-kb Bam 
HI fragment containing the 
variable length polymor-
phism as a probe. The sequence shown is the last 60 bp of the penultimate 3' exon (top line) followed 
by the entire 875-bp sequence of the 3-most exon. The nucleotide position designated by the number 
1 corresponds to the first base of the last exon. A consensus polyadenylation signal sequence is 
underlined. Relevant restriction enzymes are shown in italics above their recognition sequences. Primers 
used for sequencing and PCR amplification are underlined and numerically designated. Indicated in 
bold letters are the five CTG repeats located between primers 409 and 410 found in this cDNA. The 
genomic sequence derived from cosmid clones F18894 and Y100263 is identical to the sequence of the 
last exon of the cDNA, except there are 20 and 11 CTG repeats, respectively Plasmid DNA was 
prepared by a routine alkaline Ivsis method. Dideoxv chain termination reactions with vector primers 
and internal primers were performed with fluorescent dye labeled dideoxynucleorides, according to 
manufacturer's specifications (Applied Biosystems), and subsequently run on an ABI 373A automated 
sequencer. DNA sequencing was also performed with radioactive nucleotides to resolve sequence 
ambiguities. 
D AGTGCCCGCTGGTGGGGCCAGGCCCCATGCACCGCCGCCACCTGCTGCTCCCTGCCAGGG 
1 TCCCTAGGCCTGGCCTATCGGAGGCGCTTTCCCTGCTCCTGTTCGCCGTTGTTCTGTCTC 
61 GTGCCGCCGCCCTGGGCTGCATTGGGTTGGTGGCCCACGCCGGCCAACTCACCGCAGTCT 
121 GGCGCCGCCCAGGAGCCGCCCGCGCTCCCTGAACCCTAGAACTGTCTTCGACTCCGGGGC 
181 CCCGTTGGAAGACTGAGTGCCCGGGGCACGGCACAGAAGCCGCGCCCACCGCCTGCCAGT 
241 TCACAACCGCTCCGAGCGTGGGTCTCCGCCCAGCTCCAGTCCTGTGATCCGGGCCCGCCC 
primer 409 с 
301 CCTAGCGGCCGGGGAGCGAGGGGCCGGGTCCGCGGCCGGCGAACGGGGCTCGAAGGGTCC 
•a primer 410 
361 TT^TAGCCGGGAATGCTGCTGCTGCTGCTOGGGGGATCACAGACCATTTCTTTCTTTCGG 
Pst I 
421 CCAGGCTGAGGCCCTGACGTGGATGGGCAAACTGCAGGCCTGGGAAGGCAGCAAGCCGGG 
•a primer 406 Hind ITI 
4 81 CCGTÇÇGTGTTCCATCCTCCACGCACCCCCACCTATCGTTGGTTCGCAAAGTGCAAAGCT 
ч primer 407 
541 TTCTTGTGCATCACGCCCTGCTCT^GGGAGCGTCrGGCGCGATCTCTGCCTGCTTACTCG 
Bam HI 
601 GGAAATTTGCTTTTGCCAAACCCGCTTTTTCGGGGATCCCGCGCCCCCCTCCTCACTTGC 
661 GCTGCTCTCCGAGCCCCAGCCGGCTCCGCCCGCTTCGGCGGTTTCGATATTTATTGACCT 
721 CGTCCTCCGACTCGCTGACAGGCTACAGGACCCCCAACAACCCCAATCCACGTTTTGGAT 
781 GCACTCAGACCCCGACATTCCTCGGTATTTATTGTCTGTCCCCACCTAGGACCCCCACCC 
841 CCGACCCTCGCGAATTAAAGGCCCTCCATCTGCCC[A]„ 
N E2 E4 E3 N E3 EO 
ІЭДШ. 
• io kb 
-*-9kb 
Fig. 2. Southern blot analysis showing varying 
degrees of allelic expansion in DM-affected indi­
viduals. Eco RI allele sizes of 9 kb and 10 kb are 
found in the normal population (lanes 1, 2, and 
6). Genetic phasing of all our DM families reveals 
that the 10-kb allele is the expanding allele in DM 
individuals. Classification of expansion is as fol­
lows: E0, no expansion; El, expansion of 0 to 1.5 
kb; E2, expansion of 1.5 to 3.0 kb; E3, expansion 
of3.0to4.5 kb; E4, expansion of 4.5 to 6.0 kb or 
more. Approximately 30% of DM individuals 1 2 3 4 5 6 7 8 9 10 11 
(affected status verified by DNA typing) show no 
allelic expansion on the Southern blot level (lanes 8 and 11). Varying degrees of expansion are seen in 
other DM individuals, ranging from El (lane 9) to E2 (lanes 3 and 10) to E3 (lanes 5 and 7) to E4 (lane 
4). N refers to normal individuals. Genomic DNA (5 μg) was digested with Eco RI, separated by 
electrophoresis on 0.8% agarose gels, and transferred to nylon membranes. Southerns were probed with 
the Bam Hl-Eco Rl fragment of pGB2.6, washed in saline sodium citrate [0.2x standard saline citrate 
(SSC)] with 0.1% sodium dodecyl sulfate (SDS) at 65°C, and exposed to x-ray film for 1 to 4 days. 
76 
(frequencies of 35% and 19%, respectively). 
The overall heterozygosity among normal 
individuals is 81%. 
PCR amplification of the CTG repeat re­
gion of genomic DNA from individuals af­
fected with DM revealed that although the 
unaffected alleles are readily amplified, the 
mutant alleles are not usually visible by ethid-
ium bromide staining and agarose gel electro-
Fig. 3. Size distribution of CTG repeats in normal 
individuals. Analysis of 32P-labeled PCR products 
bv denaturing acrvlamide electrophoresis shows 
repeat lengths ranging from 5 to 28 repeats. The 
most common repeats in the normal population 
{5 repeats, 35%; 13 repeats, 19%) are designated 
by the arrows. Pnmer 409 ( 1 μg) was radioac-
tively labeled with -y-[32P|adenosinc triphosphate. 
CTG repeats were amplified with genomic D N A 
from various normal individuals in standard PCR 
reactions containing 50 ng of both primer 409 
and 410, and 10 ng of radiolabeled primer 409. 
Amplified products were resolved by gel electro­
phoresis on 8% Polyacrylamide. Dried gels were 
exposed to Kodak X-AR5 film and auroradio-
graphed at room temperature for 17 hours. Se­
quencing reactions generated from a conrrol Tem­
plate were used as molecular size standards. 
phoresis. In order to determine whether the 
mutant alleles were in fact amplified, a syn­
thetic (CTG) 1 0 oligonucleotide was used to 
probe a Southern blot of PCR products. 
Genomic DNA amplified by PCR from indi­
viduals with DM showed a distinct smearing 
of the hybridization signal above the normal 
alleles, presumably due to heterogeneity of 
the expanded allele. In contrast, the oligonu­
cleotide probe hybridized only to the normal 
alleles in unaffected individuals {Fig. 4). 
As discussed above, nearly 70% of indi­
viduals with DM show distinct expansion of 
the variable region by Southern blot analysis 
of genomic DNA. However, most of the 
remaining 30% that do not show allelic 
expansion by Southern blotting show some 
increase in the sizes of the mutant allele bv 
the PCR-based oligonucleotide assay. Only 
a few of our DM families (2 of 98) are 
negative by both types of analysis. These 
families may represent unique mutations of 
the DM gene that do not involve an increase 
in the number of CTG repeats. 
Occasionally, in DM individuals a faint 
higher molecular size band detectable by 
ethidium bromide and agarose gel electro­
phoresis is amplified by PCR. This occurs 
only with DNA from DM individuals that 
show minimal or no visible expansion of the 
10-kb Eco RI or 9.5-kb Hind III allele. 
These bands produce an intense hybridiza­
tion signal when bound to the (CTG) 1 0 
oligonucleotide (Fig. 4). Selective PCR am­
plification of these bands followed by direct 
DNA sequence analysis showed no differ­
ences in the DNA sequence flanking the 
CTG repeat (from primer 407 to primer 
409) (Fig. 1) in comparison to normal 
individuals. Only the number of CTG re­
peats appeared to vary between normal and 
DM alleles, although this was difficult to 
N E0 E2 E1 E4 E4 E2 E2 Fig. 4. Southern blot analysis of PCR-
amplified genomic DNA from normal (N) 
and DM-affected (E) individuals. South­
erns were probed with а ( С Т С )
Ш
 oligo­
nucleotide. PCR-amplificd DNA from 
DM individuals shows a distinct smearing 
of the hybridization signal, presumably 
due to heterogeneity of the expanded al­
lele. In contrast, the oligonucleotide probe 
hybridized only to the normal alleles in 
unaffected individuals. Individuals who 
show no expansion (E0) at the Southern 1 2 3 4 5 6 7 8 9 f0 11 12 13 14 15 16 
blot level show clear expansion with the PCR-based assay (lane 10). In some PCR-amplified samples 
from DM individuals, the hybridization smear produced bv the labeled ( C T G ) | 0 oligonucleotide is faint 
and could be mistaken for that of an unaffected individual (lane 13). However, examination of Southern 
blot analysis of Eco R I - or Hind III -digested genomic DNA probed with pCìB2.6 or pGP1.5 reveals 
the presence of a greatly expanded allele (E4) in this individual. Presumably, a greatly increased number 
of CTG repears is refractory to PCR amplification under the conditions used. Thus, appropriate 
molecular diagnosis of DM should include both Southern blot analysis of genomic DNA and the 
hybridization analysis of PCR-amplified DNA. Genomic DNA (2 μg) was PCR-amplified with primers 
406 and 409 by a standard protocol and 30 cycles of 94°C for 1 min, 60°C for 1 min, and 72°C for 1.5 
mm. Amplified products were separated by electrophoresis on 1% agarose gels, transferred onto nylon 
membranes, and probed with a labeled ( C T G )
m
 oligonucleotide. Membranes were washed in 6 x SSC 
with 0 .1% SDS at 40°C and exposed to x-ray film overnighr. 
determine unequivocally because of severe 
compression problems in the sequencing 
gels, a problem similarly encountered in the 
DNA sequence analysis of CGG repeat in 
the fragile X mutation (//). However, the 
compression problems were typically evi­
dent after about ten trinucleotide repeat 
units were sequenced from either strand of 
the mutant allele. These sequencing data, 
combined with the observation that strong 
hybridization smears were produced by 
probing with the ( C T G ) l 0 oligonucleotide, 
suggests that the difference in this region 
between the DM and normal alleles is due to 
the variable number of CTG repeats. 
Our results suggest that DM is caused 
primarily by a mutation or mutations that 
increase the size of a genomic fragment due 
to the amplification of a CTG repeat. This is 
similar to the trinucleotide repeat mutation 
in fragile X (8, 11) and in X-linkcd spinal 
and bulbar muscular atrophy {13). Nearly all 
individuals with DM (98%) in our popula­
tion display an increased number of CTG 
repeats, which can be detected by Southern 
blot analysis of genomic DNA or hybridiza­
tion analysis of a PCR-based assay or both. 
We have demonstrated that these trinucle­
otide repeats are located within the last exon 
of the DM gene. This gene has recently been 
suggested to encode a putative serine-threo­
nine protein kinase, as deduced from the 
DNA sequence analysis of human (14) and 
homologous mouse (15) cDNAs. In light of 
the surprising result that the DM mutation 
is found in the 3' noncoding region of the 
DM candidate cDNA, it will be interesting 
to examine the role of this defect in the 
pathogenesis of myotonic dystrophy. 
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CHAPTER 
3.2 
Brief report: 
Reverse mutation in myotonic dystrophy 
New England Journal of Medicine 328: 476-480 (1993) 
BRIEF R E P O R T : REVERSE M U T A T I O N I N 
M Y O T O N I C D Y S T R O P H Y 
H A N G BRUNNFR, M D , G F R T J A N S L N , M Se , 
WILL4» N I I I F S F N , M \ R P F I R N F I E N , 
CHRISIINL. E M DE D I E , M D 
C H R I S J H O W E L L R , M D , 
BERNARD -4 \ \N O O S T P H D , Bt W I L R I N G A , P H D , 
H ANS H l l GFR R O P F R S , M D , 
\\D H I B L R I J M SMEETS P H D 
M 1 l O T O N I C dsstroph\ is a multis\ stem disorder that is t ransmuted in an autosomal dominant 
fashion and is characterized b\ muscular weakness 
and atrophv clinical and clcclronuographic e\idence 
of rmolonia ocular cataiact, and various other ab­
normalities such as cardiac conduction disturbances, 
testicular atrophv in males premature balding, in­
creased risk from anesthesia and mental retardation 
in cases u n h earK onset ' It is the most common in­
herited muscular d)s t roph\ ol adulthood, with an in­
cidence ol appmximatclv 1 per УЮ0 people 1 he clin­
ical expression ol i m o t o i m d\st ioph\ is variable, 
rançinç from neonatal mortahtv to a complete db 
sence of s )mptoms RecentK, the disorder has been 
shown to be caused bv an increased number of cyto 
s inc - th \mid ine -çuan ine (CTG) trinucleotide repeats 
in the V untranslated region of a protein kinase 
цепе located in ihe ql i i band of chromosome 19 ' ( i 
I he normal gene has IK tween Ъ and 40 С I G trinucle­
otide r t p t a t s , whereas ui\ototnc cKstiophv alleles 
have fremi approximate 1\ 50 to several thousand such 
repeats The sevenlv oí the clinical svmptoms ol 
mvotonic dvstrophv. usuallv increases with transmis-
sion to subsequent generations a phenomenon that 
has been termed anticipation r' This is paralleled 
bv лп mcrtase in the length of the C T G repeat se­
que псе ' Il has been suggested thai the progressive-
1\ increasing sc ν er it\ ol mvotonic dvstiophv eventual-
lv leads to iht extinction ol the disease Irom a given 
pedigree "' 
Genetic theorv assumes that there is equilibrium 
between the incidence of new deleterious gene muta­
tions and then subsequent loss from the population 
through the ι educed viabihtv and fei tihtv of their car­
riers No allow.inti is made in human genetic epi 
dennologv lor inu hanisms that change the mutation 
itself Irom abnormal lo normal Reverse mutation — 
i t the spontaneous collection ol a deleterious mu 
t.ition upon tiansmission to unailecied oilsprmg — 
has noi been reported m humans although it has been 
Frnmlhi Oqtirtminl-.nl Hum m ÍHIKIILS tH CT Η Ά N M R Ν Η Д. Ο 
Η Η Κ H J M S ι ιικΙ ( Л Нюіі L\ imi HIM.IIOLV ( d J B W l l niversuv 
Hospital jtiJ M L J K a l I Jtultv Nijmn-tn ind 'h<- ІХрліпіі.пь of Human Genet 
к s (С Ι Μ D I and NcuroloLV ( t J 11 l l rmirs in llnspiul МаамгкЬі — both 
m ihi N [hirlands Vdilrf-v aprini n q ILMS IO Dr Druiimr it tin. IXp innn.ni ol 
H u m i n t i o n i k s Ι Π,ΜΓΜΚ Ilospnil NiiiiK bui P O Box 9101 hSiXIHB N4 
MILLA η tin. Vlhir l nuls 
SupjtdTtnl In Lr mts li 111 thL Αιικπν in MIISLUI ir Dwrnphv As SOL ι ano π the 
Prilliti ΒυιπκΙοηιΚ ιЯ7 2644) and the LX ut м ht i orsthungsgemunschaft 
iRo 1«Ч IS 4) 
observed at low frequencies in bacteria and cultured 
mammal ian cells 
We report here on two families with myotonic dys­
trophy in which a reverse mutation has occurred In 
the first family, an expanded C T G trinucleotide re­
peat found in a clinically aíTected man decreased in 
size to a normal allele of 24 C T G trinucleotide repeats 
in his healthy infant daughter Similarly in the second 
family the expanded allele found in the clinically 
aíTected father changed to a normal-sized allele con-
taining 19 C T G trinucleotide repeats in his healthy 
25-\ear-old son The normalization of the mutated 
mvotonic d\strophv gene in these oiTspnng can be ex-
plained bv the mitotic and (possiblv) meiotie ínsiabil-
it\ of the expanded C T G repeat sequence 
C A S E R E P O R T S 
Family 1 
In Famih 1 (Fig 1) prenatal diagnosis was requested bv a ¿J 
year old woman (Subject II 4) and a 21 vcar old man (Subjut II 
3) Mvoionic dvstrophv had been diagnusid in tin man two ^iars 
earlier on the basis of mild musini ar wι akin ss ι li η κ. al and ι li d u ­
cal evidence of mvotonia and a famiK history of lin disordtr Tin 
family was studili! with genetic markers closek linked to the myo 
tonn dvstrophv gem Ml chnicalk affected famiK membri s earned 
the same haplotvpe for the ЛРСХ 2 VSSM and \7S,b VSSM mark 
ers which flank the mvotonic dvstroph) locus l h e proband was 
heierozvgous for these markers Prenatal diagnosis wis therefore 
considered leasible I he first pregnancx was terminated alter DNA 
marker anaksis performed on a sample ol chorionic villus obtained 
b\ biops\ indicated that the fetus (Subject III 1 ) had inherited the 
mvotonic dvstrophv mutation Examination o( Inai tissues con 
firmed the results I hi siiond pregnarnv was terminated when 
intrauterine diath was diagnosid b> ultrasonograph six days alter 
a transcervical chorionic ν ìllus biopsv had b u n perlormed DNA 
anaksis indicated that this fitus (Subjut III 2} would ha \ i b u n 
unafletted In tin third pngnantv giiittn marker anaksis again 
indicated that tin fetus (Subject III 3) had receded the abnormal 
DN Λ marker haplotvpc In view of the small genetic distances be 
tu ceti markers in the region of the im nmiur d\ stropliv gene ' ' 1 the 
chance that the fetus carried the mvotonic dvstrophv mutation was 
estimated to be greater than W percent Mut mon anaksis was 
subsequently perlormed to determine the si?e ol the ( 1 (» repeat in 
the mvotonic rivstrophv gene ol chis fetus in order to obtain more 
reliable prognostic information 
Family 2 
In Famik 2 ( b g I) л 24 vear old man (Sub)ect 11 2) ind his 2I 
veir old sister (Subject II I) were examined (or signs of mvotonic 
dvstrophv because ol a historv ol the disease in several relatives 
nu lud in ς their lather (Sub]e< t I 1 ) ( linn al examination including 
elettromvographv and slit 1 imp examimtinn w is normal in both 
Subjcit l l 1 and Subjtn II 2 However anaksis with g< tutu mark 
irs flanking the mummie dvsuophv lotus showed tb и ι hi son (Sub 
jeit II 2) had inherited the p-n<_rnal chiomosonn l'I th it tarries the 
mvotonic dvstrophv gene m this iamilv Bit tust Subjut II 2 was 
now considered to bi ι tai m r of tin invutoiiu tlvstrophv ціііі tin 
(lumai ixaniHi т о п including ill t trormogi iphv of ID musilis 
M S lepeated when he wis ^Ί vcirs old Tins reexiininaiion ic 
vealed no sicns ol mvotonu dvstrnph\ Hecmseol the discn ρ m a 
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the myotonic dystrophy mutation and their 
respective detection methods have been 
previously described."'13 All the markers 
were tested at least twice. Using a recent-
ly described polymerase-chain-reaction as-
say,7 we tested the expansion of the CTG 
trinucleotide repeat in genomic DNA. The 
CTG trinucleotide repeat was amplified 
with flanking primers, and the resulting 
DNA fragments were separated by electro-
phoresis on I percent and 4 percent agarose 
gels. A Southern blot, made from the 1 per-
cent gel, was probed with a (CTG),0 oligo-
nucleotide end-labeled with phosphorus-32, 
and the hybridizing fragments were visual-
ized by autoradiography. Normal alleles 
were identified by the same polymerase-
chain-reaction assay, with a 3¿P-end-labeled 
amplification primer. The amplification 
product was separated by electrophoresis 
on a 6 percent polyacrylamide-7 M urea 
sequencing gel and visualized by autora-
diography. For the purposes of paternity 
testing, several highly polymorphic loci 
were tested on chromosomes 3, 15, 17, and 
1 9 12.16-33 T h e s i z e s o f a | | e ] c s w e r c deter-
mined for each locus by comparison with 
control samples of known size, as well as bv 
measurement on an automated sequencing 
system with Gene Scanner software (Ap-
plied Biosystems. Foster City. Calif.). An in-
ternal-lane size standard {Gene Scan-2500 
Rox, Applied Biosystems) was added as a 
reference control for aligning peak data. The 
paternity index and the probability of pa-
ternity were calculated as previously de-
scribed.''4 
The research plan was approved by the 
medical ethics committee of the Nijmegen 
University Hospital. 
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In Fami ly 1, genet ic m a r k e r s 
flanking the myotonic dystrophy 
mutation indicated that the third 
fetus (Subject III-3) had received 
the abnormal chromosome 19 from the father. Analy­
sis of the causative myotonic dystrophy mutat ion 
showed an abnormal expanded allele in the father, but 
not in a sample of chorionic villus from the fetus 
(Fig. 1). The fetus had two normal alleles (Fig. 2), 
the larger of which (with 24 C T G trinucleotide re­
peats) was apparently inherited from the father. How­
ever, this allele was clearly different from the fa­
ther 's normal chromosome 19, which carried an allele 
of 11 C T G trinucleotide repeats. This suggested 
that a reverse mutation had occurred, through which 
the abnormal expanded C T G trinucleotide repeat in 
the father (approximately 150 to 600 C T G trinucleo­
tide repeats) (Fig. 1) had decreased in size to a nor­
mal allele of 24 C T G trinucleotide repeats in the 
fetus. After the birth of a normal girl, identical 
results were obtained in a sample of cord blood 
and in fibroblasts from the umbilical cord. Attempts 
to detect mosaicism for the reverted allele were un­
successful in other tissues from the father. We did not 
find additional reverted alleles after analyzing DNA 
from cultured skin fibroblasts and sperm from Subject 
Figure 1. Linkage Analysis and Mutation Analysis in Two Families with Myotonic 
Dystrophy. 
The squares denote male family members, and the circles female family members. 
The slash denotes a deceased family member. Prenatal diagnoses are indicated by 
diamonds. The shaded symbols indicate clinically affected subjects. Subjects carrying 
a reverted myotonic dystrophy gene are marked by an asterisk. In Family 1, all the 
affected subjects carry the 3 allele for the APOC2-VSSM marker and the 1 allele for the 
X75b-VSSM marker at locus D19S112 (boxed). Subject III-3 has also received these 
alleles from her father. In Family 2. Subject II-2 has inherited the 1 allele for the pD10 
marker at locus D19S63 and the 4 allele for the X75b-VSSM marker at locus D19S112. 
This haplotype (boxed) carries the myotonic dystrophy mutation in several affected 
family members, including the father (Subject 1-1). Mutation analysis (lower panel) 
defected both normal alleles (with 5 to 40 CTG trinucleotide repeats) and abnormal 
alleles (with >50 CTG trinucleotide repeats). The size of the alleles, expressed as the 
number of CTG trinucleotide repeats, is shown beside the blots. In Family 1, Subject 
III-3 does not have an expanded allele. However, the marker haplotype suggests that 
she has inherited the myotonic dystrophy mutation from her father. In Family 2. Subject 
1-1 has an abnormal expanded allele of 150 to 500 CTG trinucleotide repeats, whereas 
his son (Subject II-2) does not have an expanded allele, although this would be 
expected on the basis of the marker haplotype 
11-3 (Fig. 3). We used several highly polymorphic sys­
tems from chromosomes 3, 15, 17, and 19 to exclude 
the possibility that Subject II-3 was not the girl's fa­
ther. The probability that Subject 11-3 was the biolog­
ic father of Subject II1-3 was greater than 0.99998 
(Table 1). 
In Family 2, an asymptomatic 25-year-old man 
(Subject 11-2) had inherited the abnormal chromo­
some 19 from his father. Expansion of the C T G trinu­
cleotide repeat could not be demonstrated, however 
(Fig. 1). Instead, there were two normal alleles (Fig. 
2), the larger of which (19 C T G repeat units) was 
inherited from the affected father. The father's mutat­
ed myotonic dystrophy gene, which contained ap­
proximately 150 to 500 C T G trinucleotide repeats, 
had therefore changed to a normal-sized allele of 19 
C T G trinucleotide repeats in the son. The reverted 
allele was also present in skin fibroblasts and semen 
from the son (Fig. 3). There were no abnormal ex­
panded alleles in these tissues. Thus , no evidence for 
either somatic or germline mosaicism was found in 
this subject. We used several highly polymorphic 
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DNA markers from chromosomes 3, 15, 17, and 19 
to exclude the possibility that Subject 1-1 was not 
the man's father. The probability that Subject 1-1 was 
the biologic father of Subject 11-2 was greater than 
0.99999 (Table 1). 
DISCUSSION 
A new class of genetic disease mutations has recent-
ly been described that is characterized by the ampli-
fication of preexisting trinucleotide-repeat units.25 
Apart from myotonic dystrophy.2 '8 the fragile X syn-
drome26 2? and X-linked spinal and bulbar muscular 
atrophy28 have been shown to be associated with this 
type of mutation. In both the fragile X syndrome and 
myotonic dystrophy, the length of the respective tri-
Mi. 
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Figure 3. Tissue Testing in Two Families with Reversal of the 
Myotonic Dystrophy Mutation. 
The pedigree symbols are as described in Figure 1. The reverted 
(normal) allele is indicated by arrows. In Family 1, the reverted 
allele was not found In either sperm (S) or cultured fibroblasts (F) 
from the father (Subject II-3). In both families the reverted allele 
was present in various tissues from the healthy offspring. These 
included a chorionic-villus sample (CV), umbilical-cord blood 
(CB), and umbilical-cord fibroblasts (CF) from Subject III-3 in 
Family 1 and peripheral-blood cells (B), cultured skin fibroblasts, 
and sperm from Subject II-2 in Family 2. 
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Figure 2 Precise Sizing of CTG Trinucleotide Repeats in Two 
Families with Myotonic Dystrophy. 
Only normal alleles (with 5 to 40 CTG trinucleotide repeats) are 
visualized on 6 percent polyacrylamide-gel electrophoresis. The 
abnormal expanded (Exp) alleles fall outside the range of frag­
ments detected in this assay. Affected subjects (Subjects II-2, II-
3, and III-1 in Family 1 and Subject 1-1 in Family 2) have only a 
single band, representing their single normal chromosome 19. 
Normal subjects (Subjects I-2, 11-1, II-4. II-5. and III-2 in Family 1 
and Subject 11-1 in Family 2) have two bands; Subject I-2 in Family 
2 has only a single band, since she inherited identical normal 
alleles of five CTG trinucleotide repeats from both her parents. In 
Family 1, Subject III-3 inherited a new normal allele of 24 CTG 
trinucleotide repeats from her affected father. In Family 2, the 
mutated allele has decreased in size, from approximately 150 to 
500 CTG trinucleotide repeats (Fig. 1 ) in the affected father (Sub­
ject 1-1) to 19 CTG trinucleotide repeats in his son (Subject II-2). 
The pedigree symbols are as described in Figure 1. 
nucleotide repeats tends to increase in subsequent 
generations, and there is a positive correlation be­
tween the length of a repeat and the severity of the 
disease. Although transmission of the fragile X muta­
tion is occasionally accompanied by a reduction in 
repeat length. 2 7 this has never resulted in an allele of 
normal size. In our analysis of more than 100 carriers 
of the myotonic dystrophy mutation, a decreasing re­
peat length has been found in only one other family. A 
complete reversal of the mutated allele that yields a 
C T G trinucleotide repeat of normal size must there­
fore be an exceptional event. 
The mechanism that causes the change from an 
abnormal expanded allele to a normal-sized allele 
is unknown. The possibility of single genetic recom­
bination is excluded in these cases, since it would 
change the DNA-marker haplotype surrounding the 
mutation. Double recombinants are also highly un­
likely, given the small genetic distances in this seg­
ment of chromosome 19. Either gene conversion (the 
substitution of one parental allele for the other 2 4 ) 
or direct deletion of the expanded repeat could ex­
plain the reversal of the mutation that we found in 
these two families. 
We considered the possibility that the instability of 
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IA*LS KFH-ЯІ-·.» У НЛЧІІЛ 1 
DI7SÍ I1 
Il 2RB 
D I S I ! 
HOX2B 
APOC2 
D15S11 
( ÎABRBl 
D19S112 
Probability 
Oliphant et dl '* 
Brewster cl j l '* 
Brett el al |T 
Demard el al І Ч 
Smeets et a] :° 
Fornata' et а] г | 
Mutiranßura et al 2 ΐ 
Muurangurd et al -1 
Jansen et a] l : 
N I ( IFOIIDEÌ is 
TÄTERN Ali V 
I B A S ^ M I T T H ) 
ALLELE 
181 
149 
115 
130 
HO 
253 
199 
112 
ALLELF 
FHEOL EA< ì 
0 36 
0 IH 
0 15 
0 1 
0 1 
0 07 
0 05 
0 19 
>0 9999K 
ГАТЕНМ1 
INI« X 
1 4 
2 4 
1 1 
5 
5 
7 6 
10 
2 6 
of paternity 
Ν Ι Π Ε Ι ' Π Γ ι Ι * IN 
IKANSMITTED 
ALLELE 
19) 
161 
135 
112(11 136 
96 
243 
183 
128 
ALLELE 
т к Д ENI ι 
0 33 
0 09 
0 15 
0 37 orO 15 
0 0 4 
0 5 
0 0 9 
0 05 
•>0 99999 
PA1FRMI 
INDEX 
1 5 
5 6 
6 7 
1 3 
12 5 
2 
5 7 
10 
the expanded C T G trinucleotide sequence in somatic 
tissues was also present in the fathers1 germlincs in the 
form of a large arrav of different-sized alleles that 
included some normal-si/rd alleles. However, DNA 
analysis of cultured skin fibroblasts and a sperm sam­
ple from the father in Family 1 (Subject II-3) showed 
a distribution of expanded repeats that was similar 
(although not identical) to that found in his peripheral 
blood. Moreover, this analysis failed to detect the 
presence of reverted alleles (Fig. 3), indicating that if 
germline mosairism is present in Subject 11-3, the fre­
quency of reverted myotonic dystrophy mutations is 
very low. Alternatively, the reversal of the mutation in 
his daughter (Subject 111-3) may have occurred in the 
early embryo. 
The fact that the allele lengths in the two subjects 
described here are entirely within the range found in 
normal subjects suggests thai they should not have 
myotonic d\stroph\ in the future. The\ thus represent 
true re\erse mutations, rather than the nonpenetrance 
of an abnormal gene. Yet it remains to be established 
whether their chromosomes have regained the normal 
stable state, since we do not know whether the ex­
panded trinucleotide-repeal sequence is the only cause 
of the DNA instability in myotonic dystrophy Analy­
sis of cultured skin fibroblasts and a sperm sample 
from Subject 11-2 in FamiU 2 showed 5 and 14 C T G 
trinucleotide repeats, identical to those detected in his 
peripheral-blood cells (Fig. 3). This suggests ihat the 
reverted allele containing 10 C T G trinucleotide re­
peats is stable in this subject's somatic tissues as well 
as in his germhne. 
In conclusion, the two subjects described liei e are 
examples of complete spontaneous corree lions of 
myotonic dystrophy mutations These results should 
be taken into account when one uses flanking DNA 
markers for genetic diagnosis,1" since it is possible that 
other genetic conditions in which the phenot\pe is 
highly variable will also prove to be associated with 
the inheritance of unstable DNA séquences." 
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CHAPTER 
3.3 
Gonosomal mosaicism in myotonic dystrophy 
patients: Involvement of mitotic events in (CTG)n 
repeat variation and selection against extreme 
expansion in sperm 
American Journal of Human Genetics 54: 575-585 (1994) 
Gonosomal Mosaicism in Myotonie Dystrophy Patients: 
Involvement of Mitotic Events in (CTG)n Repeat Variation and 
Selection against Extreme Expansion in Sperm 
Gert Jansen,* Patrick Willems,* Marga Coerwinkel,* Willy Nillesen/ Hubert Smeets,* Lieve Vits,* 
Chris Höweler,5 Han Brunner,* and Bé Wieringa* 
*Department of Cell Biology and Histology and department of Human Genetics, Faculty of Medical Sciences, University of Nijmegen, Nijmegen, 
'Department of Medical Genetics, University of Antwerp, Antwerp, and 'Department of Neurology, Academic Hospital Maastricht, 
University of Maastricht, Maastricht 
Summary 
Myotonic dystrophy (DM) is caused by abnormal expansion of a polymorphic (CTG)„ repeat, located in the DM 
protein kinase gene. We determined the (CTG)n repeat lengths in a broad range of tissue DNAs from patients 
with mild, classical, or congenital manifestation of DM. Differences in the repeat length were seen in somatic 
tissues from single DM individuals and twins. Repeats appeared to expand to a similar extent in tissues 
originating from the same embryonal origin. In most male patients carrying intermediate- or small-sized 
expansions in blood, the repeat lengths covered a markedly wider range in sperm. In contrast, male patients with 
large allele expansions in blood (>700 CTGs) had similar or smaller repeats in sperm, when detectable. Sperm 
alleles with > 1,000 CTGs were not seen. We conclude that DM patients can be considered gonosomal mosaics, 
i.e., combined somatic and germ-line tissue mosaics. Most remarkably, wc observed multiple cases where the 
length distributions of intermediate- or small-sized alleles in fathers' sperm were significantly different from that 
in their offspring's blood. Our combined findings indicate that intergencrational length changes in the unstable 
CTG repeat are most likely to occur during early embryonic mitotic divisions in both somatic and germ-line 
tissue formation. Both the initial CTG length, the overall number of cell divisions involved in tissue formation, 
and perhaps a specific selection process in spermatogenesis may influence the dynamics of this process. A model 
explaining mitotic instability and sex-dependent segregation phenomena in DM manifestation is discussed. 
Introduction 
Dynamic mutation m simple-sequence motif* (Richards 
and Sutherland 1992) is a new principle in human mo-
lecular genetics It has now been demonstrated that 
simple-sequence-motif instability is causally involved in 
spinal and bulbar muscular atrophy (or Kennedy dis-
ease; La Spada et al. 1991), fragile X syndrome (Fu étal. 
1991, Kroner et al. 1991, Verkerketal 1991; Yu et al 
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1991), myotonic dystrophy (DM) (Brook et al. 1992; Fu 
étal 1992; Mahadevan et al 1992), Huntington discase 
(HD) (Huntington's Disease Collaborative Research 
Group 1993), spinoccrabcllar ataxia type 1 (Orr et al. 
1993), and fraxF (Knight et al. 1993). Though quite 
different disorders, fragile X syndrome, DM, and HI) 
may have several mutational/mechanistic aspects in 
common. All three diseases show atypical segregation 
patterns, referred to as the "Sherman paradox" in frag-
ile X syndrome (Sherman et al. 1985) and as "anticipa-
tion" in DM (Howelcr et al. 1989) and HD (Ridley et al 
1988). In each of these disorders, founder chromo-
somes are implicated (Conncally et al. 1989; Richardset 
al. 1992; Imhcrt et al 1993), repeat length and disease 
seventy arc correlated (Yu et al. 1992; Harley et al. 
1993; Huntington's Disease Collaborative Research 
Group 1993), and there is an almost-identical threshold 
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length for the trinucleotide motifs (approximately 3 5 -
40 trinucleotides) above which instability occurs (Brun 
пег et al 1992, Maepherson et al 1992, Huntington's 
Disease Collaborative Research Group 1993) Although 
this suggests that similar molecular mechanisms under 
lie the unstable behavior of the mutations, in DM fami 
lies the enormous fluctuations in repeat length and 
clinical severity are most evident and easy to study The 
high prevalence of the disorder, the parental influences 
on disease severity (Harper 1989), the availability of 
large families, and tissue biopsy samples render DM a 
particularly interesting model in which to study dy 
namic mutations 
The causative mutation in DM, an expanding (CTG)„ 
repeat, is located in the 3' UTR of a gene encoding a 
putative protein kinase, known as " D M - P K " (Brook et 
al 1992, Fu et al 1992, lansen et al 1992è, Mahadevan 
et al 1992) The gene is expressed predominantly in 
smooth, skeletal, and heart muscle and at low levels in 
brain and endocrine tissues (Jansen et al \992b) This 
pattern of expression parallels the tissues affected by 
the DM phenotype In normal individuals, the (CTG)„ 
repeat may vary in length between 3 and 37 repeat units 
(Brunncr et al 1992, H Sniects, H Brunner, and W 
Nillesen, personal communication) with length distri 
butions clustered at 5, 11-14, and 18-22 С TGs in the 
normal population (Brook et al 1992, Brunner et al 
1992, ru et al 1992, Mahadevan et al 1992, Imbert et 
al 1993) When tested within individual pedigrees, 
CTG repeats in the 3-37 trinucleotide size range segre­
gate stably in a Mendehan fashion This suggests that 
the mutation rate for " n o r m a l " alleles has an upper 
limit similar to that estimated for many other microsat 
ellites typed in human and mouse (Jeffreys et al 1988), 
typically between I O " 2 and 1Ü " Fxpandcd repeats are 
much more unstable, and there is a positive correlation 
between the length of the repeat and its instability 
(Hunter et al 1992, Shclbournc et al 1992, Brunncr et 
al 1993a, Lavedan et al 1993/;) The length of the re 
peat ranges from 42 to approximately 150 in nonmani 
festing or mildly affected patients to several thousand 
CTG units in more severely affected individuals or con-
genital cases of DM (Hunter et al 1992, Brunncr et al 
1993a, Harley et al 1993) 
While studying CTG repeat lengths in tissue speci 
mens from various DM individuals, wc observed that 
CTG repeats up to approximately 100 repeat units were 
detected as defined, though often faint, bands Larger 
repeat alleles appeared as a diffuse smear because of 
mitotic instability (Brunncr et al 1992, Hunter et al 
1992, Mahadevan et al 1992, Shelbourne et al 1992) 
To assess the occurrence of mitotic repeat length vana 
tions within DM patients, we analyzed a broad range of 
tissues from both single patients and twins with mild, 
average, and sevire disease manifestation To address 
further the mechanism and de\ elopmental timing of the 
CTG repeat instability, wc also studied repeat lengths in 
germ line tissues and compared CTG length in father's 
sperm with that in his child's blood Our findings show 
that intcrgcnerational CTG repeat length changes oc 
cur mainly during early embryonic mitotic divisions, 
resulting in both somatic and germ-line tissue mosaicism 
Material and Methods 
Patient Tissues 
Blood samples were collected from a large panel of 
DM patients, investigated by the diagnostic DNA ser 
vices at the University of Ni|mcgcn, the Department of 
Medical Genetics, University of Antwerp, and the Dc 
partment of Neurology, University of Maastricht 
Sperm samples were obtained from selected patients, 
by the diagnostic DNA services at the University of 
Ni|mcgcn and the Department of Medical Genetics of 
the University of Antwerp DNA was isolated accord 
ing to standard procedures (Miller et al 1988) 
Tissue samples obtained at autopsy from one female 
DM patient (patient h, who died at age 66 years and 
who presented classical DM features including ni)o 
toma, ci tar jct , apathetic behavior, and progressive di 
gestive and respiratory problems, with onset at age 42 
years) were taken within 4 h of death Samples of skele-
tal muscle (quadriceps), heart muscle, ovary, uterus, 
skin, liver, kidney, brain (frontal cortex and thalamus), 
lung, adrenal gland, thymus, pancreas, mesenteric 
lymph node, and spleen of this patient were snap frozen 
in liquid nitrogen and stored at - 8 0 ° C Similarly, tis 
sues from a congenital case (patient L), two congenital 
twins (28 wk old prematures who died 2 wk after birth 
from respiratory insufficiency), and an affected embryo 
(P) aborted in week 12 were prepared and stored at 
- 8 0 ° C for DNA analysis DNA was isolated using 
standard procedures (Maniatis et al 1988) Clinical 
diagnosis of patients was as based on the criteria cstab 
lishcd by the Myotonic Dystroph) Working Group 
(Griggs et al 1989) 
Validation and Optimalization of the (CTG)„ Length 
Analyses Southern Blotting versus PCR Analysis 
hor the examination of genomic DNAs from mdivid 
ual tissue samples Southern blot analysis and PCR typ 
ing were used Southern blot analysis is the only suit 
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able method fot the analysis of long and heterogeneous 
С TG expansions in tissues from severely affected classi­
cal DM patients and cases of congenital DM For each 
sample, 10 μg of genomic DNA was digested with 
HmdlH (Bethesda Research laboratories), clectro-
phorescd on 0.7% agarose gels, and transferred onto 
nylon membranes (Hybond N+; Amersham) Southern 
blots were probed with the 1 8-khp Hmdlll/ßemHI 
fragment of probe pGB2.6 (Aslamdis et al. 1992), which 
detects the repeat expansion. Blots were washed at 0.2 
X SSC, 0.2% SDS final stringency, at 65°C, and were 
exposed to Kodak X-Omar S him for 1-14 d at -80°C 
using two intensifying screens 
Although the Southern blot analysis of DM-PK al-
leles can be significantly improved by the parallel use of 
different restriction enzymes (ι е., TcoRl, Bg/I, BamHl, 
Hwdlll) that generate suitably si7cd DNA fragments 
spanning the CTG repeat, it is not particularly suitable 
to detect small CTG expansions 1 hcrcforc, for the de­
tection of DM alleles of up to 1,200 trinucleotide units, 
we applied the PCR/blotting method adapted for the 
visualization of the variable simple-sequence motif 
(VSSM; Jansen et al. 1992«; Mahadevan et al. 1992). 
When this method is used, large repeats typically appear 
as a broad smear on agarose gels, while acrylamide gels 
arc better for the detection of length variations of 
shorter alleles (Brunner et al. 1992). In the standard 
assay, equal amounts of PC R products (~0.S μg) were 
loaded on 1% agarose gels (1% agarose, 40 mM Tris, 1 
niM EDI A, adjusted ro pH 7 6 with glacial acetic acid) 
and resolved by electrophoresis. DNA was transferred 
to nylon membranes (Hybond N + ) and probed with a 
(CTG)|0 oligonucleotide end-labeled with 12l'. 
Initially, to test whether false priming of incom­
pletely elongated products, followed by aberrant elon­
gation during the subsequent PCR reaction cycles, 
could be involved in signal smearing in the PCR assay, 
we varied the reaction conditions (cycling times, anneal­
ing temperature or dNTP, and ion concentrations). 
This did not significantly change the length distribution 
of PC R products and thus was ruled out as an impor­
tant source of apparent length heterogeneity For all 
subsequent amplification reactions, therefore, condi­
tions as described elsewhere (Mahadevan et al 1992) 
were used Still, illegitimate heteroduplcx formation be­
tween (CTG)„ and (CAG)„ strand products may occur 
during the renaturanon step in the last reaction cycle 
In order to circumvent this problem, PCR products 
were also analyzed by denaturing gel electrophoresis, 
using an adapted standard protocol (Maniatis et al. 
1988) In brief, 1% agarose gels (1% agarose, 1 mM 
EDTA, SO m M NaCI) were equilibrated for 30 mm in 
30 m M NaOH, 1 m M FDTA; and PCR samples were 
adjusted to 10 mM NaOH, 0.2 mM EDTA, 0.6% Fi-
coll-400, 0 01% bromophenol blue dye, before loading 
on the gel. Alkaline gels were electrophorescd for 24 h 
at 20 V in 30 mM NaOH, 1 mM EDTA, and blotted 
and probed as described for the standard assay above. 
By using the denaturing electrophoresis where heterolo­
gous strand pairing cannot occur, the extent of smear­
ing was significantly reduced. 
Results 
Tissue Heterogeneity within Individuals 
By comparing CTG repeat lengths among different 
tissues in four unrelated patients, we identified clear 
intraindividual somatic heterogeneity. The 15 tissue 
samples from a female DM patient (F) with onset of 
muscle disease at age 42 years, who died of respiratory 
insufficiency at the age of 66 years, were especially inter­
esting. Conventional Southern blot analysis of her tis­
sue DNAs revealed diffuse bands of 1,000-1,300 CI Gs 
in most tissues. The somatic heterogeneity became 
more apparent when the PCR-based analyses on native 
and denaturing gels were used (fig 1). The distribution 
of CTG repeat lengths varied among tissues, though 
some overlap was evident. Most strikingly, a distinct 
band of 1 kbp was seen in both thalamus and frontal 
cortex. The size distributions and intensities of the sig­
nals were reproducibly seen in different DNA prepara­
tions from the same tissues in this patient 
Similar analyses were performed on material ob­
tained at autopsy from two infants (patients I and P) 
with congenital DM. Heterogeneity of repeat length 
was shown by Southern blot analysis in tissues of pa­
tient I The largest Cl G repeat expansions were found 
in heart DNA, followed by fibroblast, liver, and brain 
DNAs (fig. 2A) An additional smaller band of approxi­
mately 5 kbp can be seen in brain DNA from this pa­
tient, although the reason for the appearance of this 
extra band, which wc have observed also in some other 
patients, remains unclear (H Smccrs and W. Nillesen, 
unpublished observations) In muscle, brain, and cho­
rion villi DNA ofaii affected embryo (P), aborted in wk 
12, ma|or repeat expansions of approximately 600-
1,000 trinucleotides were detected (not shown) I hese 
repeats were significantly larger than those in either of 
the parental blood DNAs, but length variation between 
tissues was not evident in this embryo. 
In all cases where no obvious allelic differences were 
found between tissues, patients carried extremely long 
repeats, and, as a consequence, minor variations may 
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Figure I Mutation analysis in 15 different tissue samples from one DM patient (F) with classical symptoms. Repeat length was 
determined using the PCR/blotting method combined with denaturing {left panel) and nondenaturing [righi panel) agarose gel electrophoresis as 
described in Material and Methods. Between most tissue samples, clear differences in intensity and the extent of smearing of the larger allele can 
be observed. Note the similarities in DNAs from frontal cortex and thalamus. Fr.cortex - frontal cortex; Adrenal - adrenal gland; and 
Mes.lymphn. = mesenteric lymph node. 
have remained undetected. Yet, from our analysis we 
conclude that unstable mitotic segregation may occur 
throughout all tissues, including peripheral blood lym-
phocytes, liver, brain, heart, and sperm (sec below). Fur-
thermore, the similarity in number of repeats in thala-
mus and frontal cortex of the one patient (F) whose 
tissues were analyzed in greatest detail suggests that the 
postmeiotic variation is most prominent in early devel-
opment. 
Developmental Stage and CTG Expansion 
To see whether there is indeed a developmental time 
window for (CTG)n length alterations to occur, we ana-
lyzed a selected subset of DNAs from 35 different tis-
sue biopsies taken from a pair of MZ twins with con-
genital onset DM. Both children were born at wk 28 of 
gestation, and died after 2 wk from respiratory insuffi-
ciency. Southern blot analysis (fig. 2ß) revealed small 
but significant fluctuations in the size of their expan-
sions (approximately 1,500 CTGs), with differences be-
tween tissues. It is significant that expansions were simi-
lar in identical tissues in both individuals. We also 
compared repeat lengths in matched blood samples of 
two MZ twins with either approximately 180 or 400 
CTGs. No obvious differences were detected. Taken 
together, these results suggest that (CTG)„ instability is 
most pronounced during early embryonic stages, i.e., 
before Carnegie stage 5b (day 10.5) of development, the 
last possible moment for MZ twinning (Phillips 1993). 
Our findings do not exclude, however, that subsequent 
expansion may continue to occur at a reduced rate in 
tissues with a high proliferative capacity. 
Does Repeat Variation Occur during Meiotic Cell 
Division? 
In DM pedigrees there is a trend toward gradual 
CTG length increase; size compression is a much rarer 
event (Shelbourne et al. 1992; Abcliovich et al. 1993; 
Brunncr et al. 1993Í»; Harley et al. 1993; Hunter et al. 
1993; Lavedan et al. 1993i>,· O'Hoy et al. 1993). PCR 
analysis of blood DNAs of parent-child pairs in our 
family material revealed many cases where a conspicu-
ously large intergencrational increase in repeat length 
occurred. In these cases, the size distributions of the 
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Figure 2 A, Sourhern blot comparison of mutation expansion in four different tissues from one congenital DM patient (L). β, Six 
different tissues of congenital DM twins. Genomic DN As ( 10 μg) from brain, heart, and liver biopsies and fibroblast culture cells from patient L 
(A) and matched biopsies from heart (both atrium and ventricle), lung, liver, kidney, and cerebrum frontale from the congenital twins (ß) were 
digested with HiHdIII, electrophoresed on a 0.7% agarose gel, and blotted and hybridized using standard procedures. In panel A, variation in 
mobility of the expanded allele (size range 12-14 kbp) can be seen, whereas the normal DM allele (8.5 kbp) shows no length heterogeneity. 
Similarly in panel ß, small fluctuations in the repeat length in different tissues (expansion up to 5 kbp) with a remarkable match between identical 
tissues are evident. Marker sizes (phage lambda DNA digested with Hmdlll) are shown to the left of each panel. 
amplification products rarely display overlap between 
blood DN As of parent and child (illustrated in the pedi-
grees shown in fig. 3). Densitometrically determined 
estimates for the percentage overlap between smeared 
signals in such parent-child combinations range gener-
ally from 0%-5%, that is, the chance that an event gen-
erating a nonpaternal allele was involved is at least 20:1 
in these cases. 
If the repeat expansion (or regression) occurred dur-
ing meiotic cell divisions, the gametes of the affected 
parent would be expected to display a length distribu-
tion similar to that in the offspring. To test this hypoth-
esis we analyzed CTG repeat lengths in blood and 
sperm DNAs from 14 male DM patients with expan-
sions in blood up to approximately 1.5 kbp (500 CTGs) 
and compared them with repeat lengths present in the 
blood of their offspring. One male did not produce 
sperm and was excluded. In figure 4A we present six 
representative families. Among the 13 families, 9 cases 
revealed wider-ranged repeat lengths in sperm than in 
blood (fig. 4A, families 1, 2, 4, 5, and 6). In one case 
(family 3), the repeat was smaller in sperm DNA; in 
three cases no evident differences were detected. When 
comparing father-child pairs, six of eight showed an 
enlargement of the repeat in the affected offspring rela-
tive to the repeat length in the father's sperm (fig. 4A, 
families 1, 2, and 5). In two of these father-child pairs 
(e.g., see family 2) the repeat length in sperm and blood 
of the father was similar, but in the affected child's 
blood a longer repeat was present. Finally, in two other 
cases the repeat was longer in the sperm sample than in 
blood of the father but was considerably smaller than in 
the child's blood. 
In one father-child pair the paternal alleles of approx-
imately 400 CTGs underwent compression to 24 CTG 
trinucleotides in the offspring (fig. 4A, family 6; Brun-
ner et al. 1993e). As nonpaternity was excluded, this 
event represents a marked intergenerational length 
change. The repeat length in blood and sperm of the 
father are of similar length (±400 and 600 CTGs), and 
the allele of 24 CTG triplets (Brunner et al. 1993fc) was 
undetectable in sperm. 
89 
020DM 021DM 
π , Π 1 
ЛБЛ ¿ИІЛ-. 
Figure 3 Non-Mendelian behavior of CTG repeat smears in 
two DM families (020 and 021). Repeat lengths were determined 
using PC К under nondenaruring conditions, and many cases of appar­
ent nonoverlap in repeat smears from parent and offspring arc-
shown. Size markers arc indicated to the left. Λ1Ι family members m 
rhe pedigrees shown arc carriers of the mutation. Patients with pheno-
typic expression of DM and asymptomatic carriers arc represented by 
blackened or unblackcncd circles and squares, respectively. 
Assuming that the repeat length in sperm provides an 
accurate estimate for the CTG length distribution at 
the time of conception, we thus consider it unlikely 
that a rare sperm cell with a significantly expanded, or 
shrunken, CTG repeat, similar to those in the child but 
undetectable in the father's sperm, contributed to zy­
gote formation. While we cannot rule out meiotic in­
volvement in expansion, our findings suggest that re­
peats expand during mitotic, postzygotic events that 
occur during the early formation of somatic and germ 
tissues. Of course we have to bear in mind that our 
analyses may not give an accurate reflection of the CTG 
repeat lengths in the single gametes that were actually 
involved in the fertilization events. Moreover, we have 
to assume that the length distribution of CTG repeats 
in germ tissues of male DM patients does not signifi­
cantly alter over the years. This may not necessarily be 
the case, as the number of cell divisions involved in 
gamete (sperm) production increases with age (see below). 
(CTC)„ Repeats with More Than I.000 Triplets Are 
Absent in Sperm 
To study the behavior of longer CTG repeats, we 
compared repeat expansions in sperm-blood DNA sam­
ples from nine males with large repeats in blood. Only 
two sperm samples contained enough DNA for South­
ern blot analysis, because of the occurrence of extreme 
oligospermia in seven males, but all could be tested by 
PCR. In four cases the CTG lengths in sperm were ap­
parently less than the lengths in blood (fig. 4ß). Patient 
V also showed this expansion limitation on Southern 
blot, underscoring the validity of the analysis. In only 
one case, the only case with an intermediate (CTG)n 
length in blood (patient IX), the mean repeat length was 
slightly longer in sperm. Although the number of sperm 
samples analyzed is limited, this is the first direct evi-
dence that restriction of expansion occurs in male trans-
mitters, as proposed by I.avedan et al. (1993л) and Mul-
ley et al. (1993). 
Discussion 
Mechanistic and Diagnostic Implications 
How does the behavior of the unstable DM kinase 
CTG repeat compare with that of other simple repeti­
tive DNA loci in other organisms? Typically, the muta­
tion frequency of VSSMs does not exceed 1 in 103 in 
meiotic cell divisions (Jeffreys et al. 1988). In contrast, 
there arc some hypervariable loci, such as the Ms6-hm 
(GGGCA)
n
 (Jeffreys et al. 1987; Kelly et al. 1989) and 
IIm-2 (Gibbs et al. 1991) loci in mice, the loci recog­
nized by probes MS32 (Jeffreys et al. 1991) and CEBI 
(Vergnaud étal. 1991), (CAC)nIoci in man (Nürnberg et 
al. 1989), and GAA motifs in chicken (Epplen et al. 
1991). These loci exhibit mosaicism in somatic tissues 
and germ lines, and although mutation rates may be 
locus dependent (being as high as 2.5%-15% per segre-
gation event), there is evidence that de novo mutations 
occur during early embryonic mitoses (Gibbs et al. 
1993). Recent analysis of the behavior of the (CGG)n 
repeat associated with the fragile X syndrome revealed 
a striking similarity to the DM situation in that repeat 
instability seems greatest during early postzygotic cell 
divisions (Wöhrle et al. 1992, 1993). However, the two 
disorders differ in that expansion limitation during sper-
matogenesis seems to be more profound in fragile X 
males where only premutations have been detected in 
paternal spermatozoa (Reyniers et al. 1993). 
Inibcrt et al. (1993) recently suggested that loci with 
19-30 trinucleotides constitute a predecessor pool for 
unstable (>42 X CTG) alleles. In a family described by 
our group, a complete reverse mutation occurred, in 
which approximately 400 CTGs reverted to 19 CTGs 
(Brunner ct al. 19934"). We now know that the son that 
inherited the normalized allele transmitted it stably to 
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Figure 4 A, Comparison of CTG repeat lengths in blood and sperm of mildly manifesting male patients and the blood of their children. 
Repeat lengths were determined in DNAs isolated from blood (B), sperm (S), or Hbroblasts (F; family 4 only) of six male patients and were 
compared with repeat lengths in blood of their children, by using PCR and denaturing electrophoresis as described in Material and Methods. In 
two cases (families Ì and S) the blood sample of the father's parent was also tested. Section 6 shows the follow-up analysis of repeat lengths in 
blood and sperm of the father of a case with complete mutation reversion, described elsewhere (Brunner et al. 199.i¿). It is striking that the 
average repeat length of 400 CTGs in blood is even further expanded in sperm (±600 CTCs), but the normalized (CT(i)24 allele present in the 
child is not present at appreciable levels in the father's sperm. Patients with phcnotypic expression of DM and asymptomatic carriers are 
represented by blackened and unblackened circles and squares, respectively, β, CTG-repcat expansion in blood (B) and sperm (S) samples of nine 
male patients with classical DM symptoms. Repeat length was determined as described above, typically, the repeat is consistently shorter in 
sperm than in blood and does not exceed a threshold length of approximately 3 kbp (approximately 1,000 CTCs). Moreover, the signal from the 
expanded allele is clearly weaker in sperm, whereas the signals from the normal alleles arc fully comparable between blood and sperm. Note that 
only in one case (IX) the repeat length span is wider in sperm; however, in this case the CI С repeat length in blood is of intermediate size. 
his first child. This finding may argue against the pres­
ence of neighbouring as-acting elements which, in cer­
tain families, render CTG repeats particularly unstable, 
regardless of their length. 
What then contributes to the extreme instability of 
the (>42 X CTG) repeats in DM, and is there a com­
mon mechanism for the dynamic behavior of hypervari­
able simple-sequence motifs? The following facts must 
be taken into account: (i) the length alteration is largely 
due to mitotic events, predominantly during early devel­
opment; (ii) there is a clear bias for expansion and a low 
tendency to contraction; (iii) the mutant alleles in the 
offspring may be more than 3-5 times larger than those 
in the affected parent (Shelbournc et al. 1992; Harley et 
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Figure 5 Putative (CTG)„ expansion mechanism. In normal individuals the t r inucleot ide repeat segregates mi tot 
low mutat ion frequency, comparabile to other VSSMs. O n expansion to a length of about 40 C T G units, the repeat 
structures (here shown as double-stranded, staggered loops, but triple-stranded helices or c r u c i f o r m structures may also 
involved in recombinat ion and repair dur ing mitosis resolve the unequal pairing o f sister chromat ids by endonucleolyt ic 
stranded gap repair, as original ly proposed by Jessberger and Berg {1991) (also see Nelson et al. 1989; M u n i et al. 1992). 
events could lead to new ( C T G ) n alleles that arc more than the sum o f rhe parental allele lengths. Disequi l ibr ium markt 
circles or boxes (O and D). It is conceivable that failure t o resolve the looped structure w o u l d ultimately lead to prefere 
allele ( including neighboring sequences), chromosome fragil i ty (as in fragile X), or perhaps even cell-cycle arrest. 
cally stably and has a 
may f o r m misaligned 
be formed). Enzymes 
cleavage and double-
M u l t i p l e consecutive 
rs are shown as open 
ntial loss of the larger 
al. 1993; Lavedan et al. 1993ft); (iv) segregation analysis 
of flanking markers excluded meiotic crossing-over 
events (Jansen et al. 1992л; Imbert et al. 1993); (ν) the 
instability of the motif seems to increase with length; 
and (vi) there is a clear paternal bias in the generation of 
new alleles Geffreys et al. 1987; Nürnberg et al. 1989; 
Vergnaud et al. 1991). In DM there is evidence that the 
largest fluctuation in CTG length and disease manifes-
tation is associated with paternal transmission of minor 
expansions (Brunncr et al. 1993a). This may in fact re-
flect the larger number of cell divisions during sper-
matogenesis. In females the ovum-to-ovum sequence 
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i n v o k e s approx imate ly 30 cell d iv is ions, whcre.is the 
n u m b e r o l cell d iv is ions f o r n u l e gamete p r o d u c t i o n 
ranges between 50 and several h u n d r e d d u r i n g the ef 
fcct ive fert i le l ife span ( L d w a r d s 1989) O t h e r gender 
influences o n the expansion mechanism cannot be 
ruled o u t 
CTG Expansion Model 
W e suggest that л mechanism similar t o that p r o 
posed for the repair o f delet ions and double-strand 
gaps in D N A by h o m o l o g o u s r e c o m b i n a t i o n (Jess-
berger and Berg 1991) mav explain many of t h i s c f ind 
ings Further s u p p o r t comes ( r o m the observat ion that 
events resembling gene convers ion can occur d u r i n g 
mitosis in t issue-culture cells ( N e l s o n et al 1989) and 
are seen f requent ly in m i t o t i c div isions in the germ-cell 
lineage of mice ( M u r t i et al 1992) W c propose that 
expansion is tr iggered by unequal pa i r ing o f sister c h r o 
mat ids, w h i c h leads t o f o r m a t i o n o f a f o u r stranded 
synaptic s t ructure d u r i n g the S, C 2 , o r M phase o f the 
cell cycle O n c e the C T G repeat has atta ined a certa in 
cr i t ical size ( ~ 4 0 C T G s ) , the f o r m a t i o n of staggered 
c r u c i f o r m structures, t r ip le-stranded structures, o r 
loops (referred t o as " l o o p s " in fig S) in the d o u b l e 
stranded D N A helices o f c i ther o f the t w o sister c h r o ­
mat ids c o u l d be in i t ia ted T h i s m i g h t lead t o unequal 
pair ing in the region o f the repeat h o m o l o g y С leavage 
o f the strands opposi te the l o o p e d s t r u c t u r e bv e n d o n u -
clease and subsequent double-stranded repair o f the 
gap, using the d o n o r strands as a template, c o u l d then 
lead t o expansion o f the recipient strand If this oc 
curred d u r i n g consecut ive m i t o t i c div is ions, new 
( C T G ) n alleles that are m o r e than the sum of the paren 
tal allele lengths c o u l d appear A l t e r n a t i v c l v , cleavage 
w i t h i n the l o o p e d segment and removal of this struc 
ture w o u l d lead to length regression or even to reversal 
o f the m u t a t i o n In this scheme, c o u p l i n g to markers in 
l inkage d i s e q u i l i b r i u m is retained and is independent 
f r o m changes m repeat length 
Simple sequence m o t i f s , d e p e n d i n g on their l e n g t h , 
may serve as pause or arrest sites f o r D N A repl icat ion 
(Baran et al 1991), as has been described f o r fragile X 
syndrome (Hansen et al 199 t). If elaborate mispaired 
structures have t o be resolved before mitosis can p r o 
cecd and if fai lure t o d o so mav delay or inhib i t mi tos is , 
then this scheme c o u l d explain the influences o n re­
peat length selection d u r i n g gametogenesis As sper­
matogenesis needs m o r e and m o r e rapid m i t o t i c cell 
div is ions than does oogenesis, this m o d e l mav expla in 
dif ferent ial effects o n C T G sizes in male and Iemale 
t r ansmú tame I avedan et al (1991д) and M u l l e y et al 
(199?) p r o p o s e d that such effects c o u l d under l ie the 
r e s t r i c t i o n o l cemgcnital D M cases t o maternal trans­
m i t í a m e 
In summary, o u r studies have demonst ra ted (C I G ) „ 
length mosaicism in germ- l ine and somatic tissues o f 
D M patients T h e occurrence o f gonosomal mosaicism 
(hdwards 1989) has impl icat ions for risk assessments in 
D M pedigrees 1 he s t rong tendency of the C T G repeat 
to expand is presumably the basis for the high pene-
t rance, the an t i c ipa t i on , and po ten t ia t ion phenomena 
in D M , and i t may expla in the progressiv eness o f the 
disease If repeat length is directly correlated w i t h dis-
ease severity, tissues w i t h shorter repeats cou ld be less 
affected than tissues w i t h longer repeats Whe the r this 
fo rms the basis fo r the extreme var ia t ion in c l in ical 
mani festat ion in D M w i l l be uncerta in un t i l repeat 
lengths in di f ferent tissues f r om m i l d , modera te , and 
severely affected pat ients can be analyzed 
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4 
DM-protein kinase mRNA and protein 
expression in man and mouse 
CHAPTER 
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No imprinting involved in the expression 
of DM-kinase mRNAs in mouse and human tissues 
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To explain the restriction of early onset cases of myotonic dystrophy (DM) to maternal transmlttance and the 
significant excess of male transmitters in the last asymptomatic generation, the involvement of parental effects 
on the autosomal dominant mode of inheritance has been suggested. Using FISH we confirmed that the DM-
kinase gene is proximal to the ApoE gene on mouse chromosome 7, close to an imprinted segment. To study 
whether there is any firm molecular basis for the speculation that imprinting may be Involved in DM we have 
analysed the expression of paternal and maternal alleles of the DM-kinase gene In human and mouse tissues. 
Length polymorphisms in the 3' non coding exons of human and mouse DM kinase genes, i.e. the variable 
[CTGJn repeat motif in humans and a newly identified Cn stretch variation in mice, served as tools to distinguish 
between allelic RNA products in various tissues. In human tissues, presence of transcripts from both parental 
alleles could be demonstrated by RT-PCR. In mouse, similar observations were made using a RNAse protection 
assay on fetal and adult muscle RNAs. We conclude that imprinting does not play a role in the expression of 
the DM kinase gene. 
INTRODUCTION 
Myotonic dystrophy (DM), one of the most prevalent autosomal 
dominant defects, is a slowly progressive multisyslemic disorder 
( I ) with myotonia, muscular atrophy, cataract and endocrine 
disfunction being the most prominent clinical features The onset 
of disease is generally late, but its course may vary widely An 
increasing severity (potentiation) and earlier onset of disease in 
successive generations (anticipation) has been demonstrated (see 
1 and refs therein for review) 
Recently it was shown that the manifestation of DM is 
correlated to the expansion of an unstable simple sequence 
[CTG]„ motif (2-4) at human chromosome 19ql3 3 It is now 
known that the unstable [CTG]„ motif in this disorder originates 
from a predecessor motif which segregates stably as a stretch 
of 5 to 37 trinucleotides in the normal population (5) In DM 
families, the repeat may increase from 50 to several thousand 
trinucleotide repeat units over successive generations This 
remarkably unstable behaviour, which shows similarities to 
findings in Fragile X, Kennedy's disease and Huntington's, has 
been coined 'dynamic mutation' (6) Detailed examination ot 
many DM families has revealed that there is an overall correlation 
between the length of the [CTG]„ repeat and the seventy of the 
clinical manifestation These findings also provide an explanation 
tor the anticipation phenomenon, for time at onset is earlier with 
increasing repeat length (7-9) 
Molecular studies have demonstrated that the CTG-motif forms 
part of the last exon of the DM-kinase gene This gene encodes 
a series of protein isoforms with serine-threonine kinase actmty 
and is strongly conserved in evolution (2,4,10) How the 
lCTG]
n
 expansion evokes its dominant, size dependent effects 
is still unknown Alteration of the DM gene product seems highly 
unlikely, as repeat expansion does not affect protein encoding 
regions of the gene The alternative possibility that the CTG 
expansion interferes with transcription, alternative splicing, or 
mRNA stability has yet to be demonstrated 
Some of the clinical features of DM are reminiscent of 
imprinting and epigenetic phenomena in mice (II) For example, 
a rare severe form of DM presenting at birth, is seen solely in 
infants that acquired the disease gene via their affected mother 
Just recently, sex-dependent differences in repeat length variation 
during transmission have been proposed as an explanation for 
this phenomenon Males with large sized repeats tend to pass 
on smaller repeats to their offspring (12, 13) Furthermore, 
though no differences in DM incidence between males and 
females have been observed, there is a significant excess of male 
transmitters in the last asymptomatic generation in large DM 
pedigrees (Brunner et al . in preparation) Parental influences 
on allelic behaviour of genes trom human chromosome 19 such 
as the DM gene remain to be clarified and information may. 
* To uhom sonespondence should be addressed 
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therefore, be gained by the study of the situation in the mouse. 
The human DM gene is situated at 19ql3.2 —13.3 in a syntenic 
group of genes found on chromosome 7 in mouse (14, 15). 
Genetic complementation has identified three segments, including 
the proximal and distal regions, of this chromosome in mouse 
as regions where imprinting plays an important role (16). For 
the proximal region, the area where the DM gene is anticipated, 
no imprinted genes have thus far been identified. The genes for 
which allele-specific expression has been experimentally 
demonstrated, Igf2 and H19 (17-19), are both in the distal area 
and are also physically linked (20). 
We decided to investigate if imprinting plays a role in the 
manifestation of DM and whether the DM gene itself is a possible 
target of imprinting. We report here on our study of parental 
effects on DM gene transcription. In mouse strains of different 
origin we have identified multiple DM-kinase gene sequence 
polymorphisms which served as molecular markers in the analysis 
of allele specific transcripts of different tissues at various time 
points in embryogenesis and development. Length differences 
in the [CTG]n repeat in DM-kinase mRNAs and the availability 
of human fetal and adult tissue RNAs from normal individuals 
enabled us to make a comparison to the situation in man. These 
analyses revealed that both alleles are expressed throughout 
development in all tissues examined. Possible alternative 
explanations for the extremely diverse clinical manifestation of 
DM are briefly discussed. 
RESULTS 
Chromosomal localization of the DM kinase gene 
The DM kinase gene was identified in a gene cluster flanked 
proximally by the ERCC1 DNA repair gene and distally by the 
D19SU2 locus (21,22). Previous evidence from the genetic and 
physical ordering of markers within this segment indicated that 
the DM gene is located at band 19q 13.3. A comprehensive series 
of markers bracketing this area of human 19q is found at the 
Figure 1. Fluorescent in situ suppression hybridization performed on metaphase spreads of cultured mouse embryonic stem (ES) cells. Probes hybridizing on chromosome 
7 are a digoxigenin labeled cosmid containing the ApoE-ApoCl gene cluster (red signal) and the DM-kinase containing cosmid mc8, labeled with biotine (yellow 
signal). A digitized computer image is shown. The position of the centromere of chromosome 7 as determined by DAPI staining is indicated by a white arrowhead. 
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centramene end of mouse chromosome 7 (14, 15) In order to 
confirm the anticipated location of the DM gene in mouse, 
cosmids containing the murine DM gene region (10) were 
hybridized m situ to metaphase chromosome spreads from mouse 
embryonal stem (ES) cells As a reference marker a cosmid 
containing the ApoE-ApoC 1 apohpoprotein genes was used The 
ApoE gene has been genetically positioned close to the 
centromere on mouse chromosome 7, and is most likely in area 
7A (23) In 30 metaphases analysed the signal from the DM 
kinase gene was either superimposed on or just proximal to the 
ApoE-ApoC 1 signal (see digitized image in Fig 1 ) Considering 
the limits of resolution in metaphases as based on our experiences 
with human metaphase chromosomes we estimate the two loci 
to be at most 5 Mb apart These findings are in keeping with 
the physical estimates for the ApoE (proximal) to DM (distal) 
distance on human 19q and are in agreement with the observation 
that the entire synthenic group of genes from human 
19ql3 1-13 3 (PepD to Kallikrein) is found inverted on the 
proximal segment of mouse 7 (14, 15) 
Identification of allelic polymorphisms in DM kinase mRNAs 
Exon segments encoding untranslated regions of mRNAs are a 
rich source of intraspecies sequence polymorphisms For the 
typing of polymorphisms that could serve to distinguish between 
the expression from maternal and paternal alleles of the DM 
kinase gene in mouse we therefore decided to focus primarily 
on the analysis of the 3' untranslated exon sequences Within 
this area in the mouse gene there is an imperfect [CTG]5 motif 
thought to be the ancient predecessor for the highly polymorphic 
[CTG]-stretch that is rendered unstable in DM patients (10) PCR 
amplification, cloning and sequencing of the cognate area from 
eight different (inbred) strains of mouse revealed the sequence 
disparities which are listed in Fig 2 Surprisingly, the [-CTGC-
TGCAGCAGCTG-] motif was similar in all mouse strains tested 
The most conspicuous differences were found at a stretch of 
12-17 C's, approximately 145 nucleotides upstream from this 
motif Our original DM-kinase B15 cDNA clones, derived from 
BALB/c mice contained 17 C's as reported (10) An additional 
G/A polymorphism was found a further 44 bp upstream, and 
also a small, 5 bp, duplication was found in M spretus just 
downstream to the C-stretch 
In the human DM gene many DNA polymorphisms have been 
identified Unfortunately, all these sequence polymorphisms, 
except for one polymorphism with a very rare allele frequency 
(36), are located in intron sequences Therefore, the [CTG]
n 
sequence variation which tends to become unstable in DM earners 
is still the only variation that is expressed and can be typed in 
mature mRNA 
Typing of allelic DM-kinase mRNA transcripts in human fetal 
tissues 
The DM-kinase mRNA is expressed most prominently in muscle, 
heart and various tissues containing smooth muscle (10) Our 
RT-PCR test for the determination of parental origin of DM-
kinase transcripts, therefore, included fetal tissues like lung, 
tongue, intestine and skeletal muscle In addition, tissues with 
a lower overall expression of the DM-kinase mRNA including 
brain, kidney, adrenal gland, skin and liver were analysed 
Surprisingly, for all tissues the essay was sensitive enough to 
yield two clear signals corresponding to the mRNAs originating 
from maternal and paternal alleles (Figs ЗА, В and С) For all 
five fetusses RT-PCR of the examined tissues gave the same 
allelic band pattern as PCR-amphfication of the DNA 
Consistently, it was the larger allelic RNA, which is of paternal 
origin in fetuses 3 and 4 and of maternal origin in fetus 5 (phase 
unknown for fetus 1 and 2), that gave a reduced signal intensity 
This is most evident for fetus 4 (Fig 3B) where the larger allele 
carries approximately 30 nucleotides PCR analysis of the 
genomic DNAs displayed the same signal differences but to a 
lesser extend We surmise, therefore, that the reduction in signal 
from the allele carrying the longest CTG-repeat can entirely be 
attributed to the reduced performance of Taq polymerase, and 
in particular reverse transcriptase, in copying the CTG-stretch 
Thus, in all cases examined parenul effects do not play a role 
in the expression of DM-kinase mRNAs in fetal human tissues 
up to 24 weeks of gestation This also holds true for the adult 
situation as in preparations from adult muscle signals from both 
allelic RNAs were present (not shown) 
Expression of DM kinase alleles in mouse 
To determine whether one or both of the DM kinase alleles were 
expressed in hybrid mice we used an RNAse protection assay 
(17) that would allow us to distinguish the different alleles of 
the DM kinase gene in the region of the polymorphic C
n
-
sequence A BALB/c derived (10) 385 bp BamHI-PstI fragment 
isolated from this region was subcloned and used as a template 
for the production of a 3 2 P labeled antisense RNA Assay of 
DM kinase RNA from the same strain as that from which the 
probe was derived will yield a 385 bp protected fragment 
However, RNA from divergent mouse strains is cleaved at 
sequence discontinuities thereby yielding a smaller protected 
fragment As shown in Figure 4a the analysis of muscle RNA 
BALB/c GGAAGATCGA GCGACCAGGG AGCGACCCAA AGCGTCTCTG TGCCCATCGC CCCCCCCCCC CCCCCCACCG CT CCG CTCCACACTT CTGTGAGCCT 
C75BI/6 GGAAGfiTCGA GCGACCAGGG AGCGACCCAA AGCGTCTCTG TGCCCATCGC CCCCCCCCCC CCCCCCACCG CT CCG CTCCACACTT CTGTGAGCCT 
DBA2 GGAAGATCGA GCGACCAGGG AGCGACCCAA AGCGTCTCTG TGCCCATCGC CCCCCCCCCC CCCCC ACCG CT CCG CTCCACACTT CTGTGAGCCT 
COI GGAAGATCGA GCGACCAGGG AGCGACCCAA AGCGTCTCTG TGCCCATCGC CCCCCCCCCC CCCC ACCG CT CCG CTCCACACTT CTGTGAGCCT 
BTBR GGAAGGJCGA GCGACCAGGG AGCGACCCAA AGCGTCTCTG TGCCCATCGC CCCCCCCCCC CC ACCG CT CCG CTCCACACTT CTGTGAGCCT 
Castaneus GGAAGGTCGA GCGACCAGGG AGCGACCCAA AGCGTCTCTG TGCCCATCGC CCCCCCCCCC С ACCG CT CCG CTCCACACTT CTGTGAGCCT 
Skive GGAAGÇ.TCGA GCGACCAGGG AGCGACCCAA AGCGTCTCTG TGCCCATCGC CCCCCCCCCC С ACCG CT CCG CTCCACACTT CTGTGAGCCT 
Spretus GGAAGGTCGA GCGACCAGGG AGCGACCCAA AGCGTCTCTG TGCCCATCGC CCCCCCCCCC CCCCC ACCG CTCCGCTCCG CTCCACACTT CTGTGAGCCT 
Figure 2. Partial sequence of the 3 exon of the DM kinase gene in various mouse inbred strains Pertinent segments of the 3 DM kinase gene area were PCR 
amplified from genomic DNAs of various mouse inbred strains and fragments were agarose gel punfied and cloned Only partial DNA sequences of the aiea with 
the relevant polymorphic positions underlined are shown Deleted positions are indicated by (-) 
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from CDl and C57BL/6J (lanes 1 and 2, respectively) resulted 
in full length protected RNA whereas the assay of muscle RNA 
from Mus musculus musculus (SKIVE strain, lane 3) and Mus 
musculus castaneus (lane 4) produced a distinct doublet of 
approximately 240 bp, corresponding to the predicted size of 
protected fragments resulting from polymorphism in the C17 
sequence. 
Since we were able to distinguish alleles of the DM kinase 
gene from different strains of Mus we cross bred these mice and 
assayed muscle RNA from the progeny. Two month old progeny 
derived from the cross of M.domesticus and M.musculus 
expressed both alleles of the DM kinase gene (Fig. 4a, lanes 5 
6 6). The same result was seen when the three week old progeny 
of M.domesticus and M.castaneus were analyzed (Fig. 4a, lanes 
7 & 8). The DM kinase gene, therefore was not imprinted in 
mice three weeks of age or older. 
To establish that the gene is not imprinted during 
embryogenesis and loses its imprint after birth, the expression 
of the DM kinase gene was also tested in embryonic hybrid mouse 
RNA (Fig. 4b). Again both alleles were detected in 16.5 and 
19 day old embryos. We therefore, conclude that the DM kinase 
gene is not subject to parental imprinting from 16.5 days 
gestational age onwards. 
DISCUSSION 
If in cases of congenital DM the affected maternal allele were 
the only allele expressed one could anticipate detrimental 
dominant effects from large expansion of the [CTG]n motif. 
This study demonstrates that there are no overt differences in 
the expression of maternally or paternally acquired DM kinase 
alleles in human tissues. The results obtained from typing of RNA 
samples of muscles in fetal and adult mice as shown in Fig. 4 
confirm and extend our observations. Of course there are 
experimental limits to our approach and the possibility remains 
that opposing—cell type dependent—imprinting effects (see ref. 
18), within the tissues or the entire embryo's examined, do play 
a role. We consider this not a very likely possibility, however, 
and tentatively conclude that imprinting phenomena are not 
involved in the expression of the DM kinase. Concomitantly, 
our findings can be considered a strong indication that imprinting 
does not contribute to the manifestation of DM. 
There was, however, good circumstantial evidence from the 
clinical manifestation of DM for the initiation of imprinting 
studies on the DM gene. We recently demonstrated that the DM 
Figure 3. RT-PCR assay of the transcripts from the DM-lonase gene. Total cellular 
RNA from fetal brain, lung, tongue, kidney, adrenal, skin (a, fetus no 1. 16. 
week of gestation) brain, muscle, liver (a. fetus No. 2, 24. week), intestine {b. 
fetus No. 3, 15. week), brain, muscle, liver, placenta (b. fetus No. 4. 19. week), 
adrenal, brain, skin, muscle, kidney, intestine (c, fetus No. 5, 13. week) was 
used as templates for reverse transcription. Amplification of cDNAs was performed 
using primers flanking a trinucleotide repeat located in the 3' untranslated region 
of the gene. Parental DNA (if avalaible) and fetal DNA were amplified in parallel. 
Each allele is represented by a double-band because of different base composition 
of the complementary strands. The same band pattern is observed in RT-PCR 
products from all fetal tissues examined (and adult liver, not shown), indicating 
biallelic expression of the DM gene. In all cases (most extreme in fetus 4) the 
weaker signal is associated with the larger allele due to reduced performance 
of the RT-PCR. 
kinase is predominantly located at the sites of neuro-muscnlar 
junctions and has a putative role in muscle fiber maturation, 
presumably via synaptogenesis during innervation (van der Ven 
et al., submitted). Absence of the DM-kina.se protein due to 
imprinting impairment may therefore lead to neonatal lethality 
in mice exactly as seen in the genetic complementation studies 
for the area on chromosome 7 where the DM gene is located (16). 
The DM gene forms part of a large syntenic group of genes 
which in man spans the entire segment between q 12 and q 13.3 
on human chromosome 19. This area, which is particularly rich 
in expressed sequences, comprises at least 107 base pairs of 
DNA and spans a sex average genetic distance of approximately 
20 — 25 cM. In mice, the physical organisation may be similar, 
but the genetic distances are much shorter due to a markedly 
reduced recombination frequency in the vicinity of the 
chromosomal centromere (14. 15). Consequently, we refrained 
from further study of the genetic ordering around the murine DM 
kinase gene. Such mapping may become more relevant once 
neighbouring genes that really contribute to the paternal effects 
on neonatal lethality have been identified. The polymorphic C-
stretch in the DM kinase gene shown in Fig. 2 may form a 
valuable addition to the currently existing set of markers for the 
proximal segment of chromosome 7. We did. however, confirm 
the anticipated location of the DM gene by using fluorescent in 
situ hybridisation in conjunction with the ApoE gene which has 
a well defined location as determined from genetic cross over 
analysis (23). Analysis of the digitized FISH images (Fig. 1) 
indicated that the DM gene is situated proximal and immediately 
adjacent to the apoE-apoC 1-apoC2 cluster which is in or close 
to mouse chromosome band A. well above the T9H breakpoint 
which demarcates the distal border of the imprinted area on the 
proximal segment of chromosome 7 (16). 
The other imprinted areas on mouse chromosome 7 are in the 
middle and at the distal tip of the chromosome (16). The best 
direct experimental evidence for the existence of imprinted genes 
points to two genes within the distal area, the H19 and Igf-2 gene 
loci (17.18). These loci have been mapped to band 11 ρ 15.5 in 
the human genome (24) and in the case of the human Η19 gene 
convincing evidence for imprinting has also been provided (19). 
Thus, as in the mouse the distal and proximal imprinted regions 
are at least 25 cM apart and genes from these regions are located 
on different human chromosomes, no direct interactions between 
imprinting effects in either domain may be expected. 
Recently it has been shown that significant CTG-repeat 
expansion can occur in transmission via both sexes in DM 
families. However, a paternal transmission of congenital DM has 
never been reported. What then are the possible mechanisms that 
remain to explain the parental effects on the features of DM if 
imprinting is excluded? Firstly, any direct effects may stem from 
influences exerted by the uterine environment in cases where the 
mother is a carrier of DM. Whether these influences are related 
to cell signalling phenomena or have a purely mechanical basis 
is currently unknown. Maternal metabolic disturbances, including 
decreased adrenal production (25). hypercatabolism of IgG and 
hyperinsulinemia (26) have been invoked. Secondly, direct 
genetic mechanisms may be involved. Instability in the [CTG]
n 
repeat leads to somatic and tissue differences in the CTG-repeat 
length (Jansen et al., in preparation), and it is possible that 
congenital DM manifests only in those cells or tissues where a 
threshold length in [CTG]„ repeat expansion has been reached 
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F i g u r e 4. RNase protection assay of muscle R N A from M dornest ¡eus. M. musculus. M.castaneus and hybrid animals . Total muscle RNA was purified and assayed 
by RNase protection as described in Materials and Methods . The product that is characteristic of M.domesticus strains is denoted by one asterisk (*) whereas the 
product that is characteristic o í M musculus and M castaneus is designated by two asterisks (**). To the left of part A approximate size standards are shown in 
base pairs a . Autoradiogram from the assay of 5 ¿¿g oí RNA from the following animals: Neonatal CD1 (lane 1). 3 week old M domesticus (C57BL 6 strain, lane 
2) . 2 month old M.musculus (SKIVE strain, lane 3) . 2 week old M castaneus (lane 4 ) . 2 month old progeny Irom the cross of M.domesticus (CBA/NJX10/X10) 
females to M musculus males (lane 5) and M.musculus females to M.domesticus (CBA NJX10 X10) males (lane 6) , 3 week old progeny from the cross of C 5 7 B L / 6 
females to M.castaneus males (lane 7) and M.castaneus females to C 5 7 B L 6 males (lane 8) b . Assay of 5 μg of R N A from the following samples : 3 week old 
C 5 7 B L 6 (lane 1). 2 week old M.castaneus muscle (lane 2) . 19 day old fetuses (lane 3) and 16.5 day old fetuses (total body R N A . lane 4) produced by crossing 
C 5 7 B L 6 females to M castaneus males . t R N A (lane 5). 
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due to a parental effect The threshold sizes may differ between 
individuals due to differences in genetic background Preliminary 
results (Brunner et al , in preparation) suggest that the average 
expansion as diagnosed from blood DNA may differ between 
sexes At the higher end of the CTG-length spectrum these length 
variations may be most pronounced A similar but more 
conspicuous effect has been reported for the maternal effects on 
CGG-repeat expansion in fra(X) (27-31) It is therefore 
conceivable that the critical repeat size can only be attained via 
maternal inheritance or via maternal influences on ongoing 
expansion at the somatic level perhaps during early 
embryogenesis Resent evidence of Mulley et al (12) and 
Lavedan et al (13) provided another possible explanation, namely 
that mtergenerational enlargement of the CTG repeat is restrained 
if paternally transmitted Gonadal atrophy and infertility are 
indeed common in carriers with long repeats and may preclude 
the formation ot sperm carrying long CTG repeats 
For the anticipation and potentiation (see 1 and refs therein) 
effects in DM, cis dominant influences of the CTG-expansion 
on DNA transcription, RNA splicing or mRNA stability have 
been postulated It is unlikely that similar mechanisms play a role 
in the sex difference of congenital transmission The steady state 
levels of allelic mRNAs in normal tissues show a nearly perfect 
fifty-fifty ratio in signal intensities Theoretically the possibility 
remains that maternally determined cis effects evoke differential 
effects on the use of allelic RNAs in alternative splicing pathways 
or the translational process Though this can conceivably occur 
via modification of ribonucleotides (A6 methylation) in hnRNA 
or mRNA, to our knowledge there is no evidence tor the existence 
of such a mechanism 
Perhaps the best hope for understanding these phenomena is 
in the generation of animal (mouse) models that carry unstable 
human DM-kinase alleles ot various lengths In the inbred mouse 
situation a great deal of the environmental and genetic variability 
seen in humans can be excluded and tissues are easily amenable 
for experimentation at all stages of development This will allow 
us to study the behaviour of the gene in the correct environment, 
and tests as described in this report can be instrumental in these 
further studies 
MATERIALS AND METHODS 
Fluorescent in situ suppression hybridisation 
Cultured mouse 129/sv embryonal stem cells CCE (32) were harvested 45 min 
after colchicine had been added (final concentration 0 2 ¿¿g/ml) Then cells were 
subjected to a hypotonic treatment in 0 075 M KCl for 10 min at 37°C and fixed 
h> washing (three times) in a mixture of 3 1 methanol/glacial acetic acid 
Chromosome preparations were made by dropping the fixed cell suspension onto 
clean moisturized glass slides Probe labeling and fluorescent in situ suppression 
hybridisation (FISH) was performed as described elsewhere (33) with some minor 
changes Briefly purified cosmids containing the DM gene (mc8) and the ApoE 
ApoCl gene cluster were labeled by standard nick translation (Life technologies 
bio nick system) with biotin 14-dATP (Sigma) or dig 11 dUTP (Boehnnger 
GmbH) respectively Labeled cosrmd DNAs (100 ng) were purified on a Sephadex 
G 50 column and mixed in with 15 μg of sonified total mouse DNA (serving 
as competitor DNA J After 10 min denaturaüon at 80°C the probe was preannealed 
at 37°C for 2h Chromosome preparations were pre treated with RNAse A (100 
/¿g/ml in2xSSC for I hourat37°C) heat-denatured in 70% Гоггпаткіе 2xSSC 
pH 7 0 at 70°C for 2 — 3 mmutes and hybridized simultaneously with both probe 
mixtures (10 μ\ mixture with 5 ng probe DNA per μΐ) at 37°C during an overnight 
incubation The biotine labeled mc8 probe was detected by successive incubations 
with avidine FTTC and biotinylated goat anü avidin anubodies (Vector laboratories) 
as described (33) The digoxigemn labeled ApoE ApoCl probe was detected by 
incubation with Rhodamine-conjugated sheep ann-digoxigenin anubody (Boehnnger 
GmbH) and Texas Red conjugated rabbit anti sheep antibod) (Jackson s 
Immunorescarch Labsj (33) Finally the slides were mounted in medium containing 
0 5 μ% ml propidium iodide (Sigma) as a DNA couruersiain and 2 3% (w v) 
1 4-diazobic>clo-(2 2 2)-octanc (Merck) antifade agent Preparations were studied 
with a Zeiss Axiophot epifluorescence microscope equipped for DAPI FITC 
and Texas Red epifluorescence Digitized images were captured using appropriate 
fluorescence filters and a Photometries high performance CH 250 a CCD camera 
controlled b> TCL image anal)Sis and processing software (TNO Delft The 
Netherlands modified b> Biological Detection Systems Pittsburgh USA) Images 
were stored superimposed and displayed in red green and blue pseudocolors 
using an Apple Macintosh Псх workstation Thirty preselected methaphases were 
analysed and photographs were taken from screen on Kodak Ektachrome 100 
EPP film The chromosome 7 centromere position was revealed by DAPI staining 
(not shown) 
Sampling of fetal and adult tissue 
With informed consent of the parents biopsies from therapeutic and spontaneous 
abortions (15-24 week of gestation) were laken within 15 h of delivery Samples 
of adult tissue were taken post mortem with consent from the relatives Mouse 
tissue was sampled as described before (17) 
Preparation оГ D\As 
Genomic DNAs of \anous inbred mice were isolated from livers using standard 
Proteinase К digestion and phenol extraction Similar procedures were used for 
the preparation ol DNA from human tissues and peripheral blood Cosmid and 
plasmid DNAs were isolated and purified using standard procedures (34) 
Preparation of RNAs 
Total RNA was prepared from the skeletal muscle of mice using the lithium 
chloride urea method (35) Total cellular RNA of human tissues was extracted 
with RNAzolB (Campro Scientiiic) Following homogenization of ihe tissue in 
RNAzolB 1/10 (\/v) chloroform was added the solution was mixed and placed 
on ice for 5 mm Samples were ccntrifuged at 4DC for 15 min and the RNAs 
were precipitated now for 45 mm at 4°C Following solubilization RNAs were 
once more precipitated prior to treatment with pancreatic DNase I 
Cloning and analysis of DM-kinase gene DNAs 
The cloning and characterisation of cosmids containing mouse strain 129/sv 
genomic DNA inserts from the DM area has been described (10) The sequence 
of the genomic mouse DNA is given in Jansen et al (10) and Mahadevan et 
al (36) Appropriate Pul Xhol and ЯатНІ Pstl fragment subclones spanning 
the relevant segments of the 3 untranslated exon of the DM kinase gene were 
derived using standard cloning methodology (34) To obtain the cognate gene 
segments of other inbred strains PCR mediated DNA amplification (37) was used 
Briefly two 18 and 19 mer primers (GER9 19 mer 5 CTCACCCGGCAG 
AGCCTGA and GER6 18 mer 5 TGTGCTGGCAGAGGTCTT) were designed 
that bracket an 1187 bp fragment situated between positions 1097 and 2283 in 
our longest cDNA clone (10) at 277 bp upstream of the poh A addition site 
In the genomic situation (36) these primers bracket a region of 1761 bp A typical 
PCR reaction reaction mixture contained 100 ng of genomic DNA 100 ng ot 
each primer and 0 2 mM dNTPs in Cetus Perkm Elmer recommended buffer 
Thirty consecutive reaction cycles at 94CC for 1 nun at 60°C for 1 min and 
at 72°C for 4 mm were used The resulting fragments were incubated for 30 
minutes at 37°C and 10 minutes at 65°C with Proteinase К blunied with Klenow 
DNA polymerase 5 phosphorylated using T4 DNA kinase (38) and digested 
with BamHl prior to cloning m BamHVEcoRV digested pBluescnpt SK+ vector 
DNA DNAs were transfected mio competent HB101 host bacteria and resulting 
colonies were analysed for the presence of inserts Irrelevant segments of the 
insert were removed by Smal cleavage and subcloning Colonies containing the 
truncated genomic DM kinase 3 fragments were sequenced usmg the supercoiled 
DNA sequencing method (39) 
RNAse protection assay 
A 385 bp BamHl Pstl fragment from the 3 portion of the mouse DM kinase 
cDNA (mouse strain BALB/c ref 10) was subcloned into the ВатШ Psil sites 
of pBluescnpt II KS (Stralagene) The template was linearized with Xbal in 
preparation for the RNase protection assaj The assay was performed essentially 
as previously described (40) except that radioactive transcripts were generated 
from the linearized plasmid usmg [a 3 2P]CTP and T3 polymerase (Promega) 
5 x 104 с ρ m of this probe was hybndized to ratal RNA overnight at 65 °C The 
samples were then digested with RNase at 37°C for lh and analyzed by 
electrophoresis on a 6 6 % acrylarmdc 7M urea gel and exposed to Kodak XAR 5 
X ray film 
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RT-PCR analysis of RNAs and PCR amplification of allelic DNAs 
Toial RNA f 125 ng> was reverse transcribed in a 10 ¡Λ mixture (I xRT-buffer 
(10 mM Tris, 50 mM KCl, 0,01 Я gelatin) 5 mM MgCK, I mM dNTPs, 4 5 
U of RNasin (Pharmacia)) with 50 U of MMLV reverse transcriptase 
(Gibcu BRL) Re\erse transcription was pnmed wich 0 05 /ig random 
he\anuclcotidcs (Pharmacia) The samples were incubated at room temperature 
for 10 mm, 37CC for 60 min, 99°C for 6 mm and cooled on ice prior to the 
addition of PCR mix In each experiment possible DNA contamination was 
excluded by the absence of signal in the sample without reverse transcriptase which 
was subjected to PCR in parallel under the same conditions 
For PCR amplification genomic DNA and cDNA were amplified for 30 cycles 
in 1 xTncine buffer (41) in the presence of [a-3 :P]dCTP O 3 0 0 0 Ci/mmol 
Amersham) As pnmers 22 mers complementary to sequences flanking the CTG-
tnnucleotide repeat sequence, which is located in the 3' untranslated region of 
the DM gene (detailed in rei 3) were used PCR cycles involved incubation at 
92°C lor 1 min, 58°C for 1 nun and 72°C for 3 min Amplification products 
were size fractionated at 60 W for 3 h on standard 6 6% denarunng Polyacrylamide 
gels After electrophoresis the gels were dried and exposed to Kodak X-ray film 
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Myotonic dystrophy kinase is a component 
of neuromuscular junctions 
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The clinical manifestation of myotonic dystrophy (DM) is correlated to the extent of expansion of an unstable 
[CTGJn DNA motif. Recent studies have demonstrated that this trinucleotide motif forms part of the last, 3' 
untranslated exon of a gene which potentially encodes multiple protein isoforms of a serine/threonine protein 
kinase (myotonic dystrophy protein kinase, DM-PK). We report here on the development of antisera against 
synthetic DM-PK peptide antigens and their use in biochemical and histochemical studies. Immunoreactive DM-
kinase protein of S3 kD is present at low levels In skeletal and cardiac muscle extracts of DM patients and normal 
controls. Immunohistochemical staining revealed that DM-PK Is localised prominently at sites of neuromuscular 
and myotendinous junctions (NMJs and MTJs) of human and rodent skeletal muscles. Furthermore, very low 
levels of immunoreactive DM-PK protein are present in the sarcoplasm of predominantly type I fibres in various 
muscles. Strikingly, presence of the protein can also be demonstrated for NMJs of muscular tissues of adult 
and congenital cases of DM, with no gross changes in structural organisation. Our findings provide a basis for 
further characterisation of the role of the kinase in protein assembly processes or signal mediation at synaptic 
sites and ultimately for the understanding of the complex pathophysiology of DM. 
INTRODUCTION 
Myotonic dystrophy (DM) is an autosomal dominant inherited 
disease and the most prevalent muscular dystrophy in adults The 
disease is progressively worsening during the life of DM 
individuals and shows increased clinical seventy over successive 
generations in DM pedigrees (anticipation, potentiation) Besides 
myotonia and muscular weakness, other symptoms point to 
defects in the central nervous system, peripheral nerves, the eye, 
the heart and endocrine tissues ' The clinical manifestation and 
the age of onsei of DM are correlated to mutational expansion 
of an unstable [CTG],, DNA repeat 2~* This expanding [CTG]
n 
repeat is located at chromosome segment 19q 13 3 and forms part 
of the 3' terminal exon of a gene encoding a protein with putative 
serine/threonine protein kinase activity In the vicinity of this 
locus are several olher genes which may also be causually 
involved in the etiology of the disease ч In spue of the recent 
progress in studying the DM mutation there is presently not much 
known about the relationship between the behaviour of the 
[CTG]
n
 repeat and its effects on gene expression or the variable 
clinical manifestation of DM For the anticipation and potentiation 
effects in DM, с is dominant influences of the CTG-expansion 
on DNA transcription, RNA splicing or mRNA stability have 
been postulated2 s Recent studies on DM-PK mRNA and 
protein levels in adult and congenital DM tissues and cell lines 
have shown conflicting results Both downregulation due to 
monoallehc expression ot the wildtype allele67 and upiegul-
anon" were found 
We have decided to focus on the comparative characterisation 
of DM-PK isoform function(s) in DM patients and normal human 
and animal controls Here we report on the tissue distribution 
of the protein product(s) of the DM-PK mRNA in normal and 
diseased muscle as a first step in our study of the molecular 
etiology of this disorder 
RESULTS 
Development of DM-kinast specific antibodies 
The predicted protein structure of DM-PK as based on 
comparison of human and mouse gene sequencing datav entails 
a putative signal domain, a kinase core domain, a connecting 
hinge region, an α-helical coiled-coil forming domain and a 
hydrophobic C-terminal end (Fig 1 ) To design synthetic peptide 
antigens, the predicted ammo acid sequences of the DM kinase 
proteins were screened for regions that were identical in man 
and mouse, but had no homology to protein sequences, including 
any of the known protein kinases, in data bases Two synthetic 
16-mer peptide antigens (DM/pepl and 2) were selected that 
' To whom correspondence should be jddressed 
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Figure 1 Structural organisation of the mouse DM kinase gene and protein(s) and localisation of the synthetic peptides used as immunogens The protein structure 
is predicted from sequence data3 y and the positions of the three synthetic peptides used for production of polyclonal antisera to the DM kinase in rabbits are given 
The lourlecnopen boxes represent the gene s regular exons shaded boxes I—V represent alternative spliced regions The N terminal end of the protein may represent 
a cleavage signal peptide the alternative intron in exon fi (region I) yields an extension of the domain with scr/lhr kinase activity the small alternative exon at the 
end of exon 8 (region П) encodes a putative glycosaminoglycan attachment sue Additional С terminal extensions represent the domains with a helical toiled coil 
conformation and the hydrophobic terminus The approximate positions of stop codons in alternative reading trames arc indicated by А В С and D 
correspond to sequences at the end of the kinase domain and 
which may be present or absent in the protein due to alternative 
splicing (Fig 1) 
In addition, one further 9 mer peptide (DM/pep3) 
corresponding to a unique variable segment of ihe otherwise 
strongly conserved ser/thr kinase domain was used to raise 
polyclonal antibodies in rabbits All antibodies reacted with the 
mouse specific DM-PK isoforms produced as Glutathione S 
transferase kinase fusion proteins in bacteria as anticipated (Table 
1 ) Anti DM/pep 1 and anti DM/pep2 differentiate between fusion 
proteins with (ι e protein 1 1) or without (ι e proteins 15 1 and 
15 IRE) the alternatively spliced exon 1 encoded amino acids 
(Table 1) Furthermore, though peptides DM/pep 1 and DM/pep2 
have a short region of overlap, no cross reactivity was observed 
on filter immobilised peptides Therefore all peptide antisera can 
be considered independent reagents 
Western-blotting 
We used these antisera to detect DM PK protein in extracts from 
tissue biopsies by Western blotting Samples of cardiac and 
skeletal muscle of normal controls and DM-patients showed 
immunoreactive protein as a distinct but rather fuzzy band of 
a molecular size of 52-53,000 daltons (Fig 2) This prolein 
was clearly smaller than the protein detected by a monoclonal 
antibody (MoAb) against the 57kD intermediate filament protein 
(IFP) vimentin10 (Fig 2C) but only marginally smaller than 
desmin10, a 53 kD IFP (not shown) which were included as 
controls Though the level of DM PK varied between tissues and 
individuals, we cannot at present reliably quantify the differences, 
the reason being that the DM PK has a highly localised tissue 
distribution (see below) Choice of sampling location, therefore, 
may bias the assay 
Table I Characterisation ol ami DM PK antisera on Western blots of GST DM 
PK fusion proteins 
Fusion prolein GST \4 IRC 
anti DM/pcpl 
anti DM/pep2 
anti DM/pcpl 
anti GST 
1
 Not tested 
Bacterial lysates harboring the GST-0 protein or GST fusion proteins containing 
truncated segments of DM PK wilh tir without the pepudc 3 anuno acid sequence 
or the alternatively spliced exon 1 were analysed b) Western blotting Presence 
or absence of antigenic reactive material with any ol the four different antisera 
(ami DM pepi ami DM'pep2 anil DM рерЗ and ami GST control) is indicated 
with + or respectively The definition of the actual content of each DM PK 
variant is given in Materials and Methods 
Immimohistochemical localisation of the DM kinase antigenic 
protein 
Affinity purified antibodies of the three DM-PK antisera were 
used for immunohistochemical localisation of antigenic protein 
in cryostat sections of human and rodent muscle In cross sections 
of adult skeletal muscle of rat (Fig 3A,C), mouse 
(Fig 3D,F,G I), and human (Fig 4A C), a rather weak positive 
overall reaction was seen within the myofibres, and near the 
sarcolemma Upon staining with anti DM/pep3, often a more 
conspicuous staining (intensities depended on the serum batch 
tested) of sites near the sarcolemma was observed (see for 
example Fig 4A) As we do not know at present whether this 
reaction can be considered specific, this issue is not further 
discussed here Using enzymatic staining for ATPase pH 4 3 (acid 
ATPase) or myosin heavy chain subtypes, fibres in adult skeletal 
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Figure 2. Immunoblottmg of extracts of normal and DM cardiac and skeletal 
muscle. Fractionated proteins of normal adult cardiac muscle (lanes 1). adult DM 
cardiac muscle (2). congenital DM cardiac muscle (3.4). normal preterm (28 weeks 
gestation) skeletal muscle (.1). congenital DM skeletal muscle (6.7) transferred 
to nitrocellulose were incubated with anti DM/pepl (A) or anti-DM/pep2 (B). 
The blot shown in (C) is the same blot as shown in (B) reincubated with RV 
202. a mouse MoAb to vimentin10. Vague staining of proteins with molecular 
sizes of 80 and > 150Ш (as seen in lanes 5) was seen with all antibodies and 
is considered aspecific The positions of molecular weight markers are indicated 
to the left 
muscle sections that yielded a weakly positive reaction in a typical 
'checkerboard-like' staining pattern, were identified as type I, 
or slow twitch oxidative fibres (Figs 4A.B; note also differences 
in overall fibre staining intensities in 4C). In cross sections of 
skeletal muscle biopsies from myopathic patients (e.g. myositis. 
Duchenne) a prominent, homogeneous staining of regenerating 
fibres was seen with the antibodies. In double labeling 
experiments these fibres were also stained by a mouse MoAb 
to embryonic myosin". Similar pictures were obtained with 
sections of embryonic mouse muscle (not shown). Upon double 
Figure 3. Immunolocalisation of DM-protein kinase in rodent skeletal muscle-
Shown are 6 μηι cryostat cross sections of normal rat limb muscle stained with 
anti DM/pepl (A,C) or with a-bungarotoxin (B). and normal mouse limb muscle 
stained with anti-DM/pep2 (D,F). anti-DM/pep3 (G,I) or a-bungarotoxin (F.,H). 
Ami DM/pepl .2 and 3 all stain NMJs (A.D.G). that were identified in the same 
section with α bungarotoxin (B.E.H). and MTJs (C.F.I). Bar - 50 /im ( D - I ) . 
or 100 ц т (A-C) . 
labeling of adult muscle sections with anti-DM/pepl, 2 and 3 
antisera and rhodamine-tagged a-bungarotoxin to label 
specifically acetylcholine receptors (AChRs), a significant portion 
of the DM-PK immunoreactivity was located at spacially 
restricted sites near the muscle fibre surface, consistent with the 
sites of neuromuscular junctions (NMJs) in both rodent 
(Fig. 3A/B, D/E, G/H) and human (Fig. 4C.E/F) muscles. 
Analysis of longitudinal and cross-sections of selected areas of 
human and rat diaphragm, known to be particularly rich in 
neuromuscular junctions, extended and confirmed this observation 
(not shown). Cultured rat myotubes also showed an obvious co-
localisation of DM-PK with spontaneously occuring clusters of 
AChRs (Fig. 5A,B). In addition to staining type I fibres and 
neuromuscular junctions, the anti-DM-PK antisera displayed a 
significant staining of myotendinous junctions (MTJs) (Figs 
3C,F,I,4D) and the intrafusal fibres in muscle spindles in skeletal 
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Figure 4- Immunolocalisation of DM-protein kinase in normal and DM human 
skeletal muscle specimens. Shown are 6 μπι cryostat cross sections of normal 
adult muscle (A—C). normal neonatal muscle ( D - F ) . congenital DM muscle 
(G,H) and a longitudinal section of a single myofibre of adult DM muscle (I,J). 
stained with anti-DM/pep3 (A.D.E.G.I), a mouse monoclonal antibody to the 
slow subtype of myosin heavy chain (B). anti-DM/pep2 (C) or a-bungaroloxin 
(F.H.J). Note that anti-DM/pep3 weakly stains the myofibres (A) that are identified 
as type I fibres in a serial section (B). Incubation with anti-DM/pep2 results in 
a similar reactivity panern (C) while also the NMJs. present m this section, are 
stained. In D the staining of human MTJs with anti-DM/рерЗ is depicted. E - J 
show that anti-DM/pep3 stains NMJs in normal preterm (E). congenital DM (G) 
and adult DM (I) skeletal muscle, that were identified in the same sections by 
an incubation with α-bungarotoxin (F.H.J). Bar = 30 μπι (I.J). 50 μπι (C-H) 
or 100 μπι (A.B). 
muscle, intercalated discs in cardiac muscle and dense plaques 
in smooth muscle cells. In the brain most neurons, including the 
cerebellar Purkinje cells, were stained (Fig. 5C,D). Similar 
results were obtained with affinity purified antibodies from all 
three antisera and in both human and/or rodent tissues. The 
reactivity patterns were not observed when immunogens ( 1 ^g/ml) 
were added to the incubations with the DM-PK antisera (Fig. 6). 
after omission of the primary antibodies, or when the ami DM-
PK sera were replaced by preimmune sera. 
Figure 5. Immunolocalisation of DM-PK in cultured rat myotubes and mouse 
brain. Shown are cultured primary rat myotubes (A,B, arrows) and 6 μπι cryostat 
sections of mouse brain (C,D) stained with anti-DM/pepl (A), a-bungarotoxin 
(B) or anti-DM/рерЗ (CD). Note the exact colocalisauon of DM-PK with 
spontaneous clusters of AChR also stained by a-bungarotoxin (arrowheads). (C) 
depicts the staining of cerebellar Purkinje cells, while in (D) the staining of the 
Amnion's horn of the hippocampus is shown. Bar - 60 μηι (A.B). 100 μπι (С) 
or 180 μπι (D). 
The structure of the DM-PK molecule with its signal sequence, 
its α-helical domain and its hydrophobic stretch is suggestive for 
an association with the sarcolemma and/or the cytoskeleton. 
Indeed, reaction patterns did not change when tissue sections were 
treated with the non-ionic detergent Triton X-100 before 
incubation with the antibodies. This means that at least some 
forms of DM-PK are non-soluble and possibly organised into 
cytoskeletal frameworks at or near the sarcolemma.12 
Evidence for presence of DM-kinase protein in NMJs of DM 
patients 
Surprisingly, muscles in autopsy material of an adult and a 
congenital case of DM, carrying increased repeat lengths of 
800-1000 and 1000- 1500 CTGs respectively, showed staining 
patterns not significantly different from those in normal muscle 
(Fig. 4). Of course, for a more accurate comparison between 
healthy individuals and DM patients, in situ quantitation of 
fluorescence signals of NMJs of muscles with a graded severity 
in disease manifestation will be required. 
DISCUSSION 
To our knowledge, this is the first analysis of the highly specific 
tissue distribution of the DM-kinase protein. As tools three 
independent polyvalent anti peptide sera were developed and 
similarities in distribution patterns in human and rodent 
no 
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Figure 6. Blocking of anti DM/PK reactivity patterns with the immunogen. Shown are a cryostat section of adult rat skeletal muscle, double stained with a-bungarotoxin 
(A) and anti-DM/pepl in the presence of 1 ^g ml immunogen (B) and serial cryostat sections incubated with anli-DM/pepl (C) or anti-DM/pepl in the presence 
of I μg/ml immunogen (D). Note the absence of anli-DM/pepl staining of NMJs (A.B: compare with Figs 3A.B) or MTJs (CD) after addition of the immunogen 
to the incubations Bar = 50 μην 
neuromuscular tissues were recorded. DM-PK antigenic material 
is prominently present in young muscle fibres and concentrates 
at many sites of cell-cell contacts in neuromuscular tissues. This 
allocation resembles the developmental and neural regulation of 
a recently described subsarcolemmal 41 kDa rat antigenic 
protein", and the intracellular routing of a synaptic 43 kDa 
protein14. Our antisera (as specified in Table I and Fig. 1) do 
recognise all DM-PK isoforms in which the ultimate C-terminal 
portion of the kinase domain is retained. In muscle the 53 kD 
protein seems to be the predominant isoform. In absence of data 
about the structural features and function(s) of the DM-PK 
isoforms we can only speculate about the significance of our 
observations and their role in the pathophysiology of DM. Most 
significant is our observation of the marked concentration of DM-
PK at sites of specialised membrane regions like NMJs and MTJs 
in skeletal muscle, intercalated discs in the heart and dense 
plaques in smooth muscle cells. It may also be of importance 
that the staining of muscle spindles, which in human occur 
prominently in head and neck region, was particularly strong. 
Preliminary typing as shown in Fig. 5C,D also showed Purkinje 
cells and several other neurons of the cerebellum and other parts 
of the brain to be stained by our antibodies. If the [CTG]
n
 DNA 
expansion interferes with the nature or expression level of the 
DM-PK it is conceivable that muscular atrophy, myotonia, heart 
failure and impaired intellectual attainment may be a direct 
consequence of changes in DM-PK regulated synaptic signal 
mediation or the assembly of the junctional architecture. This 
suggestion is in keeping with earlier theories that have classified 
DM as a disease of unresponsiveness to innervation or 
abnormality in the control of muscle 1 5 1 6 1 7 resulting in 
attenuated fibre development in the diaphragm, tongue, pharynx 
and neck regions in cases of congenital DM,1·1*·1'·20 and with 
the experimental support for altered motor neuron excitability 
in DM21. In this respect it is interesting to note that Kobayashi 
et al.22 described that AChR clusters on cultured myofibres 
from DM-patients were immature and less well organised when 
compared to myofibres derived from normal muscle. 
Recent reports describe that levels of DM-PK mRNA and 
protein in muscle of congenital DM or adult DM patients are 
altered. Fu et al.6 and Novelli et al.1 reported that expression 
was reduced due to only wild type allele expression7 in the more 
severe cases of adult DM. In contrast. Sabourin et oí.8 found 
elevated levels of mutant mRNA in congenital DM tissues and 
in cell lines. We surmise that these apparently conflicting 
results—at least in part—can be explained by variations in 
expression levels in different fibres during maturational or 
regenerative processes. Moreover our results underscore that the 
protein is found at highest concentrations in highly specialised, 
non-homogeneously distributed structures of muscular tissues. 
Thus, the choice of sampling location may, especially in skeletal 
muscles, actually be a critical determinant in RNA and protein 
quantitation assays. Very recently it has been shown that DM-
PK (perhaps as a result of alternative splicing) can partition over 
particulate and cytosolic fractions2'. Therefore, a consensus has 
to be reached about the most efficient protein extraction 
procedures for radiolabeled immunoassays or Western blotting. 
At present due to the overall lack of data on properties of DM-
PK protein isoforms these procedures cannot easily be 
standardised. In any event, our results do not reveal an overt 
lack or grossly abnormal structural organisation of DM-PK or 
AChRs in NMJs of DM patients, despite significant (CTG)n 
expansion. 
In conclusion, although our morphological findings fit certain 
clinical observations, further speculation must await the 
characterisation of the precise subcellular location of DM-PK— 
pre- or postsynaptic, intra- or extracellular—as well as the 
identification of substrate proteins that undergo phosphorylation 
by DM-PK. Furthermore, in order to establish correlations 
between our morphological findings and the clinical picture, we 
need to generate more refined, DM-PK isoform-specific, 
immunogenic reagents and sophisticated ultrastructural 
procedures to examine the many affected tissues of DM patients 
and to explain the highly complex multisystemic character of this 
frequent heritable disorder. 
MATERIALS AND METHODS 
Production of GST7DM-PK fusion proteins 
Truncated mouse DM-PK cDNAs, with and without the alternative intron I region 
(ref.5. Fig. 1) or the N-terminal portion of DM-PK were cloned into the pGEX-2T 
expression vector24 and GST/DM-PK fusion proteins were produced in E.coli 
using standard procedures24. Fusion protein 15.1. starting in exon 4. lacks region 
I and contains regions II. III. IV. and V; fusion protein 1.1 lacks the N-terminal 
portion of the DM-PK catalytic domain, starts in exon 8. but contants regions 
I. II. and HI. and lacks regions IV and V. Fusion protein 15. IRE was produced 
from a pGEX 2T vector containing a 5' RACE extended cDNA (Jansen et al.. 
unpublished) which spans the entire N terminal portion of DM-PK with exception 
of region I. ending just before region II. 
I l l 
Generation and affinity purification of polyclonal antisera ABBREVIATIONS 
Synthetic DM peptides RLGRDFEGATDTCNFD (peptide I) GLRDSVPPF 
TPDFEGA (peptide 2) and NGDRRW1TQ (peptide \) were synthesiscd using 
standard procedures and coupled to bovine serum albumin (BSA) with 
maleimidohcxanoyl N hydroxy succi mm ide (MHS)2*1 (peptides I 2) or used as 
antigen directly (peptide 3) To raise polyclonal antiscra rabbits were injected 
lour times at three week intervals (1 mg peptide/injection in Freunds adjuvant) 
and sera were collected Specific antibodies (ami DM pepi and ami DM pep2 
respeclivelv) were affinity purified from the sera using the partialis purified 
glutathione S transferase/DM kinase fusion protein I 1 Bacteria were lyscd and 
the insoluble Iraction containing the inclusion bodies-6 was pelleted by 
ceninfugation Proteins were solubdised in О 25Я SDS/100 mM MOPS pH 6 5 
and linked to Affigel 15 columns following the recommendations of the 
manufacturer (BioRad) Anli DM peptide sera were intubated with the column 
material for λ h Unbound proteins were removed by extensive washing with 
Phosphate Buffered Saline (PBS) Specifically bound immunoglobulins were eluted 
from the column with 100 mM glycine HCl pH 2 5 After adding 0 I volume 
lOxPBS and neutralisation with NaOH the same procedure was repeated with 
the immunogen (i e peptides coupled to BSAJ linked to Affigel 15 After 
neutralisation immunoglobulins were used in our experiments Details regarding 
the preparation ol peptide 1 immunogenic material and and DM/pep λ antibodies 
will be reponed elsewhere (H F Ε Μ Β Ρ ) 
Characterisation of antisera on Western blots with GST/DM-PK proteins 
and muscle extracts 
Bacteria with the appropriate pGEX constructs14 were induced with 1PTG to 
synthesize GST or GST'DM PK lusion proteins according to standard procedures 
Bauern were pelleted b> cent π fugai ion and boiled in SDS sample buflcr Extracts 
ol normal and DM tissues were produced bv boiling 20 μπι crvostat ussuc sections 
in SDS sample buffer Samples were run on SDS Polyacrylamide gels and 
transferred to nitrocellulose using standard procedures Blots containing bacterial 
extracts were incubated with the affirurs punlicd DM PK ontisera at \anous 
dilutions in Tris buffered saline 0 05^ϊ Twccn 20 (TBST) or as a control with 
a mouse ami GST MoAb developed at our laboratory (G В ten Dam unpublished 
results) to identify GST and Іичоп proteins Western blots with tissue extracts 
were incubated with the anti DM PK sera m a I 500 dilution in TBST or with 
mouse MoAbs against vimciitin or desmin"1 (kind gifts ol Dr F Ramaekers 
Maastricht The Netherlands) at a 1 3 dilution in TBST Subsequcntl) the blots 
were incubated with alkaline phosphatase conjugated secondare antibodies and 
developed in substrate solution using a Promega Protoblot kit according to the 
manufacturers specifications 
ImmunohistuLhemicfd procedures, collection of tissues and cultnation of 
mvotubes 
Human tissues were obtained with inlormed consent al autopsy Irom one Iemale 
DM patient (died at age 66 classical DM leatures) and Irom a congenital Lase 
of DM (28 weeks premature died after birth from respirators lnsulhciLncs ) 
Muscle biopsies were collected immediatcls alter death (rodent tissues) or wiihin 
5-8 hours post mortem (hunnn tissues) They were fiwen in liquid nitrogen 
and stored at П5°С 
Rat myotubes were cultured in vitro and prepared lor immunofluorescence 
anakses as described earlier1 ч For LmniunosLiining cnostat tissue sections 
(6 μτη thick) were pre incuba ted with 10 9f normal swine or goat serum in PBS 
Subsequently they were incubated with anti DM pepi anti DM pep2 ami 
DM/pcp3 or mouse MoAbs spceihc for the embrvoruc or slow subtype of tmosin 
hca\\ chain (kind gifts ol Dr A Wessels Amsterdam I he Netherlands) The 
sections wLre rinsed in PBS and incubated with FITC labeled s*ine anti rabbit 
immunoglobulins (Dakopatts Glostrup Denmark) or Te\as Red labeled goal ami 
mouse immunoglobulins (Southern Biotcchnologv Associates Birmingham 
Alabama USA) all according to standard conditions'"7 In most experiments 
rhodamine labeled α bungaroioxm (Molecular Probes Ine Eugene OR LSA) 
was added to the conjugate Spicific labeling WAS sisuahsecl with a Zeiss Axioskop 
Huorcscence nucroseope Tnion \ 100 extractions were perlormed b\ incubation 
ol mc tissue sections in 0 ^ Tnton X 100 in PBS during 5 mm at room 
icmpcrature Controls included omission ol primary antibodies substitution of 
immune sera b\ prcimmune sera and incubation in the presence of excess 
concentrations of soluble immunogen 
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CHAPTER 
5 
Mouse models 
with altered DM-protein kinase expression 
CHAPTER 
5.1 
Cardiomyopathy or mild degeneration of neck 
musculature but no complete DM phenotype in 
mice with abnormal levels of 
myotonic dystrophy protein kinase 
CARDIOMYOPATHY OR MILD DEGENERATION OF NECK 
MUSCULATURE BUT NO COMPLETE DM PHENOTYPE IN MICE 
WITH ABNORMAL LEVELS OF MYOTONIC DYSTROPHY 
PROTEIN KINASE 
Gert Jansen, Patricia J.T.A. Groenen, Paul H.K. Jap, Marga Coerwinkel, Frank 
Oerlemans, Marleen Dekker1, Anton Berns1, Bärbel Gohlsch2, Dirk Perte2, Jaap J. 
Plomp3, Peter С. Molenaar3, Peter F.M. van der Ven & Bé Wieringa 
Department of Cell Biology and Histology, University of Nijmegen, The Netherlands, ' Department of 
Molecular Genetics, Netherlands Cancer Institute, Amsterdam, The Netherlands,2 Faculty of Biology, 
University of Konstanz, Germany and J Division of Membrane Physiology and Pharmacology, 
Department of Physiology, University of Leiden, The Netherlands. 
Myotonic dystrophy (DM) is caused by the expansion of a (CTG)n repeat located in the 
3' UTR of the DM-protein kinase (DM-PK) gene. How the expansion exerts its detrimental 
effect is unresolved. To study the influence of altered gene expression levels, mice with a 
targeted deletion of the first seven exons in the DM-PK gene were generated. In both the 
heterozygous and the homozygous null mutant mice no overt phenotypical abnormalities 
could be observed, except for mild and variable pathology in the head and neck muscles at 
advanced age. Also, several mice lines with graded levels of over-expression of a normal 
human DM-PK transgene were created. Mice with the highest DM-PK expression show 
hypertrophic cardiomyopathy, enhanced neonatal mortality, and breeding problems, but 
no clear involvement of skeletal muscle. The cardiac myopathy in these transgenic animals 
matches the pathology seen in many advanced-stage DM patients and may provide a useful 
model for study of progressive heart disease. As non of our mutant mouse models exhibits 
the complex spectrum of clinical features seen in DM patients our results strengthen the 
contention that DM may not be a simple loss or gain of function effect. 
The clinical manifestation of myotonic 
dystrophy (DM) is highly variable and may 
include myotonia followed by progressive 
weakness and wasting of muscle, cardiac 
conduction defects, smooth muscle involve-
ment, mental retardation, hypersomnia, ocular 
cataracts, testicular atrophy and endocrine 
disfunction (7). The phenotypic expression 
has been shown to be correlated to the expan-
sion of a (CTG)n trinucleotide repeat (2-4), 
with earlier age at onset and more severe 
disease manifestation in patients with increas-
ing repeat length (5). Although this correla-
tion is by no means absolute, the concept of 
"triplet dosage-dependent disease manifes-
tation" is undisputed. 
Amongst the eight now known dynamic 
trinucleotide repeat diseases, the expanding 
repeat in DM is unique in that it is located in 
the 3' UTR of the gene involved (DM-PK; 2-
4, 6). It is still an open question whether the 
expanded repeat influences the gene, its RNA 
or protein products, or the entire cellular 
context in which it is expressed (7). Unfor-
tunately, quantitative studies of DM-PK 
mRNA and protein levels in DM patient 
material have yielded contradictory results 
(refs. 8, 9 vs. 10) and did not yet add to our 
knowledge of the mechanisms involved. 
We report here on our efforts to clarify 
the influence of altered DM-PK expression 
levels on muscular functions in mouse mod-
els. First, we disrupted the coding potential 
of the DM-PK gene by the homologous re-
combination strategy outlined in Fig. 1A. For 
mutagenesis in embryonic stem (ES E14) 
cells, a vector was used in which the first 
seven exons of the DM-PK gene were re-
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Fig. 1. Gene targeting of the 
mouse DM-PK gene in ES 
cells. (A) Genomic structure 
of the mouse DM-PK (black 
boxes) and DMR-N9 (open 
boxes) genes, structure of the 
pDMHyTK targeting vector 
(11), and predicted structure 
of the targeted DM-PK allele. 
Exons are represented as open 
(DMR-N9) от black (DM-PK) 
boxes and numbered, ATG 
indicates translation initiation 
site. The location of the 5' 
probe, a 1.5 kbp HindHl-
Barriñl fragment, and 3' 
probe, a 1.2 kbp ЯнкШІ-
BarriRl fragment, is shown. 
The expected sizes of genomic 
ВатШ and НіпаШ fragments 
that hybridize with the 5' 
probe are: A constant ВатШ 
4.0 kbp fragment and HindlU 
bands of 5.5 and 9.0 kbp for 
the wild type and mutant 
alleles (one Hindlll site is de­
leted). Likewise, for the 3' probe we expect a constant НЫШ 13 kbp fragment and ВатШ bands of 4.5 
kbp and 6.5 kbp for wild type and mutant, respectively (one BamHl site is destroyed due to ligation to a 
Bglll terminus). The transcriptional orientation of the HSV-tk and HygroB genes is indicated with ar­
rows. (B) Southern blot analysis of genomic DNAs from three mutant and one WT control ES cell lines 
(11) after Hindu! or ВатШ digestion with the 5' probe, and analysis of mouse tail DNAs from WT, he­
terozygous and homozygous mutant mice (12) after ВатШ digestion, with the 3' probe. Fragment sizes 
are indicated. (C) Northern blot analysis of heart, skeletal muscle and brain RNA (10 μg), isolated from 
a wild type (+/+), heterozygous (+/-) and homozygous (-/-) mutant mouse. The blot was probed with a 
mouse DM-PK and GAPDH probe (11). Abbreviations: WT, wild type; H, HindlU; B, ßamHI. 
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placed by a hygromycinB (hygroB) resistance 
cassette. Genuine targeting events were iden­
tified by Southern blot analysis (Fig. 1A, B; 
11) and occurred in a frequency of one in 
forty clones. Ultimately, six different targeted 
clones were microinjected into mouse strain 
C57BL/6 blastocysts, and highly chimaeric 
pups were derived (12). After mating chi­
maeric male mice with female C57BL/6 mice 
we scored transmission of the ES cell genome 
in two founders (A15 and A33). Offspring 
was tested for the mutation by the polymerase 
chain reaction (PCR) and confirmed by 
Southern blot analysis of tail DNA (Fig. IB; 
12), Fifty per cent of the agouti Fl offspring 
were heterozygous for the DM-PK null muta-
DM-PK 
GAPDH 
tion. Such mice were sibling-mated to homo­
zygosity and again a normal Mendelian distri­
bution was observed. 
To ascertain the silencing of DM-PK 
expression, total RNA was isolated from 
heart, skeletal muscle and brain (12). Nor­
thern blot analysis confirmed that the DM-PK 
mRNA level was lowered to approximately 
50% in heterozygous mice. Homozygous 
animals lacked DM-PK mRNA or any trun­
cated form completely (Fig. 1С). Strikingly, 
subsequent probing with other cDNA probes 
from the DM region revealed that the hygroB 
cassette insertion also partly affects polyade-
nylation or proper termination of the up­
stream DMR-N9 (or human 59; refs. 6, 13) 
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gene. This is presumably an effect of the 
dense organization in this area, for although 
the hygroB insertion is outside the DMR-N9 
transcription unit we noticed an increase in 
size (to " 4 kb) and decrease in level of 
normal DMR-N9 mRNA (= 2.5 kb) in brain 
which was most conspicuous in homozygous 
mutant animals (not shown). The effects of 
this unanticipated phenomenon are still under 
study. DM-PK expression was also assessed 
using different polyclonal antibodies to the 
DM-PK protein, anti-DM/pep2 (14), and RK-
DMK (15). On Western blots (16) (Fig. 3D) 
antisera RK-DMK and DM/pep2 did identify 
a 70 kDa protein in muscle extracts of the 
wild type mouse, which was absent in the 
knock out mutant. In addition, aspecific 
reactivity on various other proteins was seen 
with both antibodies. The 70 kDa protein, 
which is different from the 52 kDa human 
protein reported by us and various other 
groups (8, 14, 17, 18), was detected with all 
antisera in muscle extracts of the transgenic 
mouse overexpressing the human DM-PK 
gene (see below), but was only barely above 
the threshold for detection in wild type mouse 
extracts, when anti-DM/pep2 was used. 
Aspecific immunoreactivity is a consistent 
problem in DM-PK analyses and has already 
been described in detail for DM API (17). We 
should thus interpret anti-DM-PK findings 
with caution. Taken together, the absence of 
the relevant DNA segment and DM-PK spe­
cific gene products on Southern and Northern 
blots, and the correct absence/presence of the 
70 kDa protein in Western blot analysis pro­
vide convincing evidence that our mice are a 
faithful model for myotonic dystrophy gene 
deficiency. However, additional effects of 
aberrant DMR-N9 transcription cannot be 
excluded entirely. 
Neonatal or adult mortality amongst chi-
maeras or in the heterozygous and homozy­
gous breeding colonies did not differ signifi­
cantly from wild type mice, and since we 
have deficient mice over 40 weeks of age, the 
DM-PK mutation appears not to affect long-
term survival under laboratory conditions. 
Careful veterinarian inspection did not reveal 
Table 1. Percentage distribution of myosin heavy 
chain isoforms 
Muscle Condition Myosin Heavy Chain 
Isoform 
Sol eus 
Psoas 
EDL 
Gastrocnemius 
Diaphragm 
Tg Control 
Tg26 
KO Control 
DM-PK -/-
Tg Control 
Tg26 
KO Control 
DM-PK -/-
Tg Control 
Tg26 
KO Control 
DM-PK -/-
Tg Control 
Tg26 
KO Control 
DM-PK -/-
Tg Control 
Tg26 
KO Control 
DM-PK -/-
I 
% 
48 
50 
28 
28 
0 
0 
0 
0 
4 
4 
0 
0 
7 
6 
6 
8 
12 
13 
6 
9 
IIa 
% 
37 
30 
47 
41 
11 
10 
3 
3 
3 
3 
2 
0 
7 
5 
4 
5 
28 
29 
22 
24 
lid 
% 
11 
16 
17 
27 
21 
20 
14 
22 
30 
33 
27 
30 
11 
12 
10 
9 
56 
53 
60 
47 
ПЬ 
% 
0 
2 
7 
3 
68 
70 
83 
75 
63 
57 
71 
70 
75 
77 
80 
78 
4 
5 
12 
20 
Myosin heavy chain isoforms were separated from 
crude myosin extracts by gradient Polyacrylamide 
gel electrophoresis (20). The silver stained gels 
were evaluated densitometrically. The muscle of 
one transgenic (Tg 26) and one DM-PK deficient 
mouse (DM-PK -/-) and their respective controls 
(Tg control and КО control) were analyzed. 
any appreciable outward anatomical or be­
havioural abnormality. Also histological 
examination (19) of representative sections of 
brain, small and large intestines, stomach, 
lung, pancreas, kidney and uterus (not shown) 
revealed no overt pathology in mice that had 
lost one or both functional DM-PK alleles, 
except for minor variations in the size of 
cerebral ventricles (not shown), which should 
be studied further. 
In order to investigate the effect of DM-
PK deficiency on skeletal and heart muscle, 
where DM-PK is highly expressed (6, 14), 
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щ 
" φ" 
Fig. 2. Histo­
logical analy­
sis of neck 
muscles of 
wild type and 
DM-PK defic­
ient mice. One 
/ші semi-thin 
eppon embed­
ded sections of 
the cleidocep-
halic muscle 
stained with 
1 % toluidin 
blue are shown for a wild type (left) and a homozygous DM-PK deficient mouse (right), magnification 
25x. Uniform smaller fibres disperse large ones in wt muscle, whereas in DM-PK deficient muscle small 
fibres of varying diameter tend to cluster in between large fibres. Note the increase in mitochondria, 
indicated as white spots in the mutant muscle. 
wÊÊÊË 
we determined the myosin heavy chain 
(MHC) composition in skeletal muscle in 
soleus, psoas, extensor digitorum longus 
(EDL), gastrocnemius and diaphragm and in 
heart in atrium and ventricle, using gradient 
Polyacrylamide gel electrophoresis (20). 
Shifts in spectra of contractile isoproteins in 
muscle fibres are often indicative for regener-
ative processes or altered response to work-
load. However, as inferred from the detailed 
analysis of one mutant and one wild type 
mouse, the MHC composition was essentially 
similar in mutant and wild type mice (Table 
1; Fig. 5C). Also histological examination of 
representative sections of heart (Fig. 6A, В 
and C) and calf muscles (not shown) revealed 
no overt pathology. In contrast, in homozy­
gous mutant mice, above 25 weeks of age, in 
musculus sternothyroideus, sternocephalicus 
and cleidocephalicus the normal pattern of 
mixed large and small fibres was shifted in 
favour of clustered smaller-sized fibres of 
varying diameter, with the presence of dis­
tinct subsarcolemmal mitochondria (Fig. 2; 
see also ref. 21). 
Although the muscle pathology was mild 
and variable and could only be observed in a 
subset of muscles and to a low extent, we 
cannot completely exclude malfunction of 
other muscles, as the system might have been 
insufficiently challenged by the minute work­
load under normal laboratory housing con­
ditions, and longitudinal experiments have not 
yet been performed. Still, the data presented 
suggest that simple gene inactivation does not 
provide a faithful experimental context for 
further study into the etiology of DM. Thus, 
under the assumption that the function of 
DM-PK is similar in mouse and human, our 
data appear to discount the possibility that 
DM is caused by a simple reduction in the 
expression of the DM-PK gene. 
To determine the effects of overexpres-
sion, we decided to use conventional trans-
genesis. A 14 kbp Nhel genomic fragment 
that contains all DM-PK exons and the last 
exon of an upstream located gene (DMR-N9 
or 59 gene; 6, 13), was chosen as starting 
material (Fig. ЗА). As the entire intergenic 
upstream region and the intron-exon organiza­
tion were left intact, we anticipated all essen­
tial cis-acting regulatory promoter and enhan­
cer elements to be present in our construct. 
The human gene contained a normal (CTG)20 
repeat that served as identification tag in the 
screening of transgenic founders and their 
offspring with a human specific PCR assay 
(4). Upon pronuclear injection in FVB zy­
gotes and reimplantation into pseudopregnant 
FVB females (22) eleven founders were 
identified by PCR screening. Southern blot 
analysis with three widely spaced probes 
(Fig. ЗА, В) was used to estimate the trans-
gene copy number and confirm the intactness 
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Fig. 3. Overexpression of the A 
human DM-PK gene in trans­
genic mice. (A) Transgene 
construct, a 14 kbp genomic 
Mel fragment containing all 
15 DM-PK exons (black 
boxes) and the last DMR-N9 
or gene 59 exon (6, 13) (gray 
box). The exons are numbered 
and the transcriptional orien- β 
tation is indicated with arrows. 
The construct contains a 
(CTGJa, repeat (open box). 
Poly adeny lat ion and ATG-  6 ШЩт ЩШ ~-«ЧЦ 
translation initiation sites and 
the location of the three hybri­
dization probes (Α-C) are j ) 
indicated (22). (B) Southern 
blot analysis of ВатШ diges­
ted tail DNAs of eleven 
founders and a wild type (WT) 
mouse probed with probe B. 
The size of the hybridizing 
ВатШ fragment is indicated 
on the left. Results were con­
firmed with probes Α-C on 
blots with BamUl, Hindlll and 
EcdRI digests (22). Founders #15, #22, #23, #26, #32 and #48 were found to contain approximately 20, 
20, 10, 25, 15 and 2 copies of the complete transgene, respectively. (C) Northern analysis of skeletal 
muscle and heart RNA isolated from Tg 26, 15, 22, 32, 23 and wild type (WT) mice. The blot, contai­
ning approximately 10 μg RNA per lane was subsequently probed with a human specific DM-PK probe, 
a mouse specific DM-PK probe and a probe for GAPDH mRNA (22). (D) DM-PK protein in DM-PK 
mutant (-/-), overexpressor (Tg 26) and wild type (+/+ or WT) mice. Blots containing tissue homogen-
ates were incubated (16) with the anti-DM-PK antiserum RK-DMK (15). Indicated with an arrow is the 
70 kDa protein detected in the muscle samples of the overexpressor mouse, and to a lesser extent in the 
wild type mouse. Additional aspecific bands can be seen in all lanes. 
«t» 
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of the transgene insert. Ultimately six foun­
ders with approximately two (Tg 48), ten (Tg 
23), twenty (Tg 15, 22, 32) or twenty-five 
(Tg 26) tandemly (head-tail) integrated copies 
were selected for further study. 
All six founders showed transmission of 
the transgene to F l offspring. Northern blot 
analysis with human and mouse specific DM-
PK probes (22) showed expression of the 
human gene only in muscle and smooth 
muscle containing tissues, exactly matching 
the endogenous expression distribution (not 
shown; 6). Significant expression could only 
be demonstrated in the F l offspring of trans­
genic lines with twenty or more copies of the 
construct (Fig. 3C). Strikingly, the relative 
contribution of the transgene to the total DM-
PK mRNA expression was higher in heart in 
all transgenic lines. The highest expression 
was found in Tg 26, where the level of trans-
gene expression in leg muscle equalled ap­
proximately half the level of endogenous DM-
PK expression and resulted in a 2-3 fold 
augmented expression in heart (Fig. 3C). A 
similar variation in levels of tissue specific 
expression is seen when comparing DM-PK 
Northern blotting data in baboon (2) and 
mouse (6). Further study is necessary to 
resolve whether this can be attributed to 
differences in heart specific promoter-, enhan-
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Tg 2« Tgl5 
Fig. 4. Fate-genotype correlations of offspring in 
the Tg 26 and Tg 15 transgenic lines. Deceased 
pups of the Fl generation of Tg 26 and Tg 15 
were not gathered and genotyped, the genotype of 
viable and dead pups in the F2 generation is 
shown separately. The survival of transgenic pups 
before weaning in the Fl generation of Tg 26 and 
Tg 15 is significantly lower than expected (Stu­
dent's t test, Ρ < 0.001) and also higher neonatal 
mortality in the F2 of Tg 26 can be seen 
(P<0.01). The transgenic F2 of Tg 15 shows the 
same phenomenon, though less pronounced. Ab­
breviations: ND, not determined; WT, wild type; 
Tg, transgenic. 
cer- or silencer-elements in the DM-PK 
genes, or to differences in the nature or com­
position of trans-acting protein factors, be­
tween primates and mouse. Polyclonal an­
tibodies to the DM-PK protein identified a 70 
kDa protein in muscle extracts, which was 
significantly more abundant in the transgenic 
than in the wild type mouse muscle (Fig. 3D; 
16). The signal intensities suggest a higher 
overexpression of the DM-PK protein than 
expected, based on the Northern blot data. An 
explanation for this finding may be a higher 
affinity of the antisera for the human protein, 
although the anti-DM/pep2 epitope is conser­
ved between human and mouse (14), or an 
enhanced stability or translatability of the 
human DM-PK mRNA. Furthermore, the 
antisera allowed for the demonstration of a 
significant part of the protein to be present in 
intercalated discs (ICDs) in heart and neuro­
muscular and myotendinous junctions (NMJs 
and MTJs) in skeletal muscle (not shown, 
14). Although none of the antisera used is 
completely free of aspecific binding, as dis­
cussed above, we may conclude that DM-PK 
overexpression in these mice does not result 
in mis-localization of the protein. Taken 
together, our data support the assumption that 
the 14 kbp Nhel genomic fragment contains 
all elements necessary to regulate correct 
DM-PK expression and routing in our Tg 
animals. 
To further evaluate the model, offspring 
of Tg 48, with only 2 copies of the transgene, 
and Tg 15 (20 copies) were used to follow the 
stability of the (CTG^o repeat over 22 meiotic 
events. As anticipated from the human situa­
tion, where a "normal" (CTG)20 repeat is 
segregating stably, no instability could be 
demonstrated by PCR typing. Although not 
checked rigorously we assume this to be 
similar in all our transgenic lines. 
Tg lines 26, 15 and 32 with respectively 
high, intermediate and low transgene expres­
sion were used for further study. Throughout 
various generations of the Tg 32 line, a nor­
mal transgenic versus wild type ratio was 
observed. In contrast, upon breeding of the 
Tg 26 and Tg 15 males with wild type female 
mice a significant underrepresentation of 
viable transgenic pups was observed. Upon 
the determination of the genotype of F2 pups 
that died before weaning, we found a 
strikingly higher neonatal mortality among 
transgenic pups in these lines (Fig. 4). An­
other consistent problem was illness and death 
of Tg 26 and 15 female mice during pregnan­
cy and after delivery. Although no clear 
pathological features could be distinguished, 
we frequently observed a hunched posture, 
bristling hair and reduced food intake in these 
animals. At death, one of the Tg 15 females 
had a flaccid, gas-filled small intestine. This 
resembled somewhat the megacolon and 
intestinal pseudo-obstruction (1, 23) seen in 
DM patients. As Tg 26 and 15 females were 
scarce no animals were sacrificed for further 
anatomical-pathological examinations. Ad-
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Table 2. Electrophysiological characteristics of 
neuromuscular junctions of Tg 26 and wild type 
mice 
Tg 26 Wild type 
MEPP amplitude 1.00 ± 0.04 0.93 ± 0.03 
(mV) 
MEPP frequency 1.17 + 0.15 1.17+.0.17 
(s1) 
EPP amplitude 32 ± 1 . 0 31+0.9 
(mV) 
Quantal content 51 ± 1.2 53 ± 2.1 
Measurements were done on diaphragms of three 
(two females and one male) Tg 26 and wild type 
mice each (25). Values are the grand mean +. 
S.E.M of the muscle means. Fifteen endplates 
were sampled per muscle. There were no statis­
tically significant differences between the means 
of the Tg 26 and wild type group. Abbreviations: 
MEPP, miniature endplate potential; EPP, end-
plate potential. 
ditionally, we never succeeded in generating 
mice with homozygous transgenes or trans-
gene combinations, i.e. higher DM-PK ex­
pression. Taken together, abundant presence 
of transgene products seems to predispose for 
prenatal or neonatal mortality in offspring and 
to induce abnormal physiological responses 
and reduced care in pregnant or lactating 
female animals. We do not know whether 
these problems are associated with malfunc­
tioning of smooth muscle containing organs. 
In overtly healthy Tg 26, 15 and 32 carriers 
no conspicuous histologic abnormalities were 
noticed in stomach, intestine or any of the 
other organs examined (including lung, liver, 
pancreas, testis, spleen, kidney and bladder) 
(19). Also no differences in small intestinal 
transit (24) of Tg 15 and wild type mice were 
found, suggesting normal peristalsis in the 
transgenic animals. Further study is necessary 
to reveal whether the problems are induced 
during periods of abnormal physiological 
stress, as reported for pregnancy as a possible 
predisposing factor for intestinal pseudo­
obstruction in DM patients (23). 
Next, a variety of assays were used to 
D I A Co DM++ Co DM-
G A S Co DM++ Co. DM-
шкш mm j ü gm тж 
мной ^ ^ В ^ШЕ^ ^ A f e а і ^ к . 
МНСІІЬ ЩЯШ ! • • ШШвШ ШвШ 
Fig. 5. Ultrastructural and biochemical analysis of 
various muscle types in transgenic and knock-out 
mice. Electron micrographs of extraocular muscle 
of (A) wild type and (B) Tg 26 mice (19). Pre-
and postsynaptic areas of the neuromuscular 
junctions demonstrated no distinct differences 
between wild type and transgenic mice. Asterisk: 
myelin whorls (effect of glutaraldehyde immer­
sion-fixation). Bar: 20 μπι. (С) Myosin Heavy 
Chain composition in diaphragm (DIA) and gas­
trocnemius (GAS) from FVB control (Co.) and 
DM-PK Tg 26 overexpressor (DM++) and 
C57BL6 χ 129/Sv wild type control (Co.) and 
DM-PK deficient mice (DM-). 
examine striated muscle function in these 
mice. Muscle action potentials were recorded 
in vitro with a glass micro-electrode in dia­
phragms of three Tg 26 mice and age 
matched wild type mice (25). No statistically 
significant differences were found in action 
potential characteristics nor in the resting 
membrane potential of muscle fibres. Further-
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servable in the cardiac tissues of other mice held under identical housing conditions. Bar: 100 μπι. 
more, no spontaneous or repetitive discharges shown) was apparently normal in Tg 26 and 
were observed in the muscles of the trans- Tg 15 mice. The differences between the 
genie animals. Also, electromyography of the MHC-isoform distributions of transgenic and 
gastrocnemius muscle of Tg 26 mice revealed DM-PK deficient mice reflect the differences 
no myotonic runs (not shown; 25). As DM- between the two mouse strains (FVB and 129 
PK in skeletal muscle is abundantly present at χ C57BL/6 respectively). Furthermore, care-
the post-synaptic side of NMJs (14), it was of fui ultrastructural inspection of the neuromus-
interest to study the electrophysiological cular junctions of extraocular muscle, a high-
properties of endplates from Tg 26 and wild ly innervated muscle frequently affected in 
type mice (25). No statistically significant DM-patients (1), of a Tg 26 mouse revealed 
differences were found in the characteristics no abnormal features in the transgenic ani-
of endplate potentials and miniature endplate mals (Fig. 5A, B). From these data it appears 
potentials. Also, the number of acetylcholine that the presence of the DM-PK transgene 
quanta released per impulse from the nerve does not noticeably affect slow, fast or highly 
ending (quantal content) was the same in Tg innervated muscle fibres. 
26 and wild type mice (Table 2). In addition, Surprisingly, upon examination of heart 
the MHC composition of the soleus, psoas, muscle a conspicuous transgene induced 
EDL, gastrocnemius and diaphragm (Fig. 5C; myopathy was seen in three different Tg 26 
Table 1; 20) and the histological appearance F2 mice, 7, 9 or 21 weeks of age (compare 
of representative areas of calf, psoas, dia- Fig. 6A and 6F), and, less severe, in four age 
phragm, masseter and tongue muscles (not matched Tg 15 mice, 9 or 21 weeks old (Fig. 
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6A and 6E). In the myocard of a Tg 32 
mouse (21 weeks old) occasionally some mild 
signs of cardiac myopathy, hardly different 
from spurious phenomena in wild type, were 
encountered (Fig. 6A and 6D). In the Tg 26 
and Tg 15 mice, of all ages, whorling dis-
turbed the regular appearance of the myocard. 
We found distinct patches of altered fibres 
with or without sarcoplasmic vacuolization, 
and clearly undergoing degenerative changes. 
In these affected areas the interstitium ex-
hibited increased collagen, encompassing 
clusters of small fibres with bizarre vesicular 
nuclei. The general histological appearance of 
the hearts in our transgenic mice was reminis-
cent to the situation in the hypertrophic 
human myocard (26). In the hearts of our 
mice we did not observe significant changes 
due to fatty infiltrations or fibrosis in the 
conductive system, nor could conspicuous 
changes in the distribution of a- and ß-cardiac 
МНС isoforms be detected (not shown; 20), 
but further detailed, longitudinal, examina­
tions are warranted. 
Basically, there is a clear correlation 
between pathological severeness and trans-
gene expression in our mouse lines. As Tg 
26, Tg 15 and Tg 32 have independent ge­
nomic integration sites, we consider it highly 
unlikely that the cardiomyopathy is the result 
of repeated insertion mutagenesis of heart 
specific genes. To further exclude trivial 
effects the mice were checked for the pres­
ence of Coxsackie В virus, as this virus can 
cause cardiac myopathy (27). No infection 
could be detected. 
The pathogenic manifestation in our Tg 
26/Tg 15 mouse model shares certain features 
with the multisystem appearance of DM in 
patients. Overexpression of the DM-PK gene 
results in enhanced prenatal and neonatal 
mortality, illness during pregnancy and, most 
consistently, the conspicuous cardiomyopathy. 
At this point we do not know whether these 
effects are progressive and can be attributed 
to either simple augmentation of DM-PK 
protein levels or to ectopic expression of 
human DM-PK protein isoforms. Most con­
vincing support for Tg 26/Tg 15 as a useful 
model comes from the scarce histological data 
on hearts of DM patients. Heart tissues of 
deceased patients show heterogeneous re­
placement of myocardium and conductive 
system by fatty infiltration and fibrosis (28). 
Indeed, the majority of adults affected with 
the disease develop ECG abnormalities, ar-
rythmias, mitral valve prolapse or congestive 
heart failure and sudden death is not an un­
common manifestation of DM (29). 
In contrast to the situation in our mouse 
model, cardiac involvement in DM patients 
usually coincides with myotonia or myopathy 
in skeletal muscle. Two observations may 
explain why we do not see this association in 
our mice. Firstly, mouse muscle is generally 
less vulnerable and less prone to develop 
atrophic lesions than human muscle due to a 
very high regenerative capacity and a reduced 
workload as a consequence of small body 
size. Differences in muscle pathology be­
tween mdx mice and Duchenne patients are 
most illustrative in this respect (30). Second­
ly, manifestation of myopathy may require 
the crossing of a threshold level in DM-PK 
mRNA and protein and the proportion of 
overexpression is significantly less in skeletal 
muscle than in heart, when compared to the 
endogenous levels of DM-PK mRNA in these 
tissues (Fig. 3C). Unfortunately, due to prob­
lems with both mothers and siblings we were 
not able to breed mice with higher expression 
in skeletal muscle. Perhaps only the use of 
DM-PK transgenes from other species (inclu­
ding mouse) or the differential use of skeletal 
muscle-specific promoter/enhancer elements 
will shed further light on this issue. 
We conclude that the Tg 26 and Tg 15 
mice offer us a valuable new model to follow 
the development of cardiac myopathy. They 
also form an easily accessible model for 
studies of alternative RNA splicing and ex­
pression of human and mouse DM-PK iso­
forms in distinct cell types. Although the 
clinical effects of CTG-repeat expansion in 
DM patients appear to be partly mimicked in 
our overexpressor mice, this model is incom­
plete and does not show us which of the many 
possible pathways for DM-PK overexpression 
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(e.g. CTG-repeat induced chromatin distor­
tion or mRNA stability effects, reviewed in 
ref. 7) is involved. Moreover, the only very 
minor effects of DM-PK deficiency (as also 
found by S. Reddy and D. Housman at MIT 
(21)) supports the assertion that myotonic 
dystrophy is not caused by the mere gain or 
loss of DM-PK expression. Perhaps even 
more useful for future fundamental studies 
and for the development of therapeutic moda­
lities would be mice with expanding CTG-
repeat mutations. Construction of such mutant 
mice has become feasible by improvements in 
gene targeting strategies and fortunately, the 
entire chromosome segment around the DM 
locus is highly similar in man and mouse (6). 
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CHAPTER 
6 
Summary and epilogue 
Summary 
Myotonic dystrophy (DM) is an autosomal 
dominant disease affecting multiple systems, 
including voluntary muscle, heart, endocrine 
organs and mental function. As DM is the most 
frequent inherited muscular disorder among 
adults it poses a serious health problem. 
Because clues to the biochemical defect were 
lacking, positional cloning strategies were 
applied to identify the underlying genetic 
defect. 
The region on chromosome 19 to which the 
DM locus was assigned was cloned in a contig 
of overlapping cosmids and YACs (paragraphs 
2.1 and 2.2). From within this contig cDNA 
and genomic probes were isolated that 
identified an unstable DNA region occurring 
uniquely in DM patients. Further charac­
terization of this region revealed the element to 
consist of a (CTG)„ trinucleotide repeat which 
is polymorphic in normal individuals and has 
the tendency to expand in DM patients 
(paragraphs 2.3 and 3.1). The unstable repeat 
was found to be localized in the 3' UTR of a 
gene with significant homology to protein 
kinases. This gene, designated the DM-protein 
kinase (DM-PK) gene, was cloned and 
characterized from both man and mouse 
(paragraph 2.4) and encodes a mRNA of 
approximately 3.3 kbp which is predominantly 
expressed in skeletal, cardiac and smooth 
muscle. The gene is organized in 15 exons, and 
contains various segments which are 
alternatively spliced. Computer analysis of the 
putative protein sequence predicts several 
distinct domains: 
1) A N-terminal leucine rich hydrophobic 
region of 40 amino acids which could function 
as a routing or aggregation signal. 
2) The actual catalytic domain with significant 
homology to the members of the subfamily of 
serine/threonine protein kinases. 
3) A short stretch of five amino acids, encoding 
a putative glycoseaminoglycan attachment site, 
whose presence is regulated by alternative 
splicing. 
4) A putative short hinge segment. 
5) A domain with an amino acid arrangement 
as found in α-helical coiled-coil structures. 
6) Three different C-terminal ends of the DM-
PK protein may exist, depending on alternative 
splicing of the region spanning the last three 
exons. Translation may stop directly after the 
coil domain, or extend into a hydrophobic or 
non-hydrophobic tail. 
Thus far, no experimental evidence has been 
generated as to the function of these different 
protein domains, except for the kinase domain. 
With the cloning of the DM locus also 
another gene was isolated, the DMR-N9 gene 
(paragraphs 2.2 and 2.5), located approximately 
1 kbp upstream of the DM-PK gene. The 
DMR-N9 gene comprises 5 exons and encodes 
a protein of 650 amino acids. Significant 
homology was found between two regions of 
the protein and WD-repeats, highly conserved 
amino acid sequences found in several distinct 
proteins with a regulatory function. Low level 
expression is found ubiquitously, localized 
higher expression was detected in brain and 
testis. 
Expansion of the (CTG)D trinucleotide 
repeat in the DM-PK gene is correlated to the 
severity and age at onset of DM (paragraph 
3.1). Although the correlation between disease 
severity and repeat length is not absolute, it 
does explain, in combination with the 
intergenerational repeat expansion, the 
phenomenon of anticipation, i.e. the increased 
severity and earlier age at onset of DM in 
subsequent generations. Generally, instability of 
the locus results in lengthening of the repeat in 
the majority of the patients. However, also 
reductions in repeat size upon intergenerational 
transmission have been described, and may 
even result in reversal of an expanded allele to 
a normal CTG repeat size (paragraph 3.2). 
In order to lift a comer of the veil around 
the actual mutational mechanism involved in the 
dynamic behaviour of the CTG repeat, the 
repeat length was determined in several tissues 
of DM patients and the expansion in blood and 
sperm of fathers was compared to that in their 
children's blood (paragraph 3.3). Specific 
features of the somatic heterogeneity of the 
repeat and the absence of CTG alleles with the 
child's repeat length in the father's sperm 
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indicateci that expansion occurs most likely 
during mitotic cell divisions, early in 
embryogenesis. Characterization of the repeat 
length in sperm of DM patients with large 
repeats (more than 800 CTGs) enabled us to 
demonstrate that repeats with more than 1000 
CTGs do not occur in sperm, presumably due 
to selection against large repeats during 
spermatogenesis. In combination with enhanced 
instability of small repeats upon paternal 
transmission, these sex differences in repeat 
transmission may explain the overrepresentation 
of non-manifesting males in the first generation 
before the disease phenotype can be recognized, 
and the restriction (apart from three recent 
exceptions) of congenital cases to maternal 
transmission. Thus, the typical progressiveness 
in the clinical manifestation of DM can most 
probably be attributed solely to the unstable 
behaviour of the CTG repeat. In agreement 
with this hypothesis, we showed that imprinting 
is not involved in the expression of the DM-PK 
gene in both man and mouse (paragraph 4.1). 
Next, as a prerequisite to the study of the 
function of the DM-PK protein we had to 
establish a more complete picture of its tissue 
distribution. Using immunolocalization tech-
niques in a comparison of the situation in man 
and mouse tissues we found DM-PK expression 
in smooth, skeletal and cardiac muscle at sites 
of cell-cell contact (paragraph 4.2): neuromus-
cular and myotendinous junctions in skeletal 
muscle, intercalated discs in heart and dense 
plaques in smooth muscle. These findings 
indicate a function of the DM-PK protein in 
assembly of the signal transduction complexes, 
or in the excitation signalling process itself. 
Finally, in order to investigate the 
molecular mechanisms involved in the 
dominant, repeat length dependent effects of 
CTG expansion we developed mouse models 
with under- and overexpression of the DM-PK 
gene product(s) (paragraph 5.1). The DM-PK 
deficient mouse model, in which the DM-PK 
gene was inactivated using the "knock out" 
technology in embryonic stem cells, showed no 
overt phenotype. The only anatomical-
pathological features that were observed 
involved fluctuations in the size of the cerebral 
ventricles, and, upon ageing, a mild and 
variable skeletal myopathy in the muscles from 
the neck and head region. Thus far, the 
heterozygous DM-mutants were found 
completely normal. If we may extrapolate the 
situation from mouse to man, this indicates that 
in patients DM disease manifestation is not 
simply caused by the silencing of the mutated 
DM-PK allele. 
In contrast, transgenic overexpressor mice 
which harbour multiple additional human DM-
PK copies do show a more distinct abnormal 
phenotype. Two different transgenic mouse 
lines showed cardiomyopathy, together with 
enhanced neonatal mortality and breeding 
problems, but no skeletal pathology. The 
absence of malfunction of skeletal muscle might 
be explained by the significantly lower 
overexpression of human DM-PK protein in 
skeletal muscle compared to heart in our 
transgenic animals. Alternatively, our findings 
can be explained by the fact that, generally, 
mouse muscle is less vulnerable and less prone 
to develop atrophic lesions than human muscle. 
Although our findings in the mouse models 
indicate that certain DM features may be 
evoked by overexpression of the DM-PK gene, 
we should interpret these findings with caution 
as modulation of kinase activity in muscle cells 
could also lead to fortuitous effects that merely 
mimic, rather than faithfully reflect, the 
manifestation of DM. I can be more firm in my 
conclusions if I consider both models 
combined. If we compare man and mouse, the 
data strongly suggest that the complex 
manifestation of DM is not due to simple loss 
or gain of DM-PK expression. Therefore, 
cellular and animal models other than described 
in this thesis should be tested prior to using our 
knowledge as a starting basis for the 
development of therapeutic modalities. 
Epilogue 
After the completion of the work described 
in this thesis several questions remain. Because 
the models provided by our mutant mice are 
obviously too simplistic, we perhaps should 
accept the possibility that CTG-expansion has 
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Figure 1. Hypothetical correlation between DM-phenotype, DM-PK expression and CTG repeat length. 
Repeat expansion (X-axis) is plotted against DM-PK mRNA level (Y-axis). The net effect of CTG-expansion 
per cell, which varies due to somatic heterogeneity of the repeat length, is indicated with a (+), for DM-PK 
overexpression, or a (-), for the negative effect of large repeats on cellular functions. Expansion of the repeat 
over 35-40 CTGs results in mRNA stabilization (+). With repeat expansion gradually more cells become 
involved in the DM phenotype. Lengthening over 300 CTGs counterbalances these effects and gives a decay 
in DM-PK mRNA level due to influences on chromatin topology and transcriptional activity, mRNA 
transport or general housekeeping functions of the entire cell (-). Thus, the steady state DM-PK mRNA level 
(expressed as the number of mRNA molecules per milligram of tissue or milligram of total RNA) is 
dependent on a delicate balance between negative and positive influences. In the last phase, upon extreme 
expansion above 1000 triplets also other genes, as DMR-N9, become involved (shaded area). 
graded effects, with differential influences on moderate lengthening of the repeat stabilizes 
the genes that are clustered around the DM 
locus. These influences could involve chromatin 
effects and effects on mRNA stability and be 
cell type dependent. We should even leave open 
the possibility that very large CTG-expansions 
do not only affect one or a few genes, but have 
a detrimental effect on the functioning of the 
cell as a whole. In this complex picture both 
synergistic and antagonistic molecular pathways 
could be involved. These concepts and 
questions cannot be resolved without further 
study. As a final contribution, therefore, I 
would like to propose a purely speculative 
working hypothesis (Fig. 1) which predicts 
three distinct phases in the development of the 
disease that should be analyzed further. 
Firstly, the hypothesis assumes that slight or 
the DM-PK mRNA. This overexpression 
induces muscular malfunction (myotonia, 
atrophy and dystrophy of skeletal muscle, 
smooth and cardiac muscle malfunction) in 
patients with repeats over 80 CTGs (H.G. 
Brunner, personal communication). Perhaps, 
the most subtle effects are seen in cases with 
cataract, where the level of overexpression has 
not yet reached the threshold for muscle 
pathology. The second parameter, that becomes 
involved upon further expansion of the repeat, 
involves a graded decrease in the level of 
expression of the DM-PK gene and/or the loss 
of activity of other cellular functions with a 
concomitant decay in DM-PK tissue level when 
the repeat has exceeded a certain critical length 
(approximately 300 CTGs). This interference 
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could act at the level of transcription, mRNA 
transport, or be due to titration of common 
RNA binding factors. As the repeat shows 
somatic heterogeneity, muscular tissues may 
contain a mixture of cells with enhanced or 
reduced DM-PK expression. With increasing 
CTG lengths the negative effects may gradually 
acquire dominance ([-] in Fig. 1). Finally, 
when the repeat reaches yet another threshold 
(approximately 1000 CTGs) also adjacent genes 
in the locus, such as DMR-N9, may become 
involved due to disturbance of the normal 
chromatin folding, replication timing effects or 
DNA fragility. In DM patients this may result 
in mental retardation, testicular atrophy and 
endocrine abnormalities. 
Obviously, it will be very difficult to test 
this hypothesis. The first clues will come from 
detailed longitudinal experiments of the DM-PK 
overexpressor and knock-out mouse models. 
Special attention should be on abnormalities in 
skeletal, cardiac and smooth muscle, or brain, 
retina and lens that develop progressively with 
ageing. Furthermore, special in situ methods 
for study of mRNA quality and quantity on a 
per cell basis in human and mouse tissues 
should be implemented. Finally, to obtain a 
more complete clinical picture (including male 
sterility, endocrine and behavioural aspects) 
future approaches should involve the 
development of additional mouse models. One 
model could involve deliberate overproduction 
of DM-PK in a more cell specific, spatially 
restricted manner, via the use of specific 
promoters. The ultimate model, of course, will 
be a mouse which harbours an unstable CTG 
repeat at the exact cognate position as found in 
DM patients, but with an otherwise unaltered 
chromosomal context. 

Samenvatting 
Myotone Dystrofie (DM) is een complexe, 
autosomaal dominante ziekte, waarbij vele 
verschillende organen en/of orgaansystemen 
aangedaan kunnen zijn. Naast cataract en 
afwijkingen aan skeletspier en het hart komen 
ook veelvuldig problemen met het spijsverte-
ringskanaal, endocriene organen en het men-
tale functioneren voor. Aangezien DM een 
frequent voorkomende ziekte is en er geen 
duidelijk biochemisch defect kon worden 
aangetoond in patiënten, werden moleculair 
genetische technieken aangewend om de 
oorzakelijke mutatie te vinden. 
Bij aanvang van het in dit proefschrift 
beschreven onderzoek, was de regio op chro-
mosoom 19q die het DM locus zou moeten 
bevatten ingeperkt tot ca. 1,5 χ IO6 basepa-
ren. Na een verdere reductie van de grootte 
van deze regio werd het gekloneerd (paragra­
fen 2.1 en 2.3) in cosmiden en YACs (Yeast 
Artificial Chromosomes). De speurtocht naar 
de DM mutatie werd vereenvoudigd door de 
identificatie van een instabiel genomisch 
fragment welke hybridiseerde met zowel 
cDNA als genomische probes (paragraaf 2.3 
en 3.1). Karakterisatie van dit instabiele 
fragment bracht een (CTG)
n
 trinucleotide 
repeat aan het licht. Deze repeat, gelokali­
seerd in de 3' ongetransleerde regio van een 
gen, is polymorf bij normale, niet aangedane, 
personen en zeer instabiel bij DM patiënten. 
Het betreffende gen, het DM-proteïne 
kinase (DM-PK) gen, werd vervolgens geka-
rakteriseerd voor de mens en de muis (para-
graaf 2.4). Bij beide organismen omvat het 
DM-PK gen 14 tot 15 kbp DNA en codeert 
het voor een mRNA van ongeveer 3,3 kb, 
afhankelijk van alternatieve splicing, en een 
eiwit van 60 tot 70 kDa. Met behulp van 
computer analyses kunnen verschillende 
domeinen in het DM-PK eiwit voorspeld 
worden. 
1) Een leucine-rijke, hydrofobe regio van 
ongeveer 40 aminozuren aan de N-terminus, 
waarschijnlijk betrokken bij het transport van 
het eiwit of bij de aggregatie met andere 
eiwitten. 
2) Het katalyüsch domein, dat grote homolo-
gie vertoont met serine/threonine proteïne 
kinases. 
3) Een korte volgorde van vijf aminozuren 
die mogelijk fungeert als glycoseaminogly-
caan additie plaats. De aanwezigheid van dit 
domein in het eiwit wordt gereguleerd door 
middel van alternatieve splicing van het DM-
PK RNA. 
4) Een korte regio zonder aanwijsbare func-
tie. 
5) Een domein met waarschijnlijk een a-
helische structuur. 
6) Drie C-terminale einden, afhankelijk van 
alternatieve splicing van exonen 12 tot 15. De 
translatie van het eiwit kan direct na de a-
helische regio stoppen, of doorlopen in een al 
dan niet hydrofobe staart. 
Er zijn geen directe experimentele aanwijzin-
gen voor de functie van regio's 1, 3, 4, 5 en 
6, verwacht wordt dat ze een rol spelen bij de 
specifieke herkenning van partner-eiwitten en 
de lokalisatie van het DM-PK eiwit binnen de 
cel. 
De klonering van het DM locus resul-
teerde in de isolatie van nog een gen, ge-
naamd DMR-N9 (paragrafen 2.2 en 2.5). Dit 
gen ligt zeer dicht naast DM-PK, ca. 1 kbp 
stroomopwaarts en dus ongeveer 15 kbp 
verwijderd van de expanderende repeat. Het 
DMR-N9 gen omvat 5 exonen in zowel mens 
als muis en codeert voor een eiwit van 650 
aminozuren. Twee segmenten in het DMR-N9 
eiwit vertonen nomologie met zogeheten WD-
repeats, geconserveerde aminozuurvolgordes 
die voorkomen in verschillende eiwitten met 
sterk uiteenlopende regulatoire functies. An-
dere indicaties omtrent de functie van het 
DMR-N9 eiwit volgen uit studies waarbij een 
geringe expressie van het gen werd aange-
toond in vrijwel alle weefsels van de muis. 
Hoge expressie werd gevonden in brein en 
testis. Zowel de locatie van het DMR-N9 
gen, zeer dicht bij de instabiele repeat, als de 
expressie in weefsels die aangedaan zijn bij 
ernstige vormen van DM, maken dit een 
relevant gen dat zeker betrokken zal blijven 
bij verdere studies naar de oorzaak van DM. 
In opeenvolgende generaties DM patiënten 
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neemt veelal de ernst van de ziekte toe en 
openbaart de ziekte zich op jongere leeftijd 
(anticipatie). Dit fenomeen kan verklaard 
worden doordat een correlatie is aangetoond 
tussen de lengte van de CTG-repeat en de 
mate van openbaring van de ziekte. Tevens 
wordt normaliter een verlenging van de repeat 
van generatie op generatie gevonden (para-
graaf 3.1). In een klein percentage van de 
gevallen wordt bij overerving echter een 
afname in repeat lengte waargenomen. In 
enkele zeer zeldzame gevallen heeft dit geleid 
tot een terugval van de repeat tot een allei 
van normale lengte (paragraaf 3.2). 
Om inzicht te verkrijgen in het mecha-
nisme dat het dynamische gedrag van de CTG 
repeat veroorzaakt, werd door ons de lengte 
van de repeat bepaald in verschillende weef-
sels van DM patiënten. Tevens werd de ex-
pansie in het bloed en sperma van vaders ver-
geleken met die in het bloed van hun kinderen 
(paragraaf 3.3). Hierbij bleek dat de verlen-
ging van de repeat waarschijnlijk optreedt 
tijdens mitotische delingen gedurende de 
vroege embryogenese. Verder bleek bij bepa-
ling van de repeat lengte in het sperma van 
DM patiënten met meer dan 800 CTG's in 
het bloed DNA, dat repeats van meer dan 
1000 CTG's afwezig waren in het sperma, 
waarschijnlijk ten gevolge van een selectie 
tegen lange repeats gedurende de Spermatoge-
nese. Deze restrictie in paternale transmissie 
van de repeat verklaart, in combinatie met de 
verhoogde instabiliteit van korte repeats bij 
paternale overerving, de over-vertegenwoordi-
ging van vaders in de laatste generatie voor-
dat de ziekte zich openbaart en het feit dat de 
congenitale vorm van DM slechts wordt 
aangetroffen na maternale overerving (op 3 
recent ontdekte uitzonderingen na). De karak-
teristieke verergering in de klinische manifes-
tatie van DM kan dus waarschijnlijk volledig 
worden toegeschreven aan het instabiele 
gedrag van de CTG repeat. De vinding dat 
imprinting niet betrokken is bij de expressie 
van het DM gen in mens en muis (paragraaf 
4.1) sluit bij deze hypothese aan. 
Voordat studies naar de functie van het 
DM-PK gen konden starten, was kennis 
omtrent de precieze weefsel verdeling van het 
DM-PK eiwit noodzakelijk. Met behulp van 
immunolocalisatie technieken werd de expres-
sie van het DM-PK eiwit aangetoond in zowel 
mens als muis bij cel-cel contact plaatsen in 
spierweefsel (paragraaf 4.2): Neuromusculaire 
en myotendineuze overgangen in skeletspier, 
intercalair schijven in hart en dense plaques 
in glad spierweefsel. Deze vindingen wijzen 
op een functie van het DM-PK eiwit bij de 
samenstelling van signaal transductie comple-
xen, of in de processen betrokken bij de 
excitatie-contractie signaal doorgifte zelf. 
Om meer begrip te krijgen van de biolo-
gische rol van DM-PK werden muizen model-
len ontwikkeld, waarbij het DM-PK gen werd 
uitgeschakeld of juist overmatig tot expressie 
werd gebracht (paragraaf 5.1). Ook konden 
we hiermee meer inzicht verkrijgen in het 
effect van repeat expansie op een moleculair 
en celbiologisch niveau. De DM-PK deficiën-
te muizen werden verkregen door het gen te 
inactiveren met behulp van homologe recom-
binatie in embryonale stamcellen. Deze mui-
zen vertonen geen duidelijke fenotypische 
afwijkingen. De enige pathologie die werd 
aangetroffen bij homozygoot mutante muizen 
bestond uit variabele tekenen van myopathie 
in skelet spieren in de kop en nek regio van 
oudere dieren. Bij heterozygoot mutante 
dieren konden tot dusverre geen abnormalitei-
ten worden aangetoond. Wanneer we de 
situatie bij de muis mogen extrapoleren naar 
die bij de mens moeten we concluderen dat 
DM, zoals het zich openbaart bij patiënten, 
niet wordt veroorzaakt door een eenvoudige 
uitschakeling van het mutante DM-PK allei. 
In tegenstelling tot de DM-PK deficiënte 
muis, vertonen de transgene muizen die extra 
kopieën van het humane DM-PK gen tot ex-
pressie brengen, wel een duidelijk fenotype. 
Bij twee verschillende transgene lijnen werd 
cardiomyopathie aangetroffen, in combinatie 
met een toegenomen mortaliteit onder pas-
geboren pups, en problemen tijdens de zwan-
gerschap. Problemen met skeletspieren kon-
den echter niet worden aangetoond. Dit kan 
verklaard worden door de significant lagere 
expressie van het DM-PK transgen in skelet-
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spier in vergelijking met hart. Tevens is 
aangetoond dat humaan skeletspier veel ge-
voeliger is, en veel sneller atrofieert dan 
muizen spier. Bovendien werden de karak-
teristieke endocriene problemen en fertiliteits 
stoornissen niet gezien. Alhoewel onze resul-
taten erop wijzen dat sommige delen van het 
complexe DM fenotype veroorzaakt kunnen 
worden door overexpressie van het DM-PK 
gen, moeten we voorzichtig zijn bij het trek-
ken van conclusies. Het kan immers niet 
worden uitgesloten dat veranderingen in de 
activiteit van een proteïne kinase in spier 
cellen toevalligerwijs resulteert in afwijkingen 
die op DM lijken. 
Wanneer we de resultaten verkregen met 
beide muizen modellen combineren en ver-
gelijken met de situatie in DM patiënten kan 
de conclusie getrokken worden dat DM niet 
wordt veroorzaakt door een eenvoudige ver-
hoging of verlaging van DM-PK expressie. 
Voordat duidelijkheid kan worden verkregen 
omtrent de additionele factoren die het com-
plexe DM fenotype mede veroorzaken, dienen 
eerst andere modellen voor DM dan die 
beschreven in dit proefschrift, getest te wor-
den. 
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